|
|
·|û¡GCliff10135274 µoªí®É¶¡:2014/10/15 ¤W¤È 01:05:51
|
¥»ª©°w¹ï¯E¹©°ò¥»±°Q½×Àù¯gªvÀø¡B§K¬ÌÀøªk¡BÁ{§É¸ê°T¡F¯E¹©¦U¶µ²£«~¬ãµo¶i«×°lÂÜ°Q½×¡FÄvª§¹ï¤â°ÊºA»P¦U¤è¶i«×°lÂÜ¡C¦P®É¯Ç¤Jª©¡uOBI-822¡BOBI-833¥H¥~ªº²£«~¡vªº¤º®e¡C·q½Ð¦U¦ì¤j¤j´N¥H¤WijÃDªº°ò¥»±Ä~Äò´£¨Ñ´¼¼z¡C ¥un¨¥¤§¦³ª«¡A¥ß½×¦³¾Ú¡A¦hªÅ¬ÒÅwªï¡C ¥»ºô»{¬°©¹«áY¹J¨ìÃþ¦üªºª¬ªp¡A¥i¥H¥Ñ¸Ó¶}ª©¤§¥D¤H¨Ó§P©w¡A ¨Ò¦p¦¹ª©´N¥ÑCliff¤j¤j¨Ó§P©wµo¨¥¤º®e¬O§_²Å¦X¸Óª©¤º®e¡A Y¥D¤H»{©w¤£²Å¡A¦A¥Ñ¥»ºô¤©¥H§R°£¡A¦p¦ó¡HBYª©¥D
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/5/29 ¤U¤È 05:24:07²Ä 1720 ½g¦^À³
|
¯E¤Í½Ð¤Å²qÁ¼,ºÃ´b³£°Ý¤½¥q^^ www.obipharma.com/index.aspx?lang=chi&fn=news_content&no=74 ¹ï©ó¦³Ãö¸Ñª¼µ²ªGªº´£°Ý¡AÅwªï¤j®a§Q¥Î¯E¹©©xºô¡uÁpµ¸§ÚÌ¡v«H½c¯d¨¥¡A¤½¥q¾ã²z«á¡A·|ºÉ¤O©ó§Y±NÁ|¦æªº§ë¸ê¤H»¡©ú·|²Î¤@¦^µª¡AY¦³¥¼ºÉªÌ¡A¦A©óºô¯¸¦^ÂСF¬Û¦P´£°ÝªÌ¡A«h®¤¤£«½Æ¡A¨Ã½Ð¯d¤U¯u¹ê©m¦W»PÁpµ¸¤è¦¡¡CÁpµ¸§ÚÌ info@obipharma.com |
|
|
·|û¡Gmetrostar10141472 µoªí®É¶¡:2016/5/29 ¤U¤È 05:06:15²Ä 1719 ½g¦^À³
|
to Iriswu¤j ¯E¹©¸³¨Æªø±i©À·O¨Ãªí¥Ü¡A¥Ø«e¶i¦æ³]p¼Ú¬ü¤T´ÁÁ{§É¸ÕÅç¡A¥i±æ¦b¤@¦~¤º§¹¦¨¡C Ó¤Hı±o¬OÁ{§É¸ÕÅç,«D³]p! ¦b¥xÆWªº¤T´Á¤§©Ò¥H¨º»ò¤[,´Nn¬O±ÄÂùª¼³]p,¹ï°Ñ»PªÌ¨Ó»¡¨S¦³«O»Ù,«Ü¦MÀI,¤]¤£¤H¹D ©Ò¥H¦b¦¬®×ªº¶i«×¤W¬Û·íªººC,³oÂI¥i¥H±q¤§«e¼Æ¾Ú±oª¾! ¦ýY¦basco «á ±oª¾OBI822®ÄªG©ú½T, ¬Û«H¯f¤H³£·|¥D°Ê¨Ó¸ß°Ý,¨Ã°Ñ»P¹êÅç, ¦¬®×ªº³t«×µ´¹ï§Ö³t, §Y¨Ï¥[¤W¥ý¸Õ¥´¥|°wªº§K¬Ì¤ÏÀ³, ¾ãÓÀøµ{À³¦b´XӤ뤺§Y¥i§¹¦¨ ¬G¤@¦~¤º±q¶}©l¦¬®×¨ì§¹¦¨Á{§É¸ÕÅç¨Ã«D¤£¥i¯à |
|
|
·|û¡GIriswu10136250 µoªí®É¶¡:2016/5/29 ¤U¤È 04:07:41²Ä 1718 ½g¦^À³
|
Lu¤jn¬Ý²M·¡ªü,¬O³]p ¼Ú¬ü¤T´ÁÁ{§É¥i±æ¤@¦~¤º§¹¦¨, ¤£¬O±z»¡ªº....,®t«Ü¦hªº. |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/5/29 ¤U¤È 03:30:00²Ä 1717 ½g¦^À³
|
¦U¦ì¤j¤j¡G ¦pªG¯un°µÁ{§É¤T´Á¡A¥H¤U³o¥y¸Ü¬O¯uªº¶Ü¡H ¼Ú¬ü¤T´ÁÁ{§É¸ÕÅç¡A¯uªº¯à¦b¤@¦~¤º§¹¦¨¶Ü¡H ´CÅé³ø¾É¡G ¯E¹©¸³¨Æªø±i©À·O¨Ãªí¥Ü¡A¥Ø«e¶i¦æ³]p¼Ú¬ü¤T´ÁÁ{§É¸ÕÅç¡A¥i±æ¦b¤@¦~¤º§¹¦¨¡C www.cw.com.tw/article/article.action?id=5075526 |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/29 ¤U¤È 02:28:09²Ä 1716 ½g¦^À³
|
ÁÙ¯u¤j ¤Á½R¤@¤U¡A¨Ì½×¤åºKn¤º®eÀ³°£¥H¤U«üªº¬O§¹¦¨9°w¥H¥~¡A¨ä¥L¦U²Õ¤ñ¸û«üªºÀ³³£¬O¥H©Ò¦³¹êÅç²Õ¯f±w(¤£ºÞ¦³µL§¹¦¨9°w)¬°°ò·Ç ¥t¥~§¹¥þ¦P·N¡A50%¹êÅç²Õ¯f±w¹F¨ì²ÎpÅãµÛ¤ô·Ç¡A822ªº½Tȱo´Á«Ý ¥¼¨Ó¸g¥Ñ¹êÅç³]p¯Ç¤J©µ¿ð»P®û¼í¯f±w¡A¨º¨ã²Îp¤WÀø®Ä¯f±w¬Æ¦Ü>50% --------------------------------------------------------------------------------------------------- ¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨ 9 ¦¸OPTª`®gÀøµ{ªÌ¡A¨äPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057) |
|
|
·|û¡GÁÙ¯u10138289 µoªí®É¶¡:2016/5/29 ¤U¤È 02:11:59²Ä 1715 ½g¦^À³
|
999¤j, ¤p§Ì¬O¥~¦æ, ¦h¦~¨Ó¦bªO¤W"®û¼í", ÄmÁà¤@¤U ... ¤½§i¤¤ªº¹êÅç²Õ«o¥u¦³50%¦³Àø®Ä, ¹êÅç²Õ¬O³Ìªì¦¬®×¤H¼Æ232¤H-°h¥X¤H¼Æ=X (¹ê»Ú°Ñ»P¹êÅç¤H¼Æ) (X-¨Ó¤£¤Î¤ÏÀ³ PD-®û¼í²{¶H-§K¬ÌµL®ÄªÌ)/X= 50%, ´«¥y¸Ü»¡¥un¦³¥´§¹9°w80%¥H¤W³£¦³§K¬Ì¤ÏÀ³ ¦A±j½Õ¤@¦¸, ¨ÅÀù¥|´Á¬OÀù²ÓM¤w¸g²¾Âà¨ì¨ä¥L¾¹©x¤F, ¨Å©Ð³Î±¼¤FÂå¥Í»¡¤U¤@Ón³Î¨ä¥L³¡¦ì, n¦A¤@¦¸¤ÆÀø, ¨S¤H¨ü±o¤F§a ... ´Nºâ¥u¦³50%¦³Àø®Ä, ¤]¤w¸g¬O¯«¯ÅªºÃĤF ... ¥H¤WÆ[©À¦p¦³¿ù»~½Ð¾É¥¿ ... |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/29 ¤U¤È 02:02:43²Ä 1714 ½g¦^À³
|
999¤j ¤ï¶Õ!¦³³¡¤À¸ê®Æ»~´Ó¡A¬°§K»~¾É¡A×¥¿¦p¤U¤å ½×¤åºKnµ²½×¦p¤U¡G ²Õ1: 50%ªº¹êÅç²Õ±wªÌ(§ÜÅé®Ä»ù´¿¦bªvÀø´Á¶¡¤º¹F¨ì ≥ 1:160) VS ¹ï·Ó²Õ¥þÅé PFS¡AHR = 0.71 [95%CI 0.52-0.97]¡Ap= 0.029¡FOS¡AHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04 ²Õ2: ²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ VS µL§K¬Ì¤ÏÀ³±wªÌ PFS¡AHR = 0.52 [95%CI 0.37-0.71]¡Ap< 0.0001¡FOS¡AHR = 0.52 [95%CI 0.29-0.92]¡Ap= 0.025 ¥Ñ²Õ2µ²½×¥iª¾¡A¦]PFSªºPÈ·¥ºÝ¤p¡A¥Ñ²ÎpÆ[ÂI¥iµø¬°¦³·¥·¥±j¯PÃÒ¾ÚÃÒ©ú²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ¨äPFSÀø®ÄÀu©óµL§K¬Ì¤ÏÀ³ªÌ ¦b²Õ1¥iµo²{¥H¨ú50%ªº¹êÅç²Õ±wªÌ»P¥þÅé¹ï·Ó²Õ¤ñ¸û¡Aµ²ªG ´Á¤¤OSªºPÈ0.04¥u²¤¤p©ó0.05 ¯Î°|ªø¤Î±i¸³©Òz¦³²£¥Í§ÜÅé¦û¹êÅç²Õ80%¥H¤W¡A¦³²£¥Í§ÜÅé´N¦³®ÄÀø®Ä ³o¥y¸Ü«üªºÀ³´N¬O²Õ2ªº¤ñ¸û Y±N²Õ1ªº¤ñ¸û¥Ñ 50%ªº¹êÅç²Õ±wªÌ(§ÜÅé®Ä»ù´¿¦bªvÀø´Á¶¡¤º¹F¨ì ≥ 1:160) VS ¹ï·Ó²Õ¥þÅé §ï¬° ¦³²£¥Í§ÜÅé¶q¤§¥þÅé±wªÌ(¬ù¬O¯Î°|ªø©ÒºÙ80%¹êÅç²Õ¯f±w) VS ¹ï·Ó²Õ¥þÅé ®£©È¨ä²Îp±À½×µ²ªG±N¬OPÈ>0.05 ·Q·Q¡A´CÅé·|¦p¦ó³ø¾É? ±N·|¬O¡AP>0.05¡A822µL®Ä!!!! |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/5/29 ¤U¤È 12:34:17²Ä 1713 ½g¦^À³
|
µL¦W¤j ·PÁ¡A·PÁ¡C ÁÂÁ±zªºÃö¤ß»P«ü¾É¡C ®e¤p§ÌºCºC®ø¤Æ¡C |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/29 ¤U¤È 12:27:39²Ä 1712 ½g¦^À³
|
999¤j¤p§Ì¤æÁx²q´ú ½×¤åºKnµ²½×¦p¤U¡G ²Õ1: ¹êÅç²Õ§K¬Ì¤ÏÀ³¶q«e50% VS ¹ï·Ó²Õ¥þÅé PFS¡AHR = 0.71 [95%CI 0.52-0.97]¡Ap= 0.029¡FOS¡AHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04 ²Õ2: ²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ VS µL§K¬Ì¤ÏÀ³±wªÌ PFS¡AHR = 0.52 [95%CI 0.37-0.71]¡Ap< 0.0001¡FOS¡AHR = 0.52 [95%CI 0.29-0.92]¡Ap= 0.025 ¥Ñ²Õ2µ²½×¥iª¾¡A¦]PFSªºPÈ·¥ºÝ¤p¡A¥Ñ²ÎpÆ[ÂI¥iµø¬°¦³·¥·¥±j¯PÃÒ¾ÚÃÒ©ú²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ¨äSPFÀø®ÄÀu©óµL§K¬Ì¤ÏÀ³ªÌ ¦b²Õ1¥iµo²{¥H¨ú¹êÅç²Õ§K¬Ì¤ÏÀ³¶q«e50%±wªÌ»P¥þÅé¹ï·Ó²Õ¤ñ¸û¡Aµ²ªG ´Á¤¤OSªºPÈ0.04¥u²¤¤p©ó0.05 ¯Î°|ªø¤Î±i¸³©Òz¦³²£¥Í§ÜÅé¦û¹êÅç²Õ80%¥H¤W¡A¦³²£¥Í§ÜÅé´N¦³®ÄÀø®Ä ³o¥y¸Ü¥Î¦b²Õ2À³¸Ó¬O¦¨¥ßªº ¦ýY±N²Õ1ªº¤ñ¸û¥Ñ ²£¥Í§ÜÅé¶q«e50%°ª VS ¹ï·Ó²Õ¥þÅé §ï¬° ¦³²£¥Í§ÜÅé¶q¤§¥þÅé±wªÌ VS ¹ï·Ó²Õ¥þÅé ®£©È¨ä²Îp±À½×µ²ªG±N¬OPÈ>0.05 ·Q·Q¡A´CÅé·|¦p¦ó³ø¾É? ±N·|¬O¡AP>0.05¡A822µL®Ä!!!! |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/5/29 ¤W¤È 11:55:16²Ä 1711 ½g¦^À³
|
walker¤j¤j§A¦n, ¥ý±ßÂI§ä §Ú¬Ý¤F¶Â½ü§B¤j¤j´£¨Ñªº ¸ò§Ú¦L¶H¤¤ªº ¦n¹³¤£¤@¼Ë §A¦Aµ¥µ¥¨ä¥L¤j¤j ªº·N¨£ ¦A¬Ý¬Ý ¤£¦n·N«ä ©êºp |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/5/29 ¤W¤È 11:53:15²Ä 1710 ½g¦^À³
|
¥xÁÞ¤j«e½ú ¸Û¤ßªº·PÁ±zªø´Á¤£Â_ªº¬°¯E¤Íªº¥I¥X¡A¦³±zªº²LÅã©öÀ´ªº«ü¾É¡A¯uªº¬O«Ü¦h«D±M·~¯E¤Í¤§ºÖ¡C ÁÂÁ±zªº´¶´ç¡A¯¬ºÖ±z¡C ªüÀ±ªû¦ò¡C ¥xÁÞ¤j«e½ú ¥½¶i¤@ª½«ÜºÃ´b...¡H ¬°¦ó¯Î°|ªø¡A±i¸³¡A¶ÀÁ`¤@¦Aªº´£¤Î80%¥H¤W¥´822ªº±wªÌ¡A³£¦³§K¬Ì¤ÏÀ³¡A¦³§K¬Ì¤ÏÀ³´N·|¦³Àø®Ä¡C µM¦Ó¤½§i¤¤ªº¹êÅç²Õ«o¥u¦³50%¦³Àø®Ä¡H ³o®t²§¦b¨º¡H À³¸Ó¬O«ç»ò¸ÑŪ¡H «Ü§x´b... ¬O§_¯à³Ò½Ð±z«ü¾É¥½¶i¡AÁÂÁ±zÄ_¶Qªº®É¶¡¡C |
|
|
·|û¡Gwalker10141977 µoªí®É¶¡:2016/5/29 ¤W¤È 11:42:21²Ä 1709 ½g¦^À³
|
¤µ¦~ ASCO ¦n¹³¦³¬ÛÃö presentation, ©Ò¥H¤~·|·Q½Ð±Ð²³°ª¤â chen¤j: ÁÂÁÂ, §Ú¦A§ä§ä ¶Â½ü¤j: ÁÂÁ±zªº¸ÑÄÀ |
|
|
·|û¡G¶Â½ü§B10141808 µoªí®É¶¡:2016/5/29 ¤W¤È 11:16:47²Ä 1708 ½g¦^À³
|
nÁA¸Ñ CDK4/6 inhibitors ´Nn¥ýÁA¸Ñ cell cycle highscope.ch.ntu.edu.tw/wordpress/?p=981 ¬O«Ø¥ß¦bÀù²ÓM·|¤£Â_²ÓM¤Àµõªº«e´£¤U ¦ý¤HÅéÁÙ¬O¦³¨Ç²ÓM·|¤£Â_¶i¦æ ²ÓM¤Àµõ ©Ò¥HCDK 4/6 inhibitors ¥i¬°¬°Â·§©Àªº¤ÆÀøÃĪ« ¬JµM¬Oªº ·íµM°Æ§@¥Î ¤]¤£¤Ö 822¬O¹º®É¥NªºÀøªk ¦]¬°¹ïÀù²ÓM¦³°ª«×ªº±M¤@©Ê ©Ò¥H°Æ§@¥Î«Ü§C n¥´±Ñ822 Ãø³á ¤p§Ì¬Ýªk ¨Ñ°Ñ |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/5/29 ¤W¤È 11:14:06²Ä 1707 ½g¦^À³
|
Pfizer ¦³Ó¦L¶H¬O ®É¶¡¦³ÂI§Ñ¤F ¨º®É¦n¹³¬Oyk¥|Ó±¡¹Ò ¦³´£¨ì³o¬°¨Ò ¨º®É ¦Ñ¥v¤j¤j «áÄò ¤]¦³poÂI ¥H¤W |
|
|
·|û¡Gwalker10141977 µoªí®É¶¡:2016/5/29 ¤W¤È 11:03:45²Ä 1706 ½g¦^À³
|
¦³¤H¹ï Pfizer CDK 4/6 inhibitors ¦³¬ã¨s¶Ü? A newer battle seems to be shaping up in a different drug class, called the CDK 4/6 inhibitors, used to treat breast cancer. The CDK stands for cyclin-dependent kinase, an enzyme tied to cell division, encoded in genes CDK4 and CDK6. The inhibitors help stop the cancer cells from multiplying. |
|
|
·|û¡G¦p¤Û¼v10141583 µoªí®É¶¡:2016/5/28 ¤U¤È 11:18:37²Ä 1705 ½g¦^À³
|
¥xÁÞ¤j ¸Û¤ßªº·PÁ±z¬°¯E¤Íªº¥I¥X¡A¦³±z¬O¯E¤Í¤§ºÖ¡CÁÂÁ¡A ¯¬ºÖ±z¡A ªüÀ±ªû¦ò! |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2016/5/28 ¤U¤È 11:11:51²Ä 1704 ½g¦^À³
|
5619¤j¡A¤p¤p·N¨£¸É¥R¦p¤U¡G 1.»~§PPDÁÙ¦³¨âºØ±¡§Î A.µL½×§ÜÅé¶q°ª§C¡A¥un¥X²{·sªºlesion´X¥G´N·|§PPD¡A¦ý¹ï§K¬ÌÀøªk¤W¦Ó¨¥¥X²{·slesionµ´¹ï¤£µ¥©óPD B.¸~½F¯uªº¥ýÅܤj25%¦AÁY¤p(¤£¬O®û¼í)¡A³o¤]·|µo¥Í¦b§K¬ÌÀøªkªºªvÀø¹Lµ{ 2.³o´X¦~°ê»Ú¤W¹ï§K¬ÌÀøªk¯S©Ê¦³»á²`´x´¤¡A¦bÁ{§É¤W¦³´XÓ»P¹L¥h¤£¦Pªº·Qªk A.¦b¥¿¦¡½T©wPD¤§«e¡A¤£©y¤¤¤îªvÀø¡A©Ò¿×¥¿¦¡½T©wPD¥]¬Aªì§PPD¤§«á¦A³sÄò¥|¶gÆ[¹î°lÂÜ...... B.¥i¥H®e§ÔÁ{§É¤WªºPD¡A¨Ò¦p¥X²{·slesion C.«ù¤[ªºSD¬O¦³§K¬Ì·N¸qªº¡A¦]¬°§K¬Ì³t«×¤ñ¸ûºC¡A¦ý®É¶¡©Ôªø¡A§K¬Ì¤WªºSD¥i¯àÅܦ¨PR¡AYERVOY´¿¦³¼Æ¨ÒSDÅÜPR¡APRÅÜCR¡A¬Æ¦Ü¦³¤@¨Òªá¤F70Ó¤ë±qPRÅÜCR ¥H¤W¼ÆÂI¸g«·s³]pÁ{§É«á·í¥i°µ¥X§óº}«Gªº¤T´Á¼Æ¾Ú ¦¹¦¸°ª§ÜÅé¼Ë¥»¼Æ¤~10x¤H¡AY¦³10%ªº»~§P(°²©ÊPD)¹ï©óPȼvÅT«D±`¥iÆ[¡A³o³¡¤À¥i½Ð¯E§J¤j»P¤p©_¤j«üÂI 3.¦³¤H¦ª¾¹D¤F©µ¿ð»P®û¼í²{¶H¡A³o´N¬O§ë¸êªº¸ê°T¤£¹ïºÙªº°ÝÃD¡A¥i¯à¤Þµo¤º½u¥æ©ö©M¨rÆN ³oÂI§Ú¨Ã¤£¦P·N ¥H«e§ÚÁ|¤F¦hÓ§K¬ÌÃĪ«ªºPFSÁ{§É¼Æ¾Ú¡AÃÒ©ú§K¬ÌÃĪ«PFSªÈ³Âªá(©Î¹³Âr¥¬)ªº¯S©Ê¡A¦ýPFSªÈ³Âªá(©Î¹³Âr¥¬)¤£¥NªíPFSªºPȤ@©w¤£¹LÃö¡A¨Ò¦pKeytruda°w¹ï¡uYervoyªvÀø¥¢±Ñ¡vªºÁ{§É¡A¹êÅç²ÕPFS2.9Ó¤ë¡A¥u¤ñ¹ï·Ó²Õ¦h0.2Ó¤ë¡A³æ¬Ý¦h³o0.2Ó¤ëÀ³¸Ó¬Û·íÃhºÃÀø®Ä§a¡H¦ýPÈ«o¬O¤p©ó0.001¡A¹LÃö¡COpdivo°w¹ïÅ쪬«D¤p²ÓMªÍÀù¡AÀY2.8Ӥ몺PFSÄY«ªÈÄñ¦b¤@°_¡A¦Ó«á¹êÅç²Õ©¿µM¤j¹Úªì¿ô¡APFSÁöµM¶È¤ñ¹ï·Ó²Õ¦h¥X0.7Ó¤ë¡A¦ýPȤ]¬O¤p©ó0.001¡C©Ò¥H¡A¡u©µ¿ð»P®û¼í²{¶H¡v¤£¥NªíPȤ@©w¤£·|¹L¡A¥¿½T»¡ªk¬O¡A§K¬ÌÃĪ«ªÈ³Âªá(©ÎÂr¥¬)¯S©Ê¾ÉPÁ{§É¦bPFS«ü¼Ð¤W¥i¯à²¤Àu©ó¹ï·Ó²Õ¡A¤]¥i¯à²¤»¹©ó¹ï·Ó²Õ¡A¦ý¤£¥i¯à¦]¬°ªÈ³Âªáªº¯S©Ê¦Ó¹wª¾PFS«ü¼Ð¤@©w¤£¹LÃö¡A¹ê°È¤WFDA¤]¤£·|¦]¬°PFS»¹©ó¹ï·Ó²Õ¦Ó¤£µ¹ÃÄÃÒ ¤]´N¬O»¡¡A¤½¥q¨Æ«e¤£¥i¯à¹w¥ýª¾¹DPȤ£¹LÃö |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/28 ¤U¤È 11:11:18²Ä 1703 ½g¦^À³
|
¤Û¼v¤j¡APT¤j ¦³Ãö´£°Ý§Ú¤w·Ç³Æ«Ü¤[¤F¡A¥Ø«e¤w·Q¨ì10Ó°ÝÃD·Ç³Æ¨Óµo°Ý¡A§Æ±æ¤j®a¤]·Q¥H¨ÇÃöÁä°ÝÃD¨Ó¦@Á¸²±Á|¡C |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/5/28 ¤U¤È 11:02:15²Ä 1702 ½g¦^À³
|
¥xÁÞ¤j ¥ýemail´£°Ý§a! Åý¤½¥q¦³®É¶¡·Ç³Æ§¹¾ã¬¢·íªº¦^ÂÐ. www.obipharma.com/index.aspx?lang=chi&fn=news_content&no=74 ¹ï©ó¦³Ãö¸Ñª¼µ²ªGªº´£°Ý¡AÅwªï¤j®a§Q¥Î¯E¹©©xºô¡uÁpµ¸§ÚÌ¡v«H½c¯d¨¥¡A¤½¥q¾ã²z«á¡A·|ºÉ¤O©ó§Y±NÁ|¦æªº§ë¸ê¤H»¡©ú·|²Î¤@¦^µª¡AY¦³¥¼ºÉªÌ¡A¦A©óºô¯¸¦^ÂСF¬Û¦P´£°ÝªÌ¡A«h®¤¤£«½Æ¡A¨Ã½Ð¯d¤U¯u¹ê©m¦W»PÁpµ¸¤è¦¡¡CÁpµ¸§ÚÌ info@obipharma.com |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/28 ¤U¤È 10:29:49²Ä 1701 ½g¦^À³
|
¦bÀù¯g§K¬ÌÀøªkªº·s»â°ì¡A¯S§O¬OÁÞ¤À¤l·sÃÄ¡A¥xÆW¯E¹©¬ãµo¹Î¶¤»P¦U¦ì¤j¤j¤@¼Ë¦bºN¯Á¾Ç²ß¤¤¦¨ªø¡A«Ü©¯¹Bªº¯E¹©¤w§ä¨ì²³æ¦³®Äªº¤èªk¨Ó¿z¿ï¯f±w¡A³oÓ¿z¿ï¹Lµ{½T«O¥¼¨ÓÁ{§É¸ÕÅ禨¥\ªº·¥¤j¤Æ¡A¦¹®É¦¹¨è§ÚÌÀ³¸Ó¬Û«H¤½¥q¡C¥t¥~¦³Å¥¤G¤ëªk»¡·|¦³Ãö¥¼¨ÓÁ{§Éªº³]p ·|¦³¤@Ó¿z¿ïªº¹Lµ{¡AÁöµM²Ó¸`ÁÙ¥¼»¡©ú¡A§Ú¬Û«H¤½¥q¤w¦³©w¨£¡A¦pªGn°µ¥þ²y¤T´Áªº¸Ü¡A¦³¥i¯à¯à²£¥Í¨¬°÷¦³§ÜÅ骺¯f±w½s¤J¹êÅç²Õ¡AµLªk²£¥Í¨¬°÷§ÜÅ骺¯f±w·í¬°¹ï·Ó²Õ¡A¥t¥~¤]¦³¤@²Õ¥´¤ÆÀøÃĽs¬°¹ï·Ó²Õ¡A¦³¥i¯à·|¦³¨âÓ¹ï·Ó²Õ¡A¹êÅç²Õ¥´ªº¤ÆÀøÃÄ·|»P¹ï·Ó²Õ¤@¼Ë¡A¹êÅç³]p²Ó¸`¤»¤ë¤¤éªk»¡·|¦A°Ý°Ý¬Ý |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/28 ¤U¤È 09:48:35²Ä 1700 ½g¦^À³
|
²³¤j¤j ¹êÅç²Õ¥´§¹¤E°wªº¤ñ²vÀ³¸Ó¤£§C ¹ï·Ó²Õ¥´ªºÃĹw¦ôMPFS¬O6Ó¤ë¡A´Nºâ¦³¤Ö¼Æ¨ü¸Õ²£¥Í§ÜÅé¡A¨äMPFS¤]«ÜÃø¶W¶V9Ó¤ë¡A¤j®a³£ª¾¹D¤@ÓÁ{§É¸ÕÅ窺Àøµ{¬O9Ó¤ë¡A¦X²z±À´ú¹ï·Ó²Õªº¨ü¸Õ¤£¤Ó¥i¯à¥´§¹¤E°w¤~PD,°²³]¹ï·Ó²Õ¦³¤@¦¨¨ü¸Õ¶W¹L¤EÓ¤ë¤~PD,¦©°£dropout 19¤H ¡A¬ù¦³10¤H¥´§¹¤E°w¡A°²³]¹êÅç²Õdropout 18¤H¡A233-18=215¤H¡A¹êÅç²Õ¥´§¹¤E°wªº¤ñ²v¨ä¹ê¤£§C¡A168-10=158¤H¡A158/215=73% ¥H¤W¬OÓ¤H¬Ýªk¡A¶È¨Ñ°Ñ¦Ò¡C |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/5/28 ¤U¤È 09:14:29²Ä 1699 ½g¦^À³
|
½×¤åºKn¤w¤½§G¡ACliff¤j¡A¤p©_¤j¡A¤Ñ©R¤jµ¥½å¹F«e½ú³£¦³ºë´ïªº¤ÀªR¡C¦³¤@¨Çª©¤Í´£¨ì¸Û«H¡A¤p§Ì²L®¡A¦b¦¹»¡»¡¦Û¤v¹ï©ó¤½¥q¸Û«Hªº¬Ýªk¡A¦p¦³ÂÕ»~¡A·q½Ð«ü¥¿¡C¥ý»¡µ²½×¡A¤p§Ì»{¬°¤½¥qªº¸Û«H¬Oȱo«H¿àªº¡A¦ý¤½¥qªv²z»Ý§ïµ½¡C ¹êÅç²Õ»P¹ï·Ó²Õ¬Û¤ñ¡AµL´c¤Æ¦s¬¡´Á(PFS) (HR = 0.96 [95% CI 0.74-1.25]¡Ap= 0.77)¡AÁ`¦s¬¡´Á(OS)ªº´Á¤¤¤ÀªR(Interim OS) (HR = 0.79 [95% CI 0.51-1.22]¡Ap = 0.29)¡C ¨âÓ«ü¼Ð¬Ò¥¼¹F¨ì²ÎpÅãµÛ®t²§¡A©Mª©¤Íªº¹w´Á¦³¤ÑÄ[¤§§O¡A²ª½ÄêÀŤF¡C³o´N¨¬¥H¤Þµo¹ï¤½¥q¡§¸Û«H¡¨ªºÃhºÃ¡C¥u´N³oÓÄêÀŤFªº¼Æ¾Ú¡A¸Ñª¼¤£¤î¥¢±Ñ¡A¥[¤W¡§§Q¯q¿é°e¡¨¡§¤º½u¥æ©ö¡¨µ¥µ¥¡§¹ú®×¡¨¡A¤½¥q´X¥G¦¨¬°¶BÄF¶°¹Î¤F¡C ¦Ó¶È¶È¦³168 ¨Ò±wªÌ (48%) §¹¦¨ 9 ¦¸ª`®gÀøµ{¡]37 ©P¡A¶W¹L9Ӥ를PD¡^¡C«ö¤Ñ©R¤jªº¦ôºâ¡A³o118¨Ò±wªÌ¤¤¡A¹ï·Ó²Õ¬ù²ö¦û54¤H¡A¹êÅç²Õ¬ù²ö¦û114¤H¡A»PÀH¾÷¤À²Õ¸ÕÅç¤H¼Æªº2:1¤ñ¨Ò¬Û·í¡C³o¤]¬O·N·Q¤£¨ìªº¤jÅå©_¡A²´¯]³£´X¥G±¼¥X¨Ó¤F¡A¥u¬Ý³oÓÄêÀŤFªº¼Æ¾Ú¡A©Ò¿×ªºÀø®Ä¤S¥i»¡¬OJÄê¡C °²³]¹êÅç²Õªº°h¥X¤H¼Æ¨Ì¤ñ¨Ò¬°25¡A232-25-114=93¡A¦©°£°h¥XªÌ¦³°ª¹F93¤H¡]45%¡^¨S¦³§¹¦¨ 9 ¦¸ª`®gÀøµ{¡A¦Ó¬O¦b¦¹¤§«e´NLR PD¤F¡C¹êÅç²Õ¦³³o»ò°ª¤ñ¨Òªº±wªÌ¨S¦³§¹¦¨ 9 ¦¸ª`®gÀøµ{¡A³oÃÒ¹ê¤F¤½¥q¸Ñª¼ªk»¡·|©Ò´£ªº¨â¤j¥¼¹F¼Ðì¦]¡G©µ¿ð²£¥Í¨¬¶q§ÜÅé¡APD¥ýµo¥Í¡F¥H¤Î²£¥Í§ÜÅé®É¦³®û¼í²{¶H¡A»~§PPD¡C¦Ó©µ¿ð»P®û¼í©Ò¾ÉPªº¡§»~§P¡¨¤ñ²v·¥°ª¡C ¨º»ò¹ï¡§«ü¼Ð¬Ò¥¼¹F¨ì²ÎpÅãµÛ®t²§¡¨ªº¥¢±æ¤§¾l¡A«Ü¦h¤H¤ß¸Ì¦³¿ò¾Ñ»PºÃ´b¡C¤°»ò®ÉÔ¤½¥q¹îı¨ì©µ¿ð¤ÏÀ³»P°²©Ê®û¼íªº¡H2012¦~¡H2013¦~¡H¬Æ¦Ü§ó¦¡H¨º»ò¡A¹îı¤§«á¡A¬°¤°»ò¤£¯à¸É±Ï¡H¬°¤°»ò¤£¯àµ¹LRÂå®v¤@¨Ç§PŪªº¡§´£¥Ü¡¨¡H±i¸³¦b¸Ñª¼ªk»¡·|¸ÑÄÀ»¡¡A¸ÕÅ窺³W«h¤£¯à¤¤³~§ó§ï¡C¤p§Ì·Q¡A³o´N¬OÂùª¼Á{§É¸ÕÅ窺¡§¸Û«H¡¨ì«h¡A¦pªG¤½¥q¹HI¤F³oÓ¡§¸Û«H¡¨ì«h¡A«áªG·¥¬°ÄY«¡Aµø¬°§@¹ú¡A«áªG·¥¬°ÄY«¡C©Ò¥H±i¸³»¡¤F¡AµwµÛÀY¥Ö¤]n°µ¤U¥h¡C ±µµÛ¤Þµo¥t¤@Ó°ÝÃD¡A¨º´N¬OÁ`¦³¤H¦ª¾¹D¤F©µ¿ð»P®û¼í²{¶H¡C¦Ó¯f¤H©Mµ´¤j¦h¼ÆªºªÑªF§ë¸ê¤H¤£ª¾¹D¡Aª½¨ì¸Ñª¼¨º¤Ñ¡C³o´N¬O§ë¸êªº¸ê°T¤£¹ïºÙªº°ÝÃD¡A¥i¯à¤Þµo¤º½u¥æ©ö©M¨rÆN¡C¦Ó¤½¥q¦b³oÓ¡§¸Û«H¡¨ì«h¤U¡A¤£¯àÁ¿¡C¦ý¬O¤£Á¿¡A«o³Q«ü±±¬°¡§¤£¸Û«H¡¨¡C ÁÙ¦³¥t¤@Ó«ä¦Ò¡C¬JµM¤½¥q¯à½T»{©µ¿ð»P®û¼íªº¡§»~§P¡¨¡Aªí¥Ü¹êÅç²Õ³o¨Ç³Q»~§PPDªº±wªÌ¡A¦b«áÄòªº°l踪¶Eµø¤¤µo²{¤F¬Y¨Ç822ªºÃĮĩM¯f¨_ªºÅܤơC¨º»ò±µµÛ¬O¡§¸Û«H¡¨©M¡§¤H¹D¡¨ªºªÈ¸¯¡C¨ÌÂùª¼Á{§É¸ÕÅ窺¡§¸Û«H¡¨ì«h¡A¤£¤¹³\¦b§PŪPD«áÄ~Äò¥¼§¹¦¨ªºª`®gÀøµ{¡C³Q»~§PPD¡]´Xªñ»~§P¦º¦D¡^¡A¥u¯à»¡¬O¤Ñ·N¡I¦Ó¦b¸Ñª¼«á¡A¨ÌÂùª¼Á{§É¸ÕÅ窺¡§¸Û«H¡¨ì«h¡A¦Ü¤µ©|¤£¯à§iª¾¯f±w¬O¦b¨º¤@²Õ¡A§ó¤£¥i¯à§iª¾¬O³Q»~§PPD¡CÁ|¨Ò¡A¥´§¹5°w«á³Q»~§PPDªº¯f±w¡A·¥¥i¯à¦Ü¤µ©|¦s¬¡¡A¦ý¬O¨ÌÂùª¼Á{§É¸ÕÅ窺¡§¸Û«H¡¨ì«h¡A¤½¥q¤£¯à¥l¦^¯f±wÄ~Äò¬I¥´«á±ªº4°w¡C³oºØ±¡´º¡A°Z¤£¥s¤H®D¼N¡I ¤p§Ì«H¥ô¯Î±i¤¨¡A¸Û«H¤£¬O°ÝÃD¡C±i¸³©M°]°È¸g²zªº¥N¦æ½æªÑ§@·~¦³¹H¥¢¡A¨£·Lª¾µÛ¡A¤½¥qªv²zÅãµM¦³«Ý§ïµ½¡C¤½¥q¦¨¥ß13¦~¤F¡A¦ý¬O©|¥¼¦³¾P°âÀ禬¡A²q´ú¤@¨Ç¤è±¬Û·í©ó¬O¦b¤@¯ë¬ì§Þ¤½¥qªº¯ó³Ð´Á¡C¯ó³Ð´Áªº¤½¥qªv²z©Î³\¤£§¹³Æ¡A©Î¸û¬°«K©y¦æ¨Æ¡A¥u¬O¤@¯ë¶Ç²£©Î¬ì§Þ¤½¥q¡A¤£·|¦³³o»òªøªº¡§¯ó³Ð´Á¡¨¡C¤@¯ë¤½¥q¦b¯ó³Ð´Á¡AªÑ²¼¬Æ¦Ü¨S¦³¤½¶}µo¦æ¡C¸g¦¹±Ð°V¡A§Æ±æ¯E¹©ªº¤½¥qªv²z§Ö§Ö§ïµ½¡A¨B¤W¥¿³~¡C |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/28 ¤U¤È 07:33:11²Ä 1698 ½g¦^À³
|
Cliff¤j ¤Ó·P¿E ±zªº¤j¤OÀ°¦£ ³o¨Ç®Ñ³æ ¤p§Ì¦¬¤U ¦AºCºCÁʶR¬d¾\¤F ¬Û·í»{¦P±zªº·N¨£ ¥ý¬Ý´Á¥Z½×¤å ³Ì·s¸ê°T ¹J¨ì¤£À´ ¦A¬d®Ñ©Î¬Oºô¸ô À³¸Ó¬O¥Ø«e³Ì¦nªº¾Ç²ß¿ìªk n«ùªÑªø¤[(«ù¤[) «D±o¦p±z¤@¼Ëªø´Á®û¼íªü ·P®¦ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/28 ¤U¤È 12:21:35²Ä 1697 ½g¦^À³
|
¥H¤U°ê®a²Îp¸ê°T´£¨Ñ²³¤j¤j°Ñ¦Ò 1 40·³¥H¤U¤£§t40·³µo¥Í¼Æ1084/12102¡A µo¥Í²v¬ù9% 2 45·³¥H¤U¤£§t45·³µo¥Í¼Æ2364/12102µo¥Í²v¬ù19.5% 3 45·³-59·³µo¥Í¼Æ5876/12102µo¥Í²v48.5% ¡A³o¤Q¤¦~µo¥Í²vªñ¨ÅÀù¤@¥b 4 60·³¥H¤Wµo¥Í¼Æ3862/12102 µo¥Í²v31.8% 5 ª`·N°·ÀË¡A¶¼¹¹B°Ê¡A»·Â÷¶ì¤Æ¾¯¡AÀô¹Ò¶Pº¸»X¥H°§C·ÀI¡A¦³®a±Ú¥v¤k©ÊÀ³©w´Á°·ÀË¡A¾é¸Ñ¬ÛÃö¸ê°T¥HºûÅ@¦Û¤v°·±d |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/28 ¤W¤È 11:33:29²Ä 1696 ½g¦^À³
|
ÁÂÁÂCliff¥Sªº¥mÀ{»P«Øij §Ú¦A«×¤ÀªR¤¤µØ¥Á°ê102¦~¥xÆWÀù¯gµn°O¸ê®Æ®w¦³Ãö¨ÅÀù¦U¦~ÄÖ¼hµo¥Í¼Æ¡A¦~»´¤k©Ên¯S§Oª`·N¡A40·³¥H¤Uµoªí²v¤w¹F9% ¤£¬O¬ü°ê¤p©ó5%¡A¥xÆW¨ÅÀù¦³¦~»´¤ÆªºÁÍ¡A¦pªG²Îp45·³¥H¤Uµo¥Í²v¤w¹F19.5%¡A³o¬O102¦~²Îp¡A¦pªG¬O105¦~À³¸Ó¤w¶W¹L20%¡A¦~»´¤k©Ên¯S§Oª`·N°·ÀË |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/5/28 ¤W¤È 10:17:00²Ä 1695 ½g¦^À³
|
¦n¾Ç¤S«ù¤[ªº¯E§J¤j¡G ¦]¬°³¥©ñ¤w¤[¡A§Y¨Ï¬O·í¦~©Àªº®Ñ¡A«á¨Ó³»¦h§ó·s¦Ü2004¦~ª©¥»¡C¤£¹LÀ°±z°Ý¨ìÁÙ¦b·L§K¬ã¨s©Ò·í±Ð±Âªº¦P¾Ç¡A¥Ø«e§K¬Ì¾Çªº±Ð¬ì®Ñ¬O¡uJaneway¡¦s Immunobiology¡v³Ì·sªº²Ä9ª©©ó2016/03/22è¥Xª©¡A«p¹F928¶¡C¡]www.garlandscience.com/product/isbn/9780815345053 ¡^ ¥i¥H°Ñ¦Ò¨ä¥L¤¤¤å®Ñ¡G §K¬Ì¾Ç¡G¡]²Ä4ª©¡^·s¤å¨Ê¶}µo¥Xª©ªÑ¥÷¦³¤½¥q¡A Á`®Õ¾\:¤è¥@µØ¡A½sµÛ¡G¤ý¬F¥ú¡A§õ^¤¤ ¡K.µ¥¡C¥i¥H¥ýÂI¡u³¹¸`¥Ø¿ý¡v¬Ý¤@¬Ý¡A¤£ª¾¹D·|¤£·|¤Ó²L¡H¡]www.wun-ching.com.tw/book_detail.asp?seq=2195 ¡^ ¦pªGn§ä¡u¸~½F§K¬Ì¾Ç¡BÀù¯g§K¬Ì¾Ç©Î§K¬ÌªvÀø¦³Ãö®ÑÄy¡v³oÃþÃD¥Ø¸û·s¡A¤£¦pª½±µÅª´Á¥Z¤º®e¥i¯à¤ñ¸û²Å¦X»Ý¨D¡C¨Ò¦p¡uwww.nature.com/reviews/focus/tumourimmunology/index.html?WT.ec_id=SLBU_COMMS ¡v¡C ©Ó¤Ñ¥S¨º´X¥»¸òÁޤƾǦ³Ãö¤£§«°Ñ¦Ò¡C «Ü©êºp¡A¦ü¥GÀ°¤£¤W¬Æ»ò¦£¡A¦]¬°³£¬OŪ´Á¥Z¬°¥D¡A®Ñ¥»¤è±ÆZ¥Í²¨ªº¡A§Ú¤j¦h¬O¤@ÓGoogle¡A¤@Áû¸£³U¡A¶Ã§ä¶ÃÂI¶ÃŪ¡A¥[¤WPubmed¡A¶Ã½Ķ¶Ã¥´¦r¶Ã¶K¤å¡A¤Ñ°¨¦æªÅ¨S¬Æ»ò³¹ªk¡K¡K ¨ä¹ê±qºô¸ô¥i¥H§ì¨ì«Ü¦h¤ñ®Ñ¥»ÁÙ·s/ÁÙ¹ê¥Îªº¸ê®Æ¡A¨Ò¦p¡G ¡uÀù¯fªº§K¬Ìªv療¡X¹L¥h¡B²{¦b»P¥¼來¡v¡]www.tomotherapy.org.tw/12newsL_200905002.pdf ¡^ ¡u§K¬ÌªvÀø (Immunotherapy) ±MÃD¡v¡]investigatortw.wordpress.com/2014/02/10/%E5%85%8D%E7%96%AB%E6%B2%BB%E7%99%82-immunotherapy-%E5%B0%88%E9%A1%8C/ ¡^ ¡u§K¬Ì¾Çì²z¡v»¯¤j½Ã¡]www2.nsysu.edu.tw/Bio/images/commen/immu98.pdf ¡^ ¥H¤U³oÓ¬O§ódetailedªº¸ê®Æ¡A¤]¬O±qºô®ü¼´¨ìªº¡G ¡ugibms.cgu.edu.tw/files/15-1041-15343,c4430-1.php?Lang=zh-tw ¡v½Ð¤U¸üªþ¥ó¡C ÁÙ¦³¤@Ó¤èªk¡A«Øij½Ð²q·Q¦Ñ¤jÀ°¦£¡A¥Lªº¤½¤l¦b³Ì°ª¾Ç©²¡A¥i¥H´£¨Ñ¤ñ¸ûupdatedªº®Ñ³æ¡C ©êºp¤F¡A²´«eÀ°¤£¤W¤°»ò¦£¡A¤é«áY¬Ý¨ì¤ñ¸ûȱoŪªº®Ñ¤@©w·|§i¶D±z¡C T^T¤j¡G ³oùؤ£¬O¤@¨¥°ó¡A¤]¤£§Æ±æ¬O¤@¨¥°ó¡A§Ú·Q¯E¤ÍÅ@ªÑ¤ß¤Á¤£Ãø·Q¹³¡A¬Û«H/§Æ±æ¤j®a¹ï¨Æ¤£¹ï¤H¡AµL½×¦hªÅ¡A¥un¨¥¤§¦³ª«¡A¨¥¤§¦³²z¡Aµo¨¥®É§â¤Þ¥Îªº¥X³B¤@¨Ö¨q¥X¨Ó¡A§Y¨Ï§ì¨ìªº¸ê®Æ¤£¬O«ÜOK¡A¦Ü¤ÖÅý¤j®aª¾¹D¬O¸ê®Æ¨Ó·½ªº°ÝÃD¡A¦Ó«D¦Û¤vªº¬Ýªk¤£·í¡A´N¥i¥HÁקK³Q·í½b¹v¡C¹³èèµo¥Íªº¡u¡K¬ü°ê¨ÅÀùµo¥Í¦b40·³¥H¤Uªº¤ñ²v¤£¨ì5¢H¡A¦ý¥xÆW40·³¥H¤U¨ÅÀù©Ò¦ûªº¤ñ²v¤w¸g°ª¹F25.2¢H¡K¡v¡]www.twhealth.org.tw/index.php?option=com_zoo&task=item&item_id=187&Itemid=21 ¡^´N¬O¤@¨Ò¡A¸Ó°òª÷·|ªº³o¤@½g¤å³¹¦³¨Ç±Ôz¤Þ³ë¥¢¸q¡A¿ù»~¸ÑŪ¤F²Îpªíªº·N¸q¡A¥HP¥xÁÞ¥S»~½ò¦a¹p¡AY·í®Éª½±µ¶K¥X¥X³B¡A«K¥i¤@¥ØÁAµM¡C ¥t¥~¡A¤Þ¥ÎÂà¶K¥L¤H¤å³¹¡A°È¥²±NÂà¶Kªºì¤å¬q¸¨¥[¤W¡u¡v¡A¨Ãµù©ú¥X³B¡Aºô¸ô¬O¤½¶}»â°ì¡A²ö§Ñ¦Û«O¡A¾i¦¨¦n²ßºD¡A¦h¯Ó¤£¤F´X¬íÄÁªº¡C Pie¤j¡A·PÁ±zªº¤À¨É¡C |
|
|
·|û¡G¤t´P10142339 µoªí®É¶¡:2016/5/28 ¤W¤È 06:22:04²Ä 1694 ½g¦^À³
|
¤ä«ù¯E¹©¡A¥xÆW¤HªºÅº¶Æ |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/5/27 ¤U¤È 10:52:00²Ä 1693 ½g¦^À³
|
§Ú̥Χë¸ê©Ð¦a²£ªººë¯«¡A¨Ó§ë¸ê¯E¹©¡A©ê¥¦¤Q¦~¤£n½æ¡A ·sÃĤ@¦ý¦¨¥\¡AÀò§Q¼Æ¤Q¿¡I¼Æ¦Ê¿¡I 5¦~«á¡A¯E¹©EPS>500¤¸¡A¦~¦~»âªÑ§Q¡I¤j®a³£ÅÜ°]°È¦Û¥Ñ¤H¡I ¤]Åý7000±iªº¡uɨ÷½æ¥X¡v¡AµLªk¦^¸É¡I¿é¨ì²æ¿Ç¤l¡I«¢«¢«¢¡I ¤ý¤å¨}Á¿¯E¹©¡AÁ¿ªº«Ü¦n¡I¡I www.eftv.com.tw/video.php?agid=14 |
|
|
·|û¡G¦p¤Û¼v10141583 µoªí®É¶¡:2016/5/27 ¤U¤È 10:43:51²Ä 1692 ½g¦^À³
|
016.05.27 OBI-822¦bASCOµo¥¬¤§¸Ñª¼µ²ªG¡AÅwªï§ë¸ê¤H´£°Ý¡C ·q·Rªº¯E¹©§ë¸ê¤H: ¦Ü¸Û·PÁ¤j®aªº±¡¸q¬Û®¼¡I ³o°}¤l¥H¨Ó¡A±zÌ©Ò¤£§[µ¹¤©ªº¹ªÀy»P¼¢°Ý¡A¤£½×¹ïÓ¤H©Î¤½¥q¦Ó¨¥¡A³£¬O¥Ã»xÃø§Ñªº®¦±¡¡A¥Ñ©ó±z̪º¤ä«ù¡A¯E¹©¤~¯à«×¹L««Á}¨¯ªº¦ÒÅç¡C¨Ó¦Û¤j®aªº°ÝÔ¡A¤£½×¬O¨Ó¹q¡B¯d¨¥¡B²°T¡Bemail¡B¬Æ©Îªá§ô¡A§Ú̳£¯à±q³o¥÷¿@±¡«p½Ë¤¤¡A²`¨è·P¨ü¨ì°í©wªº«H¿à»P°Ut¡C«H¿à¡A¨Ó¦Û±M·~ªº¤F¸Ñ¡A°Ut¡A¬O°ò©ó¹ï¬ãµo±Ï¯f¸Ñµh·sÃĪº¦@¦P´Á«Ý¡G¤]¥¿¬O³o¼Ëªº´Á¬ß¡A®É®É´£¿ô¨Ã¤Þ»â§ÚÌ¡G¤£½×¹J¨ì¦h¤jªº®À§é¡A©l²×¤£§Ñªì¤ß¡A¨Ã±q¤¤§ä¨ì¾Ä°_ªº¤O¶q¡A«i´±¦V«e¦æ¡I ±q¤G¤ë¸Ñª¼¨ìASCO¡A§Ú̦@¦P¸g¾ú¤F³oº©ªøªºµ¥«Ý¡F¬°´£¨Ñ¥R¤À¡B³z©úªº¸ê°T¡A°£¤F¤w©ó5/19´¦ÅS¥Z¸ü©óASCOªº¤¤^¤åª©½×¤åºKn¥~¡A¹ï©ó¤j®a¼ö¤Á·Q¶i¤@¨B¤F¸ÑOBI-822Á{§É¸ÕÅ窺µ²ªG¡A§Ú̯S§O¶}©ñ³oÓ¶é¦a¡A¹ï©ó¦³Ãö¸Ñª¼µ²ªGªº´£°Ý¡AÅwªï¤j®a§Q¥Î¯E¹©©xºô¡uÁpµ¸§ÚÌ¡v«H½c¯d¨¥¡A¤½¥q¾ã²z«á¡A·|ºÉ¤O©ó§Y±NÁ|¦æªº§ë¸ê¤H»¡©ú·|²Î¤@¦^µª¡AY¦³¥¼ºÉªÌ¡A¦A©óºô¯¸¦^ÂСF¬Û¦P´£°ÝªÌ¡A«h®¤¤£«½Æ¡A¨Ã½Ð¯d¤U¯u¹ê©m¦W»PÁpµ¸¤è¦¡¡CÁpµ¸§ÚÌ ·q¯¬¥¦w! |
|
|
·|û¡G¦p¤Û¼v10141583 µoªí®É¶¡:2016/5/27 ¤U¤È 10:37:35²Ä 1691 ½g¦^À³
|
¯E¹©¤½¥q¹ï©ó¤j®a¼ö¤Á·Q¶i¤@¨B¤F¸ÑOBI-822Á{§É¸ÕÅ窺µ²ªG¡A¯S§O¶}©ñ¶é¦a¡A¹ï©ó¦³Ãö¸Ñª¼µ²ªG¥i¥H´£°Ý¡C §Ú³s¦p¦ó°Ý³£¤£·|¡C¬O§_¥i¥H·Ð½ÐCliff¤j¡B¥xÁÞ¤j¡B¹Ç§AÅó±ø±ø¤õ¡Bchen6053¡B¤Ñ©R¤jµ¥¥N¤j®a´£°Ý¡A ³o¸Ì¥ýÁÂÁ¤F¡C |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/5/27 ¤U¤È 12:53:10²Ä 1690 ½g¦^À³
|
Keytruda Keytruda¬Oªý断³Q称为PD-1ªº细M³q¸ôªº²Ä¤@个³Q§å㪺药ª«¡A¥¦¨îÉóÊ^§K¬Ì¨t统§ð击¶Â¦â¯À½F细Mªº¡C 2014¦~9¤ë4¤é¬ü国¹«~药«~监·þºÞ²z§½(FDA)±Â权¥[³t§åãKeytruda(pembrolizumab)为ªv疗对¨ä¥L¤£¦A¤Ï应ªº±ß´Á©Î¤£¥i¤Á°£¶Â¦â¯À½F¡C ¡@¡@Keytruda¬O·N¦V¥Î¤_¥H¤Uªv疗¡G¥Î¥ì¤Ç单§Ü[ipilimumab]¡A¤@Ïú类«¬§K¬Ìªv疗¡C对¶Â¦â¯À½F±wªÌ¨ä肿½Fªí达¤@Ïú°ò¦]¬ð变³Q称为BRAFV600¡AKeytruda¬O·N¦V为¥Î¥ì¤Ç单§Üªv疗¦Z¨Ï¥Î©M¤@ÏúBRAF§í¨î剂¡A¤@Ïúªv疗thatªý断BRAF°ò¦]¬ð变ªº¬¡©Ê¡C 试验编辑 ¡@¡@¦b173¨Ò临§É试验¦³±ß´Á¶Â¦â¯À½F¦b¥H«eªv疗¦Z¯e¯f进®i参¥[ªÌ¤¤ÚÌ©wKeytrudaªº疗®Ä¡C©Ò¦³参¥[ªÌ¥ÎKeytrudaªv疗¡A©Î¦b±À¯ò剂¶q2mg/kg©Î¦b较°ª剂¶q10mg/kg¡C¦b±µ¨üKeytruda¦b±À¯ò剂¶q2mg/kg参¥[ªÌªº¥b数¡A约24%¦³¥L们ªº肿½F皱缩¡C®Ä应«ù续¦Ü¤Ö1.4¦Ü8.5个¤ë©M¦b¤j¦h数±wªÌ继续¶W过这个时间¡C¦b10mg/kg剂¶q¬Û¦ü¦Ê¤À²v±wªÌ¦³¥L们ªº肿½F皱缩¡C ¡@¡@¦b这个试验¤H¸s411¨Ò¦³±ß´Á¶Â¦â¯À½F参¥[ªÌ¤¤ÚÌ©wKeytrudaªº¦w¥þ©Ê¡CKeytrudaªº³Ì±`见°Æ§@¥Î¬O¯h劳¡A«y¹Â¡A恶¤ß¡A¥Ö肤æ±Ö}¡A¥Ö¯l¡A¹±ýú£§C¡A«K¯µ¡A关节µh©M¸¡泻¡CKeytruda还¦³对严«§K¬Ì¤¶导ªº°Æ§@¥Îýͯà¡C ¦b411¨Ò¦³±ß´Á¶Â¦â¯À½F参¥[ªÌ¡A严«§K¬Ì¤¶导ªº°Æ§@¥Î¯A¤Î°·±d¾¹©x¡A¥]¬AªÍ¡A结肠¡A¿E¯À-¥Í¦¨¸¢Ê^©M¨x脏¡A¤£±`见发¥Í¡C[1] |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/5/27 ¤U¤È 12:49:13²Ä 1689 ½g¦^À³
|
ÁöµM¬O¶Â¦â¯À½F ¤]¥i¥H°Ñ¦Ò¤@¤U: ASCOºKn发¥¬ Àq¨F东Keytruda临§É试验结ªG³ß¤H news.bioon.com/article/6683105.html |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/27 ¤W¤È 11:42:07²Ä 1688 ½g¦^À³
|
ÁÂÁ¦ϫ§¤j¡A©Ó¤Ñ¤j¡AµL¦W¤j¡A®È¤H¤j´£¨Ñªº¸ê°T¤À¨É |
|
|
·|û¡G®È¤H10142235 µoªí®É¶¡:2016/5/27 ¤W¤È 09:33:00²Ä 1687 ½g¦^À³
|
¦Ï¤j¡A¥xÁÞ¤j25%¨ÅÀùªº¤ñ¨Ò¬O¨C¤Q¸U¤H¤f ¤Ñ¤UÂø»x¦³¥@¬É¦U¦aªº¤ñ¸û www.cw.com.tw/article/article.action?id=5049130 |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/27 ¤W¤È 09:30:33²Ä 1686 ½g¦^À³
|
¦]FL¥¿±`²ÓM¤]±a¦³GH series§Üì¡A¾ÉP¨Ï¥Î822(¤Î¥¼¨Ó¥ô¦ó¥HGH series¬°°ò¦ªº¥ô¦ó¬Ì])¥¼¨Ó¨Ï¥Î¦b¡u¦´Á¹w¨¾¡v®É¡A¥i¯à¶·Á׶}Ãh¥¥°ü¤k¥ÎÃĨä¼vÅT²Ê²¤µû¦ô¦p¤U¡G 1. ¥¼¨ÓGH¥¥xªº10´XºØ¾A¥ÎÀù¯g¡AÃh¥¥°ü¤k¬Ò¶·ª`·N 2. ¨k©ÊµL¸ÓÃþºÃ¼{ 3. ¥xÆW°ü¤k¨ÅÀù¼vÅT¦p¤U 45·³¥H¤U°ü¤k¥e©Ò¦³¨ÅÀù¤ñ²v¬ù15%¡A¹ï¬Ì]¾A¥Î¥«³õ¼vÅT¤p 45·³¥H¤W°ü¤k¤j¦h¹LÃh¥¥¦~ÄÖ¡A¥i¨Ï¥Îªø®Ä«¬¬Ì] 45·³¥H¤U¤´¦³Ãh¥¥¦Ò¶q¤§°ü¤k¡A¥i¨Ï¥Îµu®Ä«¬¬Ì] 4. ¥xÆW°ü¤k10Àù¯g¼vÅT¦p¤U 45·³¥H¤U°ü¤k¥e10¤jÀù¯g¤ñ²v¬ù8.9%¡A¹ï¬Ì]¾A¥Î¥«³õ¼vÅT¤p ¸ê®Æ¨Ó·½¡Gtcr.cph.ntu.edu.tw/main.php?Page=A5B2 2006~2010¦~²Îp¸ê®Æ |
|
|
·|û¡G©Ó¤Ñ10142520 µoªí®É¶¡:2016/5/27 ¤W¤È 09:21:02²Ä 1685 ½g¦^À³
|
¤ô§ñ ¥xÁÞ¤j¦³Àùµn¸ê®Æ®w!!!XD |
|
|
·|û¡G©Ó¤Ñ10142520 µoªí®É¶¡:2016/5/27 ¤W¤È 09:14:58²Ä 1684 ½g¦^À³
|
www.mohw.gov.tw/news/531349778 ¦º¦]²Îp ¨ä¹ê¬Ì]¦b¤½¦@½Ã¥Í¯e¹w¨¾Âå¾Ç¤W°µªº¬O«e´Á¹w¨¾¸ò«á´Á´î¨a ©Ò¥H¥»¨Ó¤]¨S¦³¬Æ»ò±Ú¸s³£¯à¾A¥Î ¯à°÷§¹¥þ¹w¨¾¸ò§¹¥þªv¡³£¬OºâÁȨì (¨ä¹ê´N¬O¨S¦³¸U¥ÎÃÄ°ÕXD) ¯¸¦b¬F©²ªº¨¤«×¨Ó»¡ªº¸Ü¡A¥²¶·²Å¦X¸û¤jªºCost-effectiveness¤~¦³¾÷·|Åܦ¨¬Fµ¦ ©Ò¥H¥¥°ü¤£¯à¥´ ©Î¬O ¥Í¨|¦~ÄÖ¤£¯à¥´¬O«Ü¥¿±`ªº (¥»¨Ó´N·|¦³¯S®í±Ú¸s) Á|¨Ò¡A§Ú¬Û«HZika¯f¬r¤]¬O³o¼Ëªº °²³]¦pªG¤§«á¦³¬Ì] ¦b¥¥°ü±Ú¸s¤]¤£·|¬OªvÀø¥Î ¦]¬°.....¦pªG·s¥Í¦Ó¥X¨ÓÁÙ¬O¤pÀY¯gªº¸Ü ¬Ì]¼t¤]·|³Q§i Á`¦Ó¨¥¤§¡A¥Í©R¥Ã»·¦³¨Ò¥~¡A©Ò¥Hn·RÅ@¦Û¤vªº¨Åé¡A¥±`n°µ¦n¨Æ ³Ñ¤Uªº¥æµ¹¦Ñ¤Ñ¸ò¬ì§Þ´N¬O¤F |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/27 ¤W¤È 09:09:15²Ä 1683 ½g¦^À³
|
¤¤µØ¥Á°ê102Àù¯gµn°O¸ê®Æ®w ¦~ÄÖ¼h ¤k©Ê¨ÅÀùµo¥Í¼Æ 15-19 1 20-24 15 25-29 95 30-34 304 35-39 669 40-44 1280 45-49 2034 50-54 2030 55-59 1812 60-64 1574 65-69 887 70-74 638 75-79 421 80-84 221 85¥H¤W 121 ¦Xp12121¤H 45-59 µo¥Í¤H¼Æ³Ì°ª¤TÓ¦~ÄÖ¼h¡A60·³«á³v¨B¤U°¡A¤k©ÊªB¤Í½Ð©w´Á°·ÀË ¡Aª`·N¶¼¹¹B°Ê¡A»·Â÷¶ì¤Æ¾¯¡AÀô¹Ò¶Pº¸»X |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/27 ¤W¤È 07:21:33²Ä 1682 ½g¦^À³
|
¦Ï«§¤j Google ¥|¤Q·³¥H¤U±o¨ÅÀù¤ñ²v ®É¶¡³]©w¤@¦~ ²Ä¤T«h ¥x¥_Àù¯g¤¤¤ß ²Ä¤@«h ¦~»´¤k©Ê¨ÅÀù¡A¤]¦³¤@¨Ç²Îp ©x¤è102¦~Àù¯gµn°O¦~³ø¡A¦³¨ÅÀù¦U¦~ÄÖ²Õ¶Zµo¥Í¤H¼Æ²Îp¡A¥|¤Q·³¥H¤Uµo¥Í²vªº½T¨S¦³¨ì25% ¡A»P¥x¥_Àù¯g¤¤¤ß²Îp¤£¦P¡C ¤j®a¦A§ä§ä¸ê°T¤À¨É |
|
|
·|û¡G¦Ï«§«§10141876 µoªí®É¶¡:2016/5/27 ¤W¤È 06:15:58²Ä 1681 ½g¦^À³
|
¥xÆW¤k©Ê¨ÅÀùªº¦nµo¦~ÄÖ°ª®p´Á¬°45·³~55·³¡A¼Ú¬ü«h¬°55·³¥H¤W¡C ¤j©è³£¹L¥Í¨|¦~ÄÖ¤F¡C »{ÃѨÅÀù(¤TxÁ`Âå°|/®a®xº[ªÀ°ÏÂå¾Ç³¡ ) wwwu.tsgh.ndmctsgh.edu.tw/chc/hpd/6_health_learning_pdf/6_health_learning20.pdf ¸òµÛ¸Ê²ú©j¤Á¨Å©Ð«e¡A§A¥²¶·nª¾¹Dªº6¥ó¨Æ(¤å / ´¿¤å§»¡]¤jªL·OÀÙÂå°|®a®xÂå¾Ç¬ì¡A¦í°|Âå®v¡^) pansci.asia/archives/41873 ¨ÅÀù¨¾ªv(½ÃºÖ³¡) www.hpa.gov.tw/BHPNet/Web/healthtopic/TopicArticle.aspx?No=201312230001&parentid=200712250033 ¨ÅÀù¿zÀˤΪvÀø¤§ª§½×(¥xÆWÂå¾Ç·|) www.fma.org.tw/2011/E-8-1.html |
|
|
·|û¡G¦Ï«§«§10141876 µoªí®É¶¡:2016/5/27 ¤W¤È 05:58:23²Ä 1680 ½g¦^À³
|
¥xÁÞ¤j¡G ±z¦n¡A·Q½Ð±Ð¸ê®Æ¨Ó·½¡C ¥xÆW¥|¤Q·³¥H¤U°ü¤kµo¥Í¨ÅÀù¬ù¦³25% ? ------------------------------------------ Ó¤H¥H¬°¤£¥i¯à¦³¨º»ò°ªªº¨ÅÀù¤ñ¨Ò¡A¨Ã䪺¤k©Ê¤Í¤H40·³¥H¤Wªº¨ÅÀù¤]¨S¦³¨ì25%¡C ¦³ªº¨Å©Ð¨}©Ê¸~½F¬O¤£¯à¦C¤J¨ÅÀùpºâ·í¤¤¡C ¥t¥~´£¨Ñ¥x¦wÂå°|³ø¾Éªº¦~»´«¬¨ÅÀù¸ê®Æ¡A¨Ñ°Ñ¡C www.tahsda.org.tw/newsletters/?p=1565 |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/26 ¤U¤È 11:16:54²Ä 1679 ½g¦^À³
|
4¥¼¨Ó¨ÅÀùOBI822¤W¥««á¿z¿ï¯à²£¥Í¨¬°÷§ÜÅ骺¯f±w¤~¾A¦X¨Ï¥Î,°t¦X¤E°wÀøµ{«á¨CX¤ë¦A¸É¥´¤@°w¡AÅý§ÜÅé¶q«O«ù¦A³Ì¨Îª¬ºA¡A¯f±wªºÁ`¦s¬¡´Á²q´ú·|¤ñÁ{§É¸ÕÅ窺Á`¦s¬¡´Áªø¡C ¼g¨ì³o¸Ì¬ðµM¤ß¤¤«Ü·PÁ¡A¯Î°|ªø¡A¯E¹©¬ãµo¹Î¶¤¡AÁÙ¦³¤£Â÷¤£±ó¤ä«ù¤½¥q¤ô·Ç«Ü°ªªºªÑªF |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/26 ¤U¤È 10:47:22²Ä 1678 ½g¦^À³
|
1§ó¥¿ °Ñ¥[>>°Ñ¦Ò µoªí²v>>µo¥Í²v 2¥¼¨Ó¹w¨¾©Ê¬Ì]§Ú¤£»{¬°¬O¥´¤@°w´N·|¥Ã¤[²£¥Í§ÜÅé¡A¤ñ¸û¥i¯à¬O¨C¦~©Î¹j¦~¬I¥´¡A°ª¦MÀI¸s¦~»´°ü¤k¦pnÃh¥¥¥Í¨|ºÉ¥i¯à´£¦¡AÃh¥¥´Á¦A»P°ü¬ìÂå®v°Q½×¤£n¥´¬Ì]¡Aµ¥¥Í¨|«á¦b¬I¥´¡C 3Á{§É¸ÕÅç¬Ý¨ìªº¦s¬¡´Á¡AMOS,MPFS ¨Ã¤£¬O¯u¥¿ªº¦s¬¡´Á¡A¦b¯u¹êªvÀøªº¥@¬É¡A¥´§¹¤E°w«á¨C¹jX¤ë¦A¸É¥´¤@°w¡AÅý§ÜÅé¶qºû«ù¦b³Ì¨Îª¬ºA¡A¦s¬¡´Á¥u·|¦A¦V¤WÃk¤É¡A¬¡ªº§ó¦n§ó¤[¡A«Ü¦h¤H¨S¦³·Q¨ì³o¤@ÂI¡C |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/26 ¤U¤È 10:31:24²Ä 1677 ½g¦^À³
|
·PÁ©ӤѤjªº¤¶²Ð ±zÀ³¸Ó¤]¬O³o»â°ìªº±M®a ©¯·| ©¯·| |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/26 ¤U¤È 10:26:15²Ä 1676 ½g¦^À³
|
¥HÃÒ¾ÚÃÒ©ú¤@¤Á ¥xÁÞ¤j¥O¤H´Ü¨Ø! |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/26 ¤U¤È 10:21:39²Ä 1675 ½g¦^À³
|
¬°Ô£¹ï·Ó²ÕªºÀø®Ä¨º»ò¦n¡H ¥Ø«e¥ÑºKn¤´µLªk§P©w¬O¹ï·Ó²Õ¥X¥G·N®Æªº¦n©Î¹êÅç²Õ¤£°÷¦n¡H ¤½¥q¸Ñª¼»¡©ú·|ªí¥Ü¡A³y¦¨¥¼¹F¼Ðªºì¦]¬O¡G ¥¼²£¥Í§ÜÅé¡B©µ¿ð¡B®û¼í¤Î±wªÌ§¹¥þµLGH series ¦]¦¹§Ú±À½×¹êÅç²Õ²£¥Í§ÜÅé¶q«e50%°ªªº±wªÌ¡A³Ì¤j¥i¯à¬O¤U¦Cì¦]©ì²Ö¸Ó²Õ¾ã²ÕÀø®Ä¡G ©µ¿ð---PD«á¦³²£¥Í¨¬¶q§ÜÅé¤~ºÙ©µ¿ð ®û¼í---³¡¤À°ª§ÜÅéªÌ¡A³y¦¨µoª¢°²©Ê¸~¤j¡A³Q»~§P´£¦PD µLGH§Üì---¦³§ÜÅé¤]µL¥Î |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/26 ¤U¤È 10:19:45²Ä 1674 ½g¦^À³
|
·j´M ¨ÅÀù¦~ÄÖ¼h ²Ä¤@«h¸ê°T¥i°Ñ¥[¡A¨ä¤¤¦³¤ÀªR¥xÆW¬ü°ê¨ÅÀù¦U¦~ÄÖ¼hµoªí²v¡A¬Û·í«nªº¸ê°T¡C ¬ü°ê¥|¤Q·³¥H¤U°ü¤kµo¥Í¨ÅÀù¥u¦³4.2% ¥xÆW¥|¤Q·³¥H¤U°ü¤kµo¥Í¨ÅÀù¬ù¦³25% ¦³¬ÛÃö°ò¦]¡A®a±Ú¥v¡A¦è¤Æ¶¼¹»P«PÀù¦]¯Àªº¦~»´¤k©ÊÀ³ª`·N°·ÀË¡A¾é¸Ñ¬ÛÃö¸ê°T¡A¦p¥H¥|¤Q·³·í¥Í¨|¦~ÄÖªº·¥¡A¥xÆW¥|¤Q·³¥H¤U¬ù¦³25%±o¨ÅÀù¡A¦pn¨Ï¥Î¹w¨¾©Ê¬Ì]¤S·QÃh¥¥®ÉÀ³»P°ü¬ìÂå®v°Q½×µû¦ô¬O§_¬°°ª¦MÀI¸s¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/26 ¤U¤È 09:55:17²Ä 1673 ½g¦^À³
|
¤@¯ë¨Ó»¡¥¼¨ÓOBI¨t¦C¤W¥«¨Ï¥Î¦b¹w¨¾»â°ì ·|¨Ï¥Îªº°ü¤kµ´¤j³¡¥÷¬O¥Í¨|´Á¥H«áªº°ü¤k¡A²z¥Ñ¦p¤U 1¥H¬ü°ê°ü¤k±o¨ÅÀù¦~ÄÖ¤ñ¥xÆW±ß¤Q¦Ü¤Q¤¦~¦¤w¶W¹L¥Í¨|¦~ÄÖ¡A¤j³¡¥÷°ü¤k³£¥i¨Ï¥Î¦b¹w¨¾¤è± 2¥H¥xÆW°ü¤k¨Ó¬Ý¡A¨ÅÀùµo¥Í¦~ÄÖ¤]¬O45·³¥H«á³vº¥¼W¥[¬ù¦Ü60·³¥ª¥k¶}©l¤U°¡A¥Í¨|«á¦A¨Ï¥ÎOBI¨t¦C©ó¹w¨¾¤W¤]³£¨S¦³°ÝÃD 3¨S¦³®a±Ú¯f¥v©Î¿ò¶Ç°ò¦]»P¬ÛÃö«PÀù¦]¯À¡A¥i¦b¥Í¨|«á¦A¬I¥´¹w¨¾©Ê¬Ì]¡C¥H¤W¬OÓ¤H·Qªk¡A¶È¨Ñ°Ñ¦Ò¡C |
|
|
·|û¡G¶Â½ü§B10141808 µoªí®É¶¡:2016/5/26 ¤U¤È 08:53:04²Ä 1672 ½g¦^À³
|
¬°¤°»ò¹ï·Ó²ÕªºÀø®Ä·|³o»ò¦n, ¥u¬Oı±o»P¨äÂk¦]©ó¹B®ð, ¤£¦p¦h·Q·Q¨ä¥Lªº¥i¯à©Ê.... §Ú²q §K¬Ì¤ÏÀ³ ¦p®û¼í©Ò³y¦¨ªº°²©ÊPD ¬O¤£¦p¹ï·Ó²Õªº³Ì¤jì¦] ¦]¬° ¹ï·Ó²ÕªºÃĪ« ¤Þµo ²ÓMä¤`ªº²ÓM«¬ºA¡]Åܤpªwªw¡^¤£¦P©ó·|Åý§ÜÅé§ðÀ»Àù²ÓM©Ò³y¦¨ªºµoª¢¤ÏÀ³¡]²ÓMÅܸ~µÈ¡^ ¬G¹êÅç²Õ¤@Ó²Õ´¥i¯à¦P®É¦³ÃĪ«¤Î¬Ì]¼vÅT ¾ãÅ髬ºA¬Ý°_¨Ó²Õ´Åܤj ®e©ö·|³Q§P¬°PD ¨ä¹ê¬O°²©ÊPD ¦Ó¹ï·Ó²Õ ³æ¯Â´N¬O ²ÓM©Î²Õ´Åܤp ¬G¶}©l³Q§P¬°PDªº¾÷²v«Ü¤p |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/5/26 ¤U¤È 08:34:13²Ä 1671 ½g¦^À³
|
FL·F²ÓM zh.wikipedia.org/wiki/%E8%83%9A%E8%83%8E%E5%B9%B9%E7%B4%B0%E8%83%9E ·F²ÓM zh.wikipedia.org/wiki/%E5%B9%B9%E7%B4%B0%E8%83%9E ¹ï÷¨Å°Êª«¨Ó»¡¡A·F²ÓM¤À¬°¨â¤jÃþ¡GFL·F²ÓM»P¦¨Åé·F²ÓM¡AFL·F²ÓM¨ú¦ÛÅnF¸Ìªº¤º²ÓM¹Î¡F¦Ó¦¨Åé·F²ÓM«h¨Ó¦Û¦U¦¡¦U¼Ëªº²Õ´¡C¦b¦¨Åé²Õ´¸Ì¡A·F²ÓM»P¥ýÅX²ÓM¾á¥ô¨Å骺״_¨t²Î¡A¸É¥R¦¨Åé²Õ´¡C¦bFLµo®i¶¥¬q¡A·F²ÓM¤£¶È¯à¤À¤Æ¬°©Ò¦³ªº¯S¤Æ²ÓM- ¥~F¼h¡A¤ºF¼h©M¤¤F¼h(°Ñ¦Ò¤H¤u¦h¯à·F²ÓM)¡A¦Ó¥B¯àºû«ù·s¥Í²Õ´ªº¥¿±`Âಾ¡A¨Ò¦p¦å²G¡B¥Ö½§©Î¸z²Õ´¡C |
|
|
·|û¡G®È¤H10142235 µoªí®É¶¡:2016/5/26 ¤U¤È 08:33:04²Ä 1670 ½g¦^À³
|
·PÁÂchen6053¤j¤j¡A¼H¼H¡I«Ü¶}¤ß¡ã |
|
|
·|û¡G¶Â½ü§B10141808 µoªí®É¶¡:2016/5/26 ¤U¤È 08:29:57²Ä 1669 ½g¦^À³
|
¥u¦³·F²ÓMªí±¦³Globe H ¤~·|³Q§ÜÅé¿ëÃÑ ¦Ó¤Þµo¤@³s¦êªº§K¬Ì¤ÏÀ³.. |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/5/26 ¤U¤È 08:28:23²Ä 1668 ½g¦^À³
|
¯E¹©2/22ªk»¡ ¤å¦rÀÉ ........ ¤U±ÁÙ¦³¤@Ó«D±`«nªº¡A´N¬O§Ú̵o²{¥¿±`¤H¬O¨S¦³GLOBO H¡A¬O§¹¥þ¨S¦³¼Ú¡A¨ì²{¦b¬°¤î³£¨S¦³§ä¨ì¡A¥u¦³¦b¨âºØ±¡ªp¤§¤U·|¬Ý¨ì¡A¤@Ó´N¬O¦bFL²ÓM¡A³o¬OGLOBO H¤j·§¬O¸ò¤Hªº¦¨ªø¡B§Ö³t¦¨ªøªº®ÉÔ¬O«D±`¦³Ãö«Yªº¡A©Ò¥H¥i¯à¨ì«á¨Ó¡B§Ú̹w´Á³o¬O°²³]¡A¥i¯à¬°¤°»ò¸òÀù¯gªø±o«Ü§ÖGLOBO H¤]¬O¦³¬ÛÃöªº¡A¦bFL´Áªº²ÓM¤W¦³GLOBO H¡Aµ¥¨ì¦¨ªø¥H«á.¨ì«D±`«D±`¦~»´ªº®ÉÔ´N¨S¦³¡A±q¦¹´N§ä¤£¨ì¡A¤@ª½¨ì¦³Àù¯g¤~§ä±o¨ì¡A³o¬O¤@Ó«D±`«nªºì«h¡A©Ò¥H±N¨Ó§ÚÌn¬Ý¥¥°ü¡A¦bÃh¥¥ªº´Á¶¡¤S¦³Àù¯gªº®ÉÔ¡A¬O¤£¬O¾A¦X¬I¥´³oÓ²£«~¡A§ÚÌn§ó¥J²Óªº¥h¬ã§P¡A¥Ø«e¬Ý¨Ó¡A¥¥°üY¬O¦³Àù¯gªº®ÉÔ¬O¤£¾A©y¬I¥´³o¼Ëªº¬Ì]¡C .................. |
|
|
·|û¡G©Ó¤Ñ10142520 µoªí®É¶¡:2016/5/26 ¤U¤È 08:27:11²Ä 1667 ½g¦^À³
|
1. molecular biology of the cell, 6ed 2. Essentials of glycobiology, 2ed 3. Carbohydrate based vaccines, methods and protocols, 2015 |
|
|
·|û¡G®È¤H10142235 µoªí®É¶¡:2016/5/26 ¤U¤È 08:20:18²Ä 1666 ½g¦^À³
|
è¬Ý¨ì°Q½×¦ê¤¤¦³´£¨ì¡A©~µM¡AFL·F²ÓM·|¨ü¨ì§ðÀ»¡C³oÅý§Ú¶}©l¾á¤ß¡A¥¿±`°·±dªº¤H¡A¦³«Ü¦h²Õ´¤]¦³·F²ÓM¡A¤ßŦ¡A°©Åè¡A¸£¡AÁöµM¼Æ¶q«D±`¤Ö¡A¤]¤£ª¾¦ó®É¨Åé·|±Ò°Ê¡A¦ý¬O¤w¸gµo²{¦s¦b¤F¡C©Ò¥H¡A¦pªGn®³¨Ó·í¹w¨¾¥Î¡A¨S¿ìªkÁ׶}¥¿±`ªº·F²ÓM¡A·|¬O«Ü³Â·Ðªº¨Æ°Ú¡H ¹ï¯f±w¦Ó¨¥¡AÁöµM±þ¦º¤FÀù²ÓM¡A¦ý¦P®É¡A¦Û¤v°·±dªº·F²ÓM¤]³\¤]±þ¦º¤F¡H³o¼Ë¦³ºØ¡A¤@¤MÂù¤bªº´äı°Ú¡I ¤£ª¾¹D¤j¤jÌ¡A«ç»ò¬Ý¡H |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/26 ¤U¤È 07:56:31²Ä 1665 ½g¦^À³
|
ÁÂÁÂ¥xÁÞ¤j¡B¤p·s¤j ´£¥X³oijÃD¯Âºé´£Ó¿ô¡A·sÃĶ}µoº©º©ªø¸ô¡BÃö¥d«« ¦ýĹ¥J¤j¤£¥Î¾á¤ß ¤@¥¹Àø®Ä¡BMOA½T¥ß¡A²Ä¤@ÁûÃÄ´N·|¥X²{ ±µµÛ¨ä¥L¾AÀ³¯gªºÁ{§É´N·|¥[³t ªì´Á¥úªvÀø10¨ÓºØÀù¥½¯f±wªº¥«³õ´N¬Û·íÅå¤H ²{¦b³Ì³Ì«nªº¬O½×¤åµoªíªº¸Ô²Ó¤º®e~~~ Yn±À¦V¦´Á¹w¨¾¡A©Î³\ ¤k©Ê¥i¨Ì¤£¦P¦~ÄÖ¶¥¬q¬I¥´µu¡Bªø®Ä¬Ì]¡A¥HÁקK¼vÅT¤k©ÊÃh¥¥¦w¥þ ¨k©Ê«h¥i¤@«ß¬I¥´ªø®Ä«¬¬Ì]¡A¥H°§C¬I¥´¦¨¥»¤Î«K§Q¬I¥´ |
|
|
·|û¡GĹ¥J10142318 µoªí®É¶¡:2016/5/26 ¤U¤È 06:55:56²Ä 1664 ½g¦^À³
|
¥x¿}¤j: §Ú©Ò¾á¼~ªº¨Æ,¬Oªø®Ä«¬¬Ì]¥´¤F²£¥Í¤F¥Ã¤[©Ê§ÜÅé,¸Ó¤k¤l¤]µLªk¦AÃh¥¥¤F,ºâ«Ü¤jªº°Æ§@¥Î§a...¤£¹L¸Ü¤S»¡¦^¨Ó¬O§_¥iºt¤Æ¦¨¨ú¥N¤k¤H·Qµ²²Ï¤S¤£´±¤â³NªºÃÄ,Á×¥¥¤S¨¾Àù1Á|2±o |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/26 ¤U¤È 06:48:11²Ä 1663 ½g¦^À³
|
Ĺ¥J¤j §A·Q¤Ó¦h¤F¡AÀ³¸Ó¥u©óÃh¥¥´Á¶¡¤~¦³¨ü¨î¡A¤£¬OÃh¥¥´Á¶¡À³¸Ó¨S¦³¼vÅT¡A¤G¤ëªk»¡¦³´£¨ì³oÓijÃD¡A³Ì«áÃh¥¥°ü¤k¬O§_¤@©w·|¨ü§Ú·Q»Ýn¸~½F±M¬ìÂå®v»P°ü¬ìÂå®v¨Ì¾ÚÁ{§É¸ÕÅçµ²ªG°t¦X¬ì¾Ç¤Wªºµo²{¦bÃĪ«¤W¥«®É·|¦³ÃĪ«¨Ï¥Î»¡©ú®Ñ[ÃĪ«¥é³æ]¨Ó³W©w¨Ï¥Î¹ï¶H¡A¥Ø«eÀ³¸Ó¥u¬O´£¥Xnª`·Nªº¹ï¶H¦Ó¤w¡C |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/26 ¤U¤È 05:59:35²Ä 1662 ½g¦^À³
|
Cliff¤j ¦³¨Ç·Qªk»P§A¤Á½R¤@¤U ¡u¨º¹êÅç²Õ¤]¥´¤FCyclophosphamide¡A®ÄªG¦bþ©O¡H²z½×¤W¨â²Õ³£¥´¤F¡A¨º¦bÀø®Ä¤ÀªR¤WÀ³¸ÓµL¤À°a¸þ¡A¦ý¸Ñª¼¨Æ¹êÂ\¦b²´«e¡A¤~¤£±o¤£»¡¹B®ð¡u¤Ó¦n¡v¡A¹J¨ì¹ïCyclophosphamide¤ÏÀ³¯S§O¦nªº¹ï·Ó²Õ¨ü¸ÕªÌ¡C¡v ¨Æ¹ê¤W, ¹êÅç²Õ©M¹ï·Ó²ÕªºPFSÀø®Ä¤ÀªR, ªº½T¬OµL¤À°a¸þ. PFS, HR = 0.96 [95% CI 0.74-1.25]¡Ap= 0.77 ¥H¹êÅ禬®×¤T¦Ê¦h¤Hªº³W¼Ò, ¥H1:2¤ñ¨ÒÀH¾÷¤À°t¦¨¨â²Õ, ¨ä¤¤¤@²Õ¹ïCyclophosphamide¤ÏÀ³ÅãµÛÀu©ó¥t¥~¤@²Õ, ¤£¬O¤£¥i¯à, ¥u¤£¹L¾÷²v¹ê¦b¬O¤Ó¤p¤F. §Ú¤]µLªk¸ÑÄÀ¬°¤°»ò¹ï·Ó²ÕªºÀø®Ä·|³o»ò¦n, ¥u¬Oı±o»P¨äÂk¦]©ó¹B®ð, ¤£¦p¦h·Q·Q¨ä¥Lªº¥i¯à©Ê. ¤]³\822¦bPFSÀø®Ä¤W, ´N¬O¨S¦³¦n³B. ©Î³\n¬ÝOS¤~¦³Àu¶Õ, ¦ý¬O¥Ø«e¼Æ¾ÚÁÙ¤£¦¨¼ô. ©Î³\ORR©Mªø§À·|¥O¤HÅåÆA, ¦ý³o¨ÇºKn¤¤³£¨S¦³´£¤Î. ©Z¥Õ»¡, ³o´X¤Ñ«ä¦Ò¤U¨Ó, ¬Ý§¹ºKn«á, §Ú¤Ï¦Ó¹ï822ªºÀø®ÄÅܱo¤ñ¸û«O¦u¤F ¥t¥~, ºKn¤¤ªº³Ì«á¤@¶µ¤ñ¸û, ¥´§¹¤E°wªº¹êÅç²Õ»P¹ï·Ó²Õ, PFS¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057) ³o¦ü¥Gªí¥Ü, ¦b«á´Á¹êÅç²Õªí²{·|¤ñ¹ï·Ó²Õ¦n, ªø§À¤ñ¸û«p ¬Û¹ïªº, «e´Á¹êÅç²Õªí²{´N¤ñ¹ï·Ó²Õ®t¤F, «e«á©è¾P, ¤~·|³y¦¨¾ãÅéÀø®Ä¤£ÅãµÛ |
|
|
·|û¡G¤p·s10141589 µoªí®É¶¡:2016/5/26 ¤U¤È 05:43:21²Ä 1661 ½g¦^À³
|
¤£¹L¯E¹©À³n°µ¤@¨ÇÃh¥¥°Êª«ªº¹êÅç´N¬O¤F,¥H§K¤é«á¦³ª§Ä³ |
|
|
·|û¡G¤p·s10141589 µoªí®É¶¡:2016/5/26 ¤U¤È 05:08:24²Ä 1660 ½g¦^À³
|
¤ÆÀø»P¶P©µ¥¹ïÃh¥¥¤]·ÀI¤£¤Ö: ¹ï¥¥°ü§ë¤©Herceptin·|¹ïL¨à³y¦¨¶Ë®`.®Ú¾Ú¤W¥««áªº¯f¨Ò³ø§i,¦bÃh¥¥´Á¶¡¨Ï¥ÎHerceptin·|´£°ª²Ä¤G¤Î²Ä¤T¥¥´Á¥X²{¦Ï¤ô¹L¤Ö²{¶Hªº·ÀI.¦pªG°ü¤k¦bÃh¥¥´Á¶¡¨Ï¥Î¤FHerceptin,©Î©ó¨Ï¥ÎHerceptin´Á¶¡Ãh¥¥,À³±NL¨à¥i¯à¨ü¨ìªº¦M®`§iª¾¸Ó°ü¤k[°Ñ¨£¯S®í±Ú¸s¤§¨Ï¥Î(7.1)]. ¦b¤W¥«¤§«á,¦b±µ¨üHerceptinªº¥¥°ü¤¤´¿¦³³ø¾ÉL¨à¦Ï¤ô¹L¤Ö¯g¦ñÀHµÇŦ¦¨ªø¤Î/©Î¥\¯à¨ü·lªº®×¨Ò. |
|
|
·|û¡GĹ¥J10142318 µoªí®É¶¡:2016/5/26 ¤U¤È 04:50:31²Ä 1659 ½g¦^À³
|
µL¦W¤j;¥x¿}¤j: FL¤¤¦³globe H,¨ºobi ¨t¦C°Z¤£¬O³q³q¤£¾A¥Î©ó·Q¥Í¤p«Äªº¤k©Ê,§ó¦~´Á¹Lªº¤~·|·Q¥Î,ÁV¿|¤F¤@¤jÁô¼~³á,¤½¥qªº¬Ýªk¤£ª¾¦p¦ó,§Æ±æ¦³¸Ñ. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/26 ¤U¤È 04:10:01²Ä 1658 ½g¦^À³
|
µL¦W¤j ®Ú¾Ú¤G¤ëªk»¡Ãh¥¥°ü¤k¤£¾A¦X¥´OBI822[¤£½×¬OÃh¥¥°ü¤k¨ÅÀù¯f±wªºªvÀø©Ê¨Ï¥Î©Î°·±dÃh¥¥°ü¤kªº¹w¨¾©Ê¨Ï¥Î]¡A¥unì¦]¬O©È¶Ë¨ìFL²ÓM©ÎFL·F²ÓM¡COBI822³oÁûÃij̤jªºÀuÂI¬O¤£·|¶Ë¨ì¥¿±`²ÓM¡A¤]¦]¬°¦p¦¹¡A°Æ§@¥Î°¦Ü³Ì§C¡A¦w¥þ©Ê©Ô¨ì³Ì°ª¡C |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/26 ¤U¤È 12:11:20²Ä 1657 ½g¦^À³
|
Àµ½ÐCliff¤j ¤¶²Ð¸~½F§K¬Ì¾Ç¡BÀù¯g§K¬Ì¾Ç©Î§K¬ÌªvÀø¦³Ãö®ÑÄy ¨Ñ°Ñ ¤¤^¬Ò¥i ·PÁ±z |
|
|
·|û¡G¤p·s10141589 µoªí®É¶¡:2016/5/26 ¤W¤È 09:58:21²Ä 1656 ½g¦^À³
|
Cliff ¤j,¬O§_ÁÙ¦³¤@ºØ¥i¯à¬O,¨ü¸ÕªÌ¥Ñ·ÑÅé©Î¨ä¥LºÞ¹Dª¾¹D¥´¤FOBI822¥²¬õ¸~,¹ï·Ó²ÕYµo²{¥´¤F¸Õ¾¯¨S¬õ¸~,´N·|»{¬°¥¼¥´822ªº¾÷·|«Ü¤j,¬G·|¿n·¥´M¨D¨ä¥LªvÀø,¬G·|²£¥Í«D¹w´Áªº§ÜÅéµ¥¦ÓÃøPD |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/5/26 ¤W¤È 09:54:28²Ä 1655 ½g¦^À³
|
§ó¥¿ : TH cell À³¬°Th cell TC cell À³¬°Tc cell TM cell À³¬°Tm cell ¥»¨Ó¬O¥´¡u¤U¼Ð¡v¡A¶K¤W¨Ó®É«o§e²{¤£¥X¤U¼Ð¦r«¬¡C |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/5/26 ¤W¤È 09:44:35²Ä 1654 ½g¦^À³
|
822 Phase II/IIIªº¸ÕÅ礤¡A¹ï·Ó²Õ¥u¥´Cyclophosphamide«o²§±`°·§§¡AÓ¤Hªº¬Ýªk¬O¡G ¤HÅ骺²ÓM§K¬Ì¹B§@¤¤¥HT«¬§K¬Ì²ÓM¬°¥D¨¤¡AT²ÓM¦³¤ºØ¡G 1. §U¤âT²ÓM¡]T helper cell¡FTH cells¡^ 2. M¬r©ÊT²ÓM¡]Cytotoxic T cells; TC cells or CTLs¡^ 3. ½Õ¸`©ÊT²ÓM¡]Regulatory T cells¡FTreg cells¡^º١u§í¨î©ÊT²ÓM¡v¡]Suppressor T cells¡^ 4. °O¾Ð©ÊT²ÓM¡]memory T cells ;TM cells¡^ 5. ±þ¤âT²ÓM¡]Natural killer T cell¡FNKT cells¡^¡]¤£¦P©ó±þ¤â²ÓMNatural killer cell¡^ M¬r©ÊT²ÓMªº¥\¯à¬O±þ±¼¨ü¯f¬r·P¬Vªº²ÓM¤ÎÀù²ÓM¡F¦Ó½Õ¸`©ÊT²ÓM¥\¯à«h¬Û¤Ï¡A·|¤ÀªcIL-10¡Badenosine¤Î¨ä¥L¤À¤lªº§@¥Î¡A¨Ó§í¨îM¬r©ÊT²ÓM¡C Cyclophosphamide«w«H·|³z¹L§í¨î½Õ¸`©ÊT²ÓM¡A¨Ó¶¡±µ¹F¨ì¬¡¤ÆM¬r©ÊT²ÓM¡A¤]´N¬O¬¡¤Æ¤F±þÀùªº¯à¤O¡C ©Ò¥H¦b822 Phase II/IIIªº¸ÕÅ礤¡AÆ[¹î¨ì¤F¹ï·Ó²Õ¥u¥´Cyclophosphamide«o¤£©öPDªº²{¶H¡A¥u±o§â¥´Cyclophosphamide¤]Âk¦]¨ä¤¤¡AÕY³o¼Ëªº±À½×¬O¹ïªº¡A¨º³o¨Ç¹ï·Ó²ÕÓ®×Å餺©Ò²£¥Íªº±þÀù§K¬Ì§ÜÅé·|¤£·|¦³¹ï§ÜGlobo Hªº§ÜÅé¡H§Úı±oÁÙ¬O¦³¥i¯à¡C¦ý¥i¯à¤£¬O¥u²£¥Í³o¤@ºØ±þÀù§ÜÅé¦Ó¤w¡C ¸g¥ÑCyclophosphamide¨ë¿E«á¡A§K¬Ìª¬ªpÀò±o¨Ç³\§ïµ½¡A±wªÌ¥»¨ªº§K¬Ì¨t²Î¦³¥i¯à¦n¨ì¨¬¥H¦Û¦æ¿ëÃÑÀù²ÓMªí±ªºGlobo H§Üì¦Ó²£¥Í¤@¨Ç¡]©Î³\²£¥Í«Ü¦h¤]»¡¤£©w¡^¹ï§ÜGlobo Hªº§ÜÅé¦Ó¤£©öPD¡C³o¥i¯à´N¬O©Ò¿×ªº¹B®ð¦n¤£¦nªºÃö«Y¡]¹J¨ì¹ïCyclophosphamide¤ÏÀ³³o»ò¨}¦nªº¨ü¸ÕªÌ¡^¡C¦Ó¤£¬O¦]¬°ª½±µ¥´¤FCyclophosphamide´Nª½±µ²£¥Í¹ï§ÜGlobo Hªº§ÜÅé¡C³o¹ï§Üì-§ÜÅé±M¤@©Êªº²z½×¬O¤£¦X²zªº¡C³q±`¤@¯ëªºª¬ªp¤U¡ACyclophosphamide¬O¯à¨ó§U´£¤É§ÜÀù¯à¤O¡A¦ý¬O¨Ã¤£¬O¨º»ò±j¡A§_«h¤S¦ó¥²¦A¬ãµo·sÃÄ¡H ¨º¹êÅç²Õ¤]¥´¤FCyclophosphamide¡A®ÄªG¦bþ©O¡H²z½×¤W¨â²Õ³£¥´¤F¡A¨º¦bÀø®Ä¤ÀªR¤WÀ³¸ÓµL¤À°a¸þ¡A¦ý¸Ñª¼¨Æ¹êÂ\¦b²´«e¡A¤~¤£±o¤£»¡¹B®ð¡u¤Ó¦n¡v¡A¹J¨ì¹ïCyclophosphamide¤ÏÀ³¯S§O¦nªº¹ï·Ó²Õ¨ü¸ÕªÌ¡C ³o»P¥Xª©¤j´£¨ìªº¡G¡u¹ï·Ó²Õ²£¥Í Globo-H §ÜÅ骺¤ñ²v¬O0¡v¨ÃµL½Ä¬ð¡A±i¸³Á¿¨º¤@¬q¸Üªº¥Î·N¥u¬OÄÄ©ú§ÜÅ骺²£¥Í¤£À³¹HI§Üì-§ÜÅé±M¤@©Êªº²z½×¡A¥´Cyclophosphamide¤£·|ª½±µÂÛ¥X¹ï§ÜGlobo H§ÜÅ骺·N«ä¡CªÑªF·|¤]¦n¡A»¡©ú·|¤]¦n¡A±i¸³ªº¸Ü»¡±o§Ö¡A¦³®É¤@®ÉÁ¿¤£²M¡A¦³®ÉÁÙ¬O·|¦³¤p¥YÀ¿¡A¦hÅ¥´X¦¸´NµL§«¡C |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/26 ¤W¤È 07:01:41²Ä 1653 ½g¦^À³
|
Pie¤j ÁÂÁ§iª¾ ®û¼í¤ÏÀ³»PT²ÓM Chen¤j ªvÀø´Á¶¡§ÜÅé¹F160¥H¤W ¥H²ÎpÆ[ÂI¨Ó¬Ý À³¸Ó¬O«ü¨C¦¸¥´°w«á ´ú¶q¿@«× ¦b¤£©w´X°w¤§¤º ¹F¨ì160 ´N¦C¬°°ª¿@«×²Õ ¤Ï¤§§C¿@«×²Õ ©Ò¥H¦X²z²q´ú ¥un´X¦¸¤¤¶q´ú¨ì¤@¦¸160 ´Nºâ¬O°ª¿@«×²Õ ±q¤@´Á¹êÅç¿@«×¹Ï¨Ó¬Ý ¬O9©P »P34©P ¤¤¦ì¼Æºw«×¹F¨ì160 ©Ò¥H¥H160¤¤¦ì¼Æ¨Ó¤Á¤À¨â²Õ ¬O¦X²zªº ³o¨â²Õ¥u¬O²Îp¤W¤À²Õ¥ÎªºÅܶµ ¥H¤W¨Ñ°Ñ |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/25 ¤U¤È 11:28:43²Ä 1652 ½g¦^À³
|
chen6053¤j PD¤§«á, À³¸Ó´N²æÂ÷¹êÅç, ´M¨D¨ä¥LªvÀø, ¤£·|¦A¦^¨Ó¶q§ÜÅé¤F ¤]¥i¥H°Ñ¦Ò¤p©_¤j»¡ªk(µoªí®É¶¡:2016/5/20 ¤U¤È 02:00:41) ¯E§J¤j ¤p§Ì¤£¬O«ÜÀ´§Aªº°ÝÃD, ¤£¹L±q¸ê®Æ¬Ý¨Ó, ®û¼í¤ÏÀ³»PT²ÓM¤ñ¸û¦³Ãö |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/5/25 ¤U¤È 02:45:48²Ä 1651 ½g¦^À³
|
Pie¤j¤j§A¦n, §A´£¨ì....¡K¦]¬°¥LÌÁÙ¨S¥X²{IgG°ª®p, ´N¤w¸gPD¤F, ´Nºâ¤§«á¹F¨ìIgG°ª®p, ¤]¶q¤£¨ì¤F¡K.. ¦ý¬O,ºKn¤W¡K....¦ý¬O¡A¦³50%ªº¹êÅç²Õ±wªÌ¡A¹ï OPT-822/OPT-821 ²£¥Í Globo H ¯S²§IgG §ÜÅé (³o¬O«ü§ÜÅé®Ä»ù´¿¦bªvÀø´Á¶¡¤º¹F¨ì ≥ 1:160)¡C¡K ³o¬q·N«ä ¸ÑŪ¤W ¡§´¿¦bªvÀø´Á¶¡¤º¨ì¡¨ ¬O¤£¬OÀ³¸Ó¬O ´NºâPD¤F ¦ýÁÙ¬O¦³´ú¶q ¤p§Ì¶È³o³¡¥÷¦³ÂI¤p¬Ýªk,¨D±Ð,ÁÂÁ ·|û¡Gpie10141536 µoªí®É¶¡:2016/5/24 ¤U¤È 10:48:51²Ä 1646 ½g¦^À³ ¡K. Y¬O±N¹êÅç²Õ¤À¬°°ª§ÜÅé¥H¤Î§C§ÜÅé¨â²Õ, ©µ¿ð¤ÏÀ³´Á¶¡³o10% PD·|¦p¦ó¤À°t©O? µª®×¬O·|¥þ³¡¤À¨ì§C§ÜÅé¤ÏÀ³³o²Õ, ¦]¬°¥LÌÁÙ¨S¥X²{IgG°ª®p, ´N¤w¸gPD¤F, ´Nºâ¤§«á¹F¨ìIgG°ª®p, ¤]¶q¤£¨ì¤F §C§ÜÅé²Õ¤H¼Æ¬ù¦û¹êÅç²Õ¤@¥b, ¹êÅç²ÕÁ`¤H¼Æ10%µ¥©ó¬O§C§ÜÅé²Õªº20% ¤]´N¬O»¡, ¦b©µ¿ð¤ÏÀ³´Á¶¡¤º, §C§ÜÅé²Õ¦³20% PD, ¹ï·Ó²Õ¦³10% PD, ¤@¶}©l¥ß¨¬ÂI´N¤£¥µ¥¤F ¹L¤F©µ¿ð¤ÏÀ³´Á¶¡, §C§ÜÅé²Õ©M¹ï·Ó²Õ¤~¶}©l¤½¥Ävª§ ©Ò¥H¾ãÅé¨Ó¬Ý, §C§ÜÅé²ÕPFS¤ñ¹ï·Ó²Õ®t¬O¦X²zªº |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/25 ¤W¤È 11:43:08²Ä 1650 ½g¦^À³
|
¥xÁÞ¤j¡B²³¤j¤j ´N¥Ø«e¬ã¨s©Òª¾ Globo H series¥u¦s¦bÀù²ÓM»P¥¿±`FL²ÓM ¦]¬°±M¤@©Ê°ª¡A©Ò¥H²£¥Í¯S²§©Ê§ÜÅé¶q»·¤£¬OKLH-STN¯à¤ñªº ©Ò¥H½×¤åºKnÅã¥Ü¥X822¨ãÀø®Ä¡C ¦ý Yn²¾©¹§ó¦´Á¡A¬Æ¦Ü°µ¬°¹w¨¾¨Ï¥Î ªí¥Ü¥¼¨Ó¶·¥[ªø§ÜÅé°O¾Ð´Á(833¥i¼WªøIgG°O¾Ð´Á) §Úªº°ÝÃD¬O FL²ÓM¤]±a¦³Globo H series ³oªí¥ÜGH¯S²§©Ê§ÜÅé±N·|¹ïÃh¥¥°ü¤kªº¥¿±`FL²ÓM¶i¦æ§ðÀ» YnÂର¹w¨¾¥Î³~¡A¨º¡K¡K¬O§_¦³¸Ñ??? |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/5/25 ¤W¤È 11:06:22²Ä 1649 ½g¦^À³
|
¥xÁÞ¤j.. ·PÁ±zªº¸Ñ»¡..³o¸Ñ»¡,·Q¨ì´Nı±o¤Ó´Î¤F.¤Ó¬ü¤F.¤H¶¡·¥«~,¤W¤Ñ©Ò½ç.. ~~~~~~~~ 2 ªk»¡·|Michael¦³Á|¨Ò¡A°²³]¥½´Á¨ÅÀù¯f±w¯à²£¥Í¨¬°÷§ÜÅé¶q¨ÓÄè·ÀÀù²ÓM¡A°²³]1000Ó³æ¦ì [°²³]©Ê§ÜÅé¶q¡A¤]³\¬O320,160,©Î640] °·±dªº¤H·Q¹w¨¾¡A¥un¥´§¹´ú¸Õ°w¾¯¯à²£¥Í¬Û¦P§ÜÅé¶q´N¯àÃÒ©ú¦³¹w¨¾®ÄªG 3¦P¼Ëªº±À²z¡A¤T´Á¯f±w¯à²£¥Í¨¬¥H®ø·ÀÀù²ÓMªº§ÜÅé¶q¤]¯à±À½×¨äÀø®Ä¡A¤@´Á¤G´Á¤]¬O¤@¼Ë ¬ü°êFDA¥i¨Ì¾Ú³oÓ±À²z¨Ó®Ö㦤¤´Á»P¹w¨¾¥Î³~¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/5/25 ¤W¤È 10:00:36²Ä 1648 ½g¦^À³
|
T^T¤j ±zªººÃ¼{¬Û«Hª©¤W¯E¤Í³£´¿¸g·Q¹L ¦ý¸g¹L¸Ô²Ó§PÂ_»PÅçÃÒµo²{®Ú¥»¸ò±z©Ò·Q§¹¥þ¤£¦P ªÑ»ù¥iº¦¨ì480~505´N¬O³oÓì¦] ¤Ñ©R¤jªº¤ÀªR«Ü³z¹ý±z¥i¥H¥h¦n¦n¬ã¨s¤@¤U ¦³§ÜÅé´N²£¥ÍÀø®Ä³o¬O«Ü¬ì¾Çªº¡A¤]´N¬O±i¸³©Ò»¡"¬ì¾Ç¤Wªº¦¨¥\" ¦Ü©óÁ{§É¤Wªº¦¨¥\¡A¦³±M®a·|ij°Q½×«á²Ä¤T´ÁÀ³¸Ó¥i¥H³]pªº«Ü¦n ¤½¥q¥¼¨ÓÀ³¸Ó¬OÃĬã¨s¦p¦óºû«ù§ÜÅé°ªºw«×¡A«ùÄò¥B±j®Ä ³o¼Ë¥¼¨Ó²×µ²³o¤Q´XºØÀù¯g±N«ü¤é¥i«Ý ªÑ²¼¬O¶R¥¼¨Ó¡A¤£¬O¶R¹L¥h»P²{¦b¡A¥¼¨Óªº»ùȯuªº¤j¨ì¥xÆW¥v¤W¥¼´¿¥X²{¹L³o¼Ëªº¤½¥q ·ç¤h¦³¿ÕµØ¡A¥xÆW¦³¯E¹©¡A6/4´¦W°ê»Ú«áÃÒ©ú¯uª÷¤£©È¤õ·Ò ~~ |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/5/25 ¤W¤È 08:46:49²Ä 1647 ½g¦^À³
|
(¤@´Á*1.0+2´Á*0.95+3´Á*0.9+4´Á*(>0.5))*16=822 ¬°¤°»òEXCEL·|ºâ¤£¥X¨Ó¡H¦Ñ±Cªº©h©h½T»{ªÍÀù¥|´Á...¯E¹©¥[ªo...´Nºâ¥u¦³10¢H¡A¤]·|¸Õ¸Õ°Ú... |
|
|
·|û¡GÁÙ¯u10138289 µoªí®É¶¡:2016/5/25 ¤W¤È 08:38:03²Ä 1646 ½g¦^À³
|
¥xÁÞ¤j, ³o´N¹ï¤F, ¤p§Ì¥»¨ÓÁÙ¦b·Q, ¨ÅÀù¥|´Á°µ§¹, ¨º¤T´Á¤G´Á¤@´Á¤]³£n°µÁ{§É¶Ü ... ¨º°Z¤£¬OÃm¤é¼o®É, ¥|´Áªº¸gÅç, À³¥i¥HÀ³ÃÒ¨ì¤T´Á¤G´Á¤@´Á¬Æ¦Ü°·±dªº¤H¨¤W, ¤£¹L¾¯¶q©Î³\»Ýn°µ½Õ¾ã .. |
|
|
·|û¡GÁÙ¯u10138289 µoªí®É¶¡:2016/5/25 ¤W¤È 08:26:29²Ä 1645 ½g¦^À³
|
¦pªGOBI-822 ¬I¥´¨ì°·±dªº¤H¨¤WÃÒ©úµL¬r©Ê, ¨º¤p§Ì¥i¤]n¥´, ¨k¤H¨ÅÀù¾÷²v¤p, ¦ý¨ä¥L15ºØÀù¯g¤@°_¹w¨¾, «eÃD¬O : n¦³°·±dªº¤HÄ@·N°µ¤HÅé¹êÅç, ¤@¯ë¤H¬O¤£Ä@·Nªº, ¦ý§Ú¹ï¤½¦Ðªº«H¥ô, Ó¤H¬O«Ü¼Ö·Nªº |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/25 ¤W¤È 08:19:03²Ä 1644 ½g¦^À³
|
µL¤j¤j 1¤¨·ù¥D¯uªº¦³»¡³oÓÃĤW¥«¥L¤]·Q¥´¤@°w¨Ó¹w¨¾¡A³o¤]ªí¹F¥X¹ïOBI822ªº«H¤ß¡C 2 ªk»¡·|Michael¦³Á|¨Ò¡A°²³]¥½´Á¨ÅÀù¯f±w¯à²£¥Í¨¬°÷§ÜÅé¶q¨ÓÄè·ÀÀù²ÓM¡A°²³]1000Ó³æ¦ì [°²³]©Ê§ÜÅé¶q¡A¤]³\¬O320,160,©Î640] °·±dªº¤H·Q¹w¨¾¡A¥un¥´§¹´ú¸Õ°w¾¯¯à²£¥Í¬Û¦P§ÜÅé¶q´N¯àÃÒ©ú¦³¹w¨¾®ÄªG 3¦P¼Ëªº±À²z¡A¤T´Á¯f±w¯à²£¥Í¨¬¥H®ø·ÀÀù²ÓMªº§ÜÅé¶q¤]¯à±À½×¨äÀø®Ä¡A¤@´Á¤G´Á¤]¬O¤@¼Ë ¬ü°êFDA¥i¨Ì¾Ú³oÓ±À²z¨Ó®Ö㦤¤´Á»P¹w¨¾¥Î³~¡C |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/5/25 ¤W¤È 08:16:10²Ä 1643 ½g¦^À³
|
§Ú·QT^T¤j¥u¬O·Q¯E¤ÍÌ¥X²M¯E¹©Åܨ¸Î¤Í§a! (©ïX??) ¥u¬O¤è¦¡¸ò½×ÂI¥i¯à¤£¤Ó§l¤Þ¤H... www.berich.com.tw/dp/TalkTalk/Talk_Detail.asp?ii=132891&CNpg=1 2015¦~4Q¤¤¸Î¡A ¦¬¦¨ ! ·|û¡GT^T10142245 µoªí®É¶¡:2016/5/11 ¤U¤È 05:48:27²Ä 2139 ½g¦^À³ ¸Ó¦W¼Lªº¦^À³´N¬O¨å«¬ªº¤jµó§n¬[¡A¤£¥²Á¿ÅÞ¿è&¬O«D¡A¥un¤@ª½¤£Â_ªº§ðÀ»(·íµM´N¤£¥²½Í¦X²z&¥¿½T©Ê¤F)¡A¯º¯º´N¦n!¦pªG§A¬Oªø´Á§ë¸êªÌ¡A·|¦b¥G³oµu´ÁªºÀ£§í¶Ü? §Ú¤Ï¦Ó°ª¿³¦³¾÷·|«ùÄò¥[½X! |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/25 ¤W¤È 07:49:39²Ä 1642 ½g¦^À³
|
Pie¤j ¤p§Ì·q¨Ø±zªº¥Î¤ß¤ÀªR ¤]»{¦P±z²ÎpÆ[ÂI §Y¦]¬°©µ¿ð¤ÏÀ³ ¦Ó¨ÏPD ¼W¥[ ¤£¹L¤p§Ì½Ð±Ð±z ´£¥XºÃ´b ¤]´N±Ð¤j®a ¬O§_®û¼í¤ÏÀ³¬O¦]¬°IgM¦b²Ä¤T¶g¹F350ªº³Ì°ªºw«×©Ò³y¦¨ ¦Ó©µ¿ð¤ÏÀ³«h¬OIgG¦b²Ä¤E¶g¹F160³Ì°ªºw«× ¤~µo¥Í¤§¬G? |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/5/25 ¤W¤È 12:56:03²Ä 1641 ½g¦^À³
|
¥xÁÞ¤j... §O§Ñ¤F,ÁÙ¦³¤j¤jªÑªF¤¨·ù¥D,´N´¿¤½¶}»¡¹L.. ¯E¹©ªºÃÄ,¥un¨ú±oÃÄÃÒ..§Ú²Ä¤@Ó´N¥ý¥´¤@°w... ¬O¨}ÃÄ.¬O§®ÃÄ,¤]¬O¥P¤¦... |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/25 ¤W¤È 12:46:59²Ä 1640 ½g¦^À³
|
T^T¤j ¨ì¥Ø«e¬°¤î, §Ú¤£»{¬°¤½¥q¸Û«H¦³°ÝÃD ¥u¬O´N¨Æ½×¨Æ, ºÉ¶q¦b¦³¸ê°T¤U, °l¨D¯u¹ê ASCO½g´T¦³, ¤½¥q¯à¼gªº´N¨º»ò¦h, ³Ñ¤Uªº¹L¨S´X¤Ñ¤j·|¤W´N·|¤½§G¤F, À³¸Ó¨S¦³¿ï¾Ü©Êªº°ÝÃD ª½±µ°ö¾i§ÜÅé, ¥´¤J¤HÅéªvÀø, ¤£´N¬O¤½¥q³W¹º¤¤ªº²£«~888¶Ü? ³o¨S¦³¨º»ò²³æªº... ¤p§Ì¤]¥H¬°¹L©ó¼ÖÆ[ªº½T¬OÓ°ÝÃD, ¦ý¦¹ª©¤ñ¸û±Mª`°Q½×°ò¥»±, Y¹ï¤½¥q¦³½èºÃ¤§³B, ¥i§_²¾¾r¨ì(²Ä¤Q¤HÆ[ÂI), ¬Û«H¯à°Q½×±o§óºÉ¿³ |
|
|
·|û¡G§Ú¬O´²¤á10141269 µoªí®É¶¡:2016/5/25 ¤W¤È 12:41:50²Ä 1639 ½g¦^À³
|
T^T10142245§A»¡Mabvax¥Lªº¥«È¬ù5»õ¥x¹ô¡A¯E¹©ªº¥«È°ª¦ô¦h¤Ö´N¦Û¤vºâ§a......§A³o¼Ëºâ§O¦³¥Î¤ß¶Ü???...........¯¬ºÖ§A»°ºò¨«¤@¸ô¶¶·.¤£°e¤F!!!!!! |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/25 ¤W¤È 12:28:18²Ä 1638 ½g¦^À³
|
©êºp¤F¡A¶}ª©ªºCliff¤j¡A¬JµM³o¸Ì¥un¤@¨¥°ó¡A´NÅý¥L̵o´§¤F! |
|
|
·|û¡G§Ú¬O´²¤á10141269 µoªí®É¶¡:2016/5/25 ¤W¤È 12:22:06²Ä 1637 ½g¦^À³
|
T^T10142245§A¬JµM¦³ºÃ°Ý¡A¦ó¤£¬Ý§O¤ä °µ¦Û¤v¬ÝÀ´ªºªÑ²¼´N¦n!!!!¥xªÑ¤S¤£¥u³o¤@¤ä¥i¥H¶R.....ÁÙ¬O§A§O¦³¥Î¤ß?????? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/25 ¤W¤È 12:21:09²Ä 1636 ½g¦^À³
|
ÁÙ¯u¤j ±i¸³¦bªk»¡¤Wªº½T¦³»¡:¦pªG¥½´Áªº¤H¥´¤F¬Ì]²£¥Í§ÜÅé¹F¨ì¬YÓ¶q´N¦³Àø®Ä, ¨º²z½×¤W°·±dªº¤H¦pªG¥´¤F¬Ì]¤]¯à²£¥Í¤@©w¶qªº§ÜÅé, À³¸Ó¤]¬O¦³Àø®Äªº, ³o¼Ë´N¯à·í§@¬O¹w¨¾©Ê¬Ì], ³o¬O¥¼¨Óµ´¹ï·|¥h°µªº °O±o¥H«e§Ú´£¨ì¤@Ó±À´ú·Qªk: ¨ÅÀùOBI822¹ï±ß´Á¯f±w¦³¥i¯à¬O¨}ÃÄ,¹ï¤¤´Á¯f±w¦³¥i¯à¬O§®ÃÄ,¹ï¦´Á¯f±w¦³¥i¯à¬O¥P¤¦(¶V¦´Á§K¬Ì¨t²Î¥¼¾D¨ü¯}Ãa) ¦pªG¨}Ãįà¥ý¨Ï¥Î¬¡¹L6-7¦~µ¥«Ý¨ÅÀùOBI833ªº°Ý¥@,¨ÅÀùOBI833 IgG ªø´Á°O¾Ð§ó±j¤j, ¹ï¦¤¤´Á¯f±w¦³¥i¯àÅܦ¨¥P¤¦,¹ï±ß´Á¯f±w¦³¥i¯àÅܦ¨§®ÃÄ(§Æ±æ¯E¹©§V¤O¬ãµoÅý¯f±w³Ì¤Ö¦A¬¡10¦~µ¥«Ý§ó·s¤@¥N¬Ì]) ¨ÅÀùOBI822 833 ¥¼¨Ó¤@©w·|±qªvÀø©Ê¬Ì]°µ¨ì¹w¨¾©Ê¬Ì],¤]·|§Ö³t¶i¦æ¦¤¤´ÁÁ{§É¸ÕÅç §Ú¬ðµM·Q°_2014¦~¦~¯Î°|ªøªººtÁ¿: °·±d°ª®p½×¾Â ¬Ì]®Úªv¨ÅÀù ¥¼¨Ó¤£¬O¹Ú www.youtube.com/watch?v=oiaZfQkegEk ¥t¥~ ¹w¨¾©Ê¬Ì]¥«³õ¬Û·í¤j(¤j®a·Q·Q±o¨ÅÀùªº¤H¦hÁÙ¬O¨S¦³±o¨ÅÀùªº¤H¦h,¨S¦³±o¨ÅÀùªº¤H·|¤£·|·Q¨C¦~¥´°w¨Ó¹w¨¾¤@¤U,¦p¦P¥´¬y·P¬Ì]¤@¼Ë) |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2016/5/24 ¤U¤È 11:59:09²Ä 1635 ½g¦^À³
|
¹ï·Ó²Õ²£¥Í GLOBAL-H §ÜÅ骺¤ñ²v¦³¦h¤Ö?? µª®×¬O""0"" ¨S¥´§Üì¦ó¨Ó§ÜÅé.. ¦A¥h§â»¡©ú·|Å¥¤@¹M... |
|
|
·|û¡G·x·x10141215 µoªí®É¶¡:2016/5/24 ¤U¤È 11:55:55²Ä 1634 ½g¦^À³
|
**®ÚªvÀù¯g**¥|Ó¦rȦh¤Ö?Åý§ÚÌÄ~Äò¬Ý¤U¥h! |
|
|
·|û¡G¸Û¤ß10142309 µoªí®É¶¡:2016/5/24 ¤U¤È 11:52:25²Ä 1633 ½g¦^À³
|
ÁöµM«Ü¤£·Q¥s¤H±N¯E¹©½æ±¼,¥i¬OÁÙ¬O§Ô¤£¦í·QÄUT^T¤j±zÁÙ¦³9Ó¥æ©ö¤é¥i¥H½æ! ¤U¬P´Á¤»¦n¹³n¸É¤W¯Z! |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/24 ¤U¤È 11:51:18²Ä 1632 ½g¦^À³
|
°e³øªº §A¦³¨S¦³¬Ý¨ì tiger365ªº°ÝÃD¡A¬JµM¤½¥q¥i¥H§i¶D¤j®a¹êÅç²Õ50%²£¥Í§ÜÅé¡A²£¥Í§ÜÅéªÌ¦s¬¡¸û¨Î¡A¨º«ç»ò¤£»¡¹ï·Ó²Õ¦h¤Ö²£¥Í§ÜÅé¡A¨º¹ï·Ó²Õ²£¥Í§ÜÅéªÌ¬O¤£¬O¤]¥i¥H¬¡ªº¦n¡C |
|
|
·|û¡GÁÙ¯u10138289 µoªí®É¶¡:2016/5/24 ¤U¤È 11:40:08²Ä 1631 ½g¦^À³
|
¯E¹©¥u°µ¥½´Á´N¤Ó²L¤F, ±i¸³¦bªk»¡¤W»¡, "¦pªG¥½´Áªº¤H¥´¤F¬Ì]²£¥Í§ÜÅé¹F¨ì¬YÓ¶q´N¦³Àø®Ä, ¨º²z½×¤W°·±dªº¤H¦pªG¥´¤F¬Ì]¤]¯à²£¥Í¤@©w¶qªº§ÜÅé, À³¸Ó¤]¬O¦³Àø®Äªº, ³o¼Ë´N¯à·í§@¬O¹w¨¾©Ê¬Ì], ³o¬O¥¼¨Óµ´¹ï·|¥h°µªº" ¥½´Á¬O«üÀù¯g¤w¸gÂX´²¨ì¨ä¥L¾¹©x¤F, ¥þ¥@¬É¦³þÓÃįà§âÀù¯g¥|´Á NEDªº, ³o¹ï¨DÂåY´÷ªº¤H¦Ó¨¥¤w¸g¬O¥P¤¦¤F ... |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2016/5/24 ¤U¤È 11:34:17²Ä 1630 ½g¦^À³
|
T^T10142245 §A¬O¨Ó¶Ãªº°Ú.. "³o¦¸¤½¥q¿ï¾Ü©Êµo¥¬ªº¼Æ¾Ú¡A¨Ã¸¹ºÙ¦³²£¥Í§ÜÅé´N¦³Àø®Ä"..¨º¯Î°|ªø¥[¤W¤½¥q¤@°_¨ÓÄF§A´N¬O°Õ. §ìµÛ¤£¯à¤½§G§¹¾ã¼Æ¾Ú´N»¡¤½¥q¿ï¾Ü©Ê....³o¦ì±M®a§A¸ò§A¦b¤¤¸ÎªO¸Ì½|ªº¨º¨Ç¦W¼L¦³¦ó®t§O.... |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/5/24 ¤U¤È 11:19:35²Ä 1629 ½g¦^À³
|
§Ú»{¦P¥xÁÞ¤j¬Ýªk... °£«DOBI-822¤£¨ãÀø®Ä,©Î»¡Àø®Ä«Ü§C.. ¥un¬O¦nªF¦è,¦n¦n¦æ¾P,Åý¥þ²yÀù¯g¯f±w¯à°÷ÂǥѦ¹¦Ó¥ý´Áª¾¹D,³o¥i¥H´N¥L̯fµhªºÃÄ,¬O¤w¸g§Ö¶}µo¥X¨Ó.. µ¹¥L̤伵¤U¥hªº«i®ð»P«H¤ßµ¥«Ý... ¥t¥~,°ê¤ºªº¨rÆN¤´¥¼½}¤â,ÂǦ¹¾÷·|.. Y·íASCO½×¤å³ø§i«á,¥þÅé»P·|ªÌ¯¸°_¨Ó¤j¤O¹ª´x³Üªöªº½Ã¬Pµe±¶Ç¦^¥xÆW.. ¨º¤£¥u¥i¥H¼·¶Ã¤Ï¥¿,¦^µ¹¯E¹©¤½¥q¤@Ó¤½¹D,¤]¦P®É¥i¥H±Ð¨|¥xÆW¤H,¦¹¨Æªº±Ð°V»P¬Ù«ä.. ¦æ¾P...¦n¨Æ... |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/24 ¤U¤È 11:00:22²Ä 1628 ½g¦^À³
|
¬ì¾Çn¦A¤£ºÃ³B¦³ºÃ¡Cº¥º¥¬Ý¨ì´XӪѤͬݥX°ÝÃD¡A³o¦¸¤½¥q¿ï¾Ü©Êµo¥¬ªº¼Æ¾Ú¡A¨Ã¸¹ºÙ¦³²£¥Í§ÜÅé´N¦³Àø®Ä¡C¦pªG¦p¦¹¡A¨º§â§ÜÅé©â¨ú¥X¨Ã¤j¶q½Æ»s¡A¦A¥´¦^¯f¤H¨¤W¡A¨º¤£´N¦³§ÜÅé¨S§ÜÅé³£¦³Àø®Ä¤F¡C Mabvax´N¬On³o¼Ë°µ¡A¦ý¬O¦b¬ü°ê¡A¥Lªº¥«È¬ù5»õ¥x¹ô¡A¯E¹©ªº¥«È°ª¦ô¦h¤Ö´N¦Û¤vºâ§a! |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/24 ¤U¤È 10:48:51²Ä 1627 ½g¦^À³
|
Ãö©ó¤µ¦´£¨ìªº°²»¡, ¨ä¤¤®û¼í®ÄÀ³À³¸Ó§ï¬°°²©ÊPD(pseudoprogression) ®Ú¾Újco.ascopubs.org/content/early/2015/08/06/JCO.2015.61.6870.full §K¬ÌÀøªk°²©ÊPD¦³¨âºØ±¡§Î 1. ®û¼í®ÄÀ³: T²ÓM¶i¤J¸~½F¤º, ¸~½F·|¥ýÅܤj, µM«á¦AÁY¤p 2. ·s¼W¯fÅÜ: T²ÓM»E¶°¦b쥻¹L¤p¦Ó±½´y¤£¥X¨ÓªºÀù²ÓM³B, ¬Ý°_¨Ó¹³¬O·s¼W¯fÅÜ PD1À³¥Î¦b¶Â¦â¯À½F¤W, ¬ù¦³3%~10%¤£µ¥ªº°²©ÊPD ¦ý¬O¤£¦PªºÀù¯g, ¤£¦Pªº§K¬ÌÀøªk, ·|¦³¦h¤Öªº°²©ÊPD, ¥Ø«e³£ÁÙ¤£²M·¡ §K¬ÌÀøªk°²©ÊPDÁÙ¦³³\¦h¥¼ª¾¤§³B 822¥i¤ÞµoB²ÓM, NK²ÓM, T²ÓM, IgM, IgG, ¸ÉÅé¨t²Îµ¥µ¥§K¬Ì¤ÏÀ³ ¨s³º·|¦³¦h¤ÖT²ÓM, ¦h¤Ö°²©ÊPD, ¥Ø«e¨ä¹ê³£ÁÙ¤£ª¾¹D ˬO¤µ¤Ñ¤S¦³¤@Ó·Qªk, ¥i¸ÑÄÀ¬°¦ó§C§K¬Ì¤ÏÀ³²ÕPFS¸û¹ï·Ó²Õ®t °ò¥»¤W¬O±q²ÎpÆ[ÂI¤Á¤J, Æ[¹î¤À²Õªº®ÄÀ³ ®Ú¾ÚCliff¤j´£¨Ñ¤@´ÁÁ{§ÉIgGªº¹Ï ¡uwww.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=21925_pq0990752003.jpg ¡v IgG¹F¨ì°ª®p160, ¬O¦b¥´§¹¥|°w¤§«á, ¬ù¦b²Ä¤E©Pªº®É¶¡, ¦b³o¤§«e¥iµø¬°©µ¿ð¤ÏÀ³(delay response) ¦b©µ¿ð¤ÏÀ³´Á¶¡, ¹ï·Ó²Õ»P¹êÅç²ÕÀ³¸Óªí²{¬Û·í °²³]MPFS 10Ó¤ë, ¨CӤ뵥³t¤U°, ¤]´N¬O5% PD, ¨Ã°²³]©µ¿ð¤ÏÀ³®É¶¡¤K¶g ¨º»ò©µ¿ð¤ÏÀ³¨âÓ¤ë®É¶¡¤º, ¹ï·Ó²Õ¹êÅç²Õ¦U¦³10% PD Y¬O±N¹êÅç²Õ¤À¬°°ª§ÜÅé¥H¤Î§C§ÜÅé¨â²Õ, ©µ¿ð¤ÏÀ³´Á¶¡³o10% PD·|¦p¦ó¤À°t©O? µª®×¬O·|¥þ³¡¤À¨ì§C§ÜÅé¤ÏÀ³³o²Õ, ¦]¬°¥LÌÁÙ¨S¥X²{IgG°ª®p, ´N¤w¸gPD¤F, ´Nºâ¤§«á¹F¨ìIgG°ª®p, ¤]¶q¤£¨ì¤F §C§ÜÅé²Õ¤H¼Æ¬ù¦û¹êÅç²Õ¤@¥b, ¹êÅç²ÕÁ`¤H¼Æ10%µ¥©ó¬O§C§ÜÅé²Õªº20% ¤]´N¬O»¡, ¦b©µ¿ð¤ÏÀ³´Á¶¡¤º, §C§ÜÅé²Õ¦³20% PD, ¹ï·Ó²Õ¦³10% PD, ¤@¶}©l¥ß¨¬ÂI´N¤£¥µ¥¤F ¹L¤F©µ¿ð¤ÏÀ³´Á¶¡, §C§ÜÅé²Õ©M¹ï·Ó²Õ¤~¶}©l¤½¥Ävª§ ©Ò¥H¾ãÅé¨Ó¬Ý, §C§ÜÅé²ÕPFS¤ñ¹ï·Ó²Õ®t¬O¦X²zªº ¨º»ò°ª§ÜÅé²Õ©O? ¥Ñ©ó©µ¿ð¤ÏÀ³´Á¶¡PD³£³Q¤À¨ì§C§ÜÅé²Õ¥h¤F, ©Ò¥H³o¬q´Á¶¡0% PD, KM¦±½uµe¥X¨Ó¬O¥ªº, ¹L¤F©µ¿ð¤ÏÀ³´Á¶¡¤~¶}©l¤U° ¬Û¹ï©ó¹ï·Ó²Õ©µ¿ð¤ÏÀ³´Á¶¡10% PD, ¤@¼Ë¬O¥ß¨¬ÂI¤£¥µ¥ °ª§ÜÅé²Õ:¹ï·Ó²Õ, PFS HR = 0.71 ¹ï·Ó²Õ:§C§ÜÅé²Õ, PFS HR = 0.52/0.71 = 0.73 (¦Û¦æ±À½×) ³o¼Ë¤ñ¸û¥X¨ÓªºPFS®t²§, ¨ì©³¦³¦h¤Ö¬O§ÜÅéÀø®Ä, ¦h¤Ö¬O¤À²Õ³y¦¨ªº, ¦ü¥G¬Ý¤£¥X¨Ó ¥H¤W¦³°µ¤@¨Ç²¤Æ¼Æ¾Úªº°²³]¨Ó¤è«K±À½×, ¤£¹L·N«ä¤j·§¬O³o¼Ë ¤Sn¦Aµ¥¤@¦¸¸Ñª¼¤F... ¥t¥~, ¤p§Ì¤]ı±o, ¥i¥H©¿²¤ÂI¾\¦¸¼ÆXX¸Uªº·s»D¤F |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/24 ¤U¤È 05:47:16²Ä 1626 ½g¦^À³
|
½Ð¤j®a °ò¨È¸Ñª¼«á¦³¥hºô¸ô¦æ¾P¶Ü¡H ¨º¯E¹©¬°¦ó¥h¡H¾Ì¦ó¥h¡H Ãø¹D¬O¿ú¤Ó¦h¶Ü¡H ·Q³q¤F ´Nª¾¹D¤½¥q»P¤jªÑªFªº¤ßºA |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/24 ¤U¤È 02:01:56²Ä 1625 ½g¦^À³
|
ªü¤å¤j §A¥i¯à»~¸Ñ¤F ¤£¬O¬ÝASCO¤@¤Ñ¥§¡³y³X¤H¼Æ¬O¤@¸U¦h¤H §Ú²q¬O¯E¹©ªº½×¤åºKnÂ൹¯S©w·s»D´CÅé ¦A¥Ñ¯S©w·s»D´CÅéÂ൹¬ü°ê¡B¼Ú¬w¤Î³¡¤À¨È¬w¦a°Ï¼sÀò·s»D³ø¾É©MªÀ¸sÂà¸ü¡A p¦³225®a´CÅé¥Z¸ü,¯E¹©¾Ç·|¦æ¾P²£«~³o¬Oȱo¹ªÀyªº¨Æ, ¥t¥~²£«~n¦n¦æ¾P¤~¦³®ÄªG,²£«~¤£¦n¦A«ç»ò¦æ¾P ¤]¨S¦³¥Î |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/5/24 ¤U¤È 01:35:43²Ä 1624 ½g¦^À³
|
¯E¹©2/22ªk»¡ ¤å¦rÀÉ (3).Âùª¼ªº¹êÅ祲¶·¦³¹ï·Ó²Õ¡A¹ï·Ó²Õ¥u¯à¥´ÆQ¤ô°w¡B¥´¤@¨Ç¹ï¥Lªº§K¬Ì¦³¤@ÂIÂI¦n³BªºªF¦è¡A¤£¦ý¬O¹ï·Ó²Õ¡A¥ÎÃIJճ£¥t¥~¥´¤FCyclophosphamide¡A Cyclophosphamide¦b§C¾¯¶q¬O¦³§K¬Ì´£¤Éªº®ÄªG¡A·íªì´N¦³¾á¤ß³o¥ó¨Æ±¡¡A³o¦¸Á{§É¦b¸Ñª¼µo²{ªº½T¦³¤Ö¼Æ¦w¼¢¾¯²Õ¥¦·|²£¥Í§ÜÅé¡A²{¦b»¡©ú¤@¤U³oÓ§ÜÅé¡A§ÚÌÁ¿ªºIGG IGM§ÜÅ餣¬O¤@¯ëªº§ÜÅé¡A¬O±Mªù°w¹ïGLOBO H²£¥Íªº§ÜÅé¡A©Ò¥H³oÓ§ÜÅé¬O«Ü¯S§Oªº¡A©Ò¦³¶i¨Óªº¯f¤H¦b¶i¨Óªº¨º¤Ñ¡A¬O§¹¥þ¨S¦³§ÜÅ骺¡A¥i¬O¥´¦w¼¢¾¯(®Ú¥»¨S¦³¥´§Ú̪º¬Ì])¥u¦³¥´Cyclophosphamide¡A©~µM¦³¤Ö¼Æ¯f¤H¤]·|²£¥Í§ÜÅé¡A³oÓ§ÜÅé·íµMºâ¦b§Ú̱b¤W¡A±N¨Ó¦bpºâPFSn§â¦w¼¢¾¯²Õªº®ÄªG¦©´î±¼¡A¦]¬°³o¤TÓì¦]¡A©Ò¥H§Ú̬Q¤Ñ¦³»¡¨ì¦³ÂI¶^¯}²´Ãè¡A¬°¦ó§Ú̪ºPFS¨S¦³¹F¼Ð¡C©Ò¥H³o¸Ì´N¬O°µ¤@Ó¤ñ¸û²³æªº»¡©ú¡A³o¬O§Ú̬Q¤Ñ¬Ý¤F¼Æ¾Ú¥H«á¡A°µ¤F¤@ÓÁ`¦@ªº²Îp¡C³oÓ¹ï§Ú̱N¨Ó¦A°µ¥þ²yÁ{§Éµ´¹ï¦³À°§U¡A«ç»ò¥h³]p³o¼ËªºÁ{§É¡A¦]¬°§@¬°¥þ·sªº·sÃÄ¡A§Ú̦b2009¦~³]pÁ{§É¨S¦³¥ô¦óªº¨Ì¾Ú¥h°µ¡A©Ò¥H¬O«D±`§xÃøªº¡A¤U±ªº¤@ÓÁ{§É§ÚÌ´N·|¦³«D±`¦hªº¸ê®Æ¡A¨Ó¥h³]p¤@Ó¤ñ¸û¦nªºÁ{§É¡C |
|
|
·|û¡Gªü¤å10138375 µoªí®É¶¡:2016/5/24 ¤U¤È 01:30:21²Ä 1623 ½g¦^À³
|
¥xÁÞ¤j, http://alexa.chinaz.com/alexa_more.aspx?domain=asco.org&upd=false ASCO¤@¤Ñ¥§¡³y³X¤H¼Æ¬O¤@¸U¦h¤H ¦pªG§âºË¨ì·s»Dªº¤H³£ºâ¶i¥h(µL½×¦³¨S¦³¿³½ì),¨º"¼ç¦b"¤H¼Æªº½T¥i¯à¦³¼Æ¤d¸U §Ú¬Ý¦n³oÁûÃÄ,¦ý¤£»{¦P¤½¥qª±³oºØ¨S·N¸qªº¼Æ¦r¹CÀ¸ |
|
|
·|û¡Gtiger36510142526 µoªí®É¶¡:2016/5/24 ¤U¤È 01:28:11²Ä 1622 ½g¦^À³
|
Hello ¤j®a¦n.. ¤p§Ì¦³¤@Ó¹ï¯E¹©¸Ñª¼¸ê®ÆªººÃ°Ý ¤§«e±i¸³¦b¸Ñª¼»¡©ú·|¤W¦³»¡ ¦³¨Ç¹ï·Ó²Õ(¥¼¬I¥´ OBI822) ªº¯f¤H¦Û¨¤]²£¥Í¤F GLOBAL-H ªº§ÜÅé PFS ¤]©µªø¤F, ³o¤]¬O¸Ñª¼¥¼¹Lªº¥D¦]¤§¤@ ¤£ª¾¹D¦³¨S¦³¤Hª¾¹D¹ï·Ó²Õ²£¥Í GLOBAL-H §ÜÅ骺¤ñ²v¦³¦h¤Ö?? °ß¦³³o¶µ¼Æ¾Ú ¤~¯à»¡©ú GLOBAL-H §ÜÅé¬O¥Ñ OBI822 »¤µo.. ¤£¬O¯f¤H¨Åé¦Û¤v´N·|²£¥Íªº... ±æºô¤W¥ý¶i¦^µª¤@¤U³á.. |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/24 ¤U¤È 01:03:43²Ä 1621 ½g¦^À³
|
ªü¤å¤j ¤£nÃhºÃ¼ç¦bÂI¾\¤H¼Æ: ¦b¥xÆW¥H¥~¡A¤w¶W¹L9452¸U¦¸ ¯E¹©¤U¤ëªì±NuASCOµoªíªº¨ÅÀù·sÃÄOBI-822²Ä¤G/¤T´ÁÁ{§É¸ÕÅ禨ªG½×¤åºKn¡A18¤é¤U¤È5®É(ªÛ¥[ô®É¶¡)¦bASCOºô¯¸¤½¥¬¥H¨Ó¡A¦b¬ü°ê¡B¼Ú¬w¤Î³¡¤À¨È¬w¦a°Ï¼sÀò·s»D³ø¾É©MªÀ¸sÂà¸ü¡Ap¦³225®a´CÅé¥Z¸ü¡Aº¤é¼ç¦bÂI¾\¤H¼Æ¦b¥xÆW¥H¥~¡A¤w¶W¹L9452¸U¦¸¡C Ó¤H¬Ýªk: 1¤£n»´©¿ºô¸ô´CÅ骺¶Ç¼½¼s«×»P³t«×, ¦b¬ü°ê¡B¼Ú¬w¤Î³¡¤À¨È¬w¦a°Ï¼sÀò·s»D³ø¾É©MªÀ¸sÂà¸ü¡Ap¦³225®a´CÅé¥Z¸ü 2¼ç¦bÂI¾\¤H¼Æ:°£¤F²Îp225®a´CÅé¥Z¸üªº¾\Ū¤H¤f¥~ ÁÙ¥]¬AÃe¤jªºªÀ¸sÂà¸ü 3¥H¤p¤pªº¥xÆW¨Ó»¡:¤¤¥¡ªÀ ¤u°Ó ªF´Ë°]¸g¨Ó¥H¶]°¨¿O¤æ¤jªº¦rÅé§Ö³t¶Ç¼½,©_¼¯ºô¯¸ ,¤¤®É¹q¤l³ø ¦Û¥Ñ®É³ø¹q¤l³ø ¦Ü¤Ö¼Æ¦Ê¸U¤H¬Ý¹L,¥²´Iºô¯E¹©ª©¦Ü¤Ö¬y¶q¤]¦³¤W¸U¤H ¦b³z¹Lline, facebook ¤À¨É ¤H¼Æ¤]«Ü¥iÆ[ 4¬ü°ê+¼Ú·ù+¤¤¤éÁú ¤H¤f¼Æ¬O¦h¤Ö? ³z¹L225®a´CÅé¥Z¸ü»PÃe¤jªºªÀ¸sÂà¸ü line, facebook Àù¯g¯f±wªÀ¸sºô¯¸ 5¤£nÃhºÃ¼ç¦bÂI¾\¤H¼Æ: ¦b¥xÆW¥H¥~¡A¤w¶W¹L9452¸U¦¸¡C |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/24 ¤U¤È 12:10:29²Ä 1620 ½g¦^À³
|
¨S·Q¨ì³o¸Ì±M®a¶V¨Ó¶V¦h¤F¡A¤£¦PstudyÁÙ¥i¥H³o¼Ë¤ñ¦s¬¡²v¡A¨º·F¹Àªá¿ú§@p2,p3, ³q³qopen label single arm ´N¦n¤F¡C «¢«¢¡C |
|
|
·|û¡Gªü¤å10138375 µoªí®É¶¡:2016/5/24 ¤U¤È 12:07:34²Ä 1619 ½g¦^À³
|
5619¤j, «Øij±z§Ñ¤F"9452¸U¦¸ÂI¾\", ¨º¥u¬O¤½¥q¤Ï¼³¹LÀYªº¤@Ó¯º¸Ü |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/5/24 ¤W¤È 11:50:48²Ä 1618 ½g¦^À³
|
·PÁ¤ѩR¤jªº¸Ô²Ó¤ÀªR©M¥Õ¸Ü¸ÑÄÀ¡A¯u¤ß·PÁ¡C822ªºÀø®Ä½T¹êÅãµÛ¡C ¯E¹©¨ÅÀù·sÃÄASCO½×¤åºKn¡A¤@©P¤º´N¦³¹O9452¸U¦¸ÂI¾\¡]¤ÓÅå¤H¤F¡AÃø¥H¬Û«H¡^¡C³oªí¥Ü¯E¹©822ªº¸ÕÅçµ²ªG¦bÂåÃĬɤw¼s¬°¤Hª¾¡C¦Ó¦b¥xÆW¡A¥Ñ©ó¡§¯E¹©®×¡¨¡AªÀ·|¤j²³´X¥GµL¤H¤£ª¾¡C ©ó¬O¡A¤p§Ì¦³ÓºÃ°Ý¡AÀø®Ä¸ÕÅçµ²ªGºKn¤½§G«á¡A¥Ó½Ð¡§®¦·OÀøªk¡¨ªº¯f±w¬O§_¤j¼W¡H²¦³º³o¥i¬O¨ÅÀù«¯gªº±Ï©RÃÄ°Ú¡C¤£¨£¥ô¦ó¬ÛÃö¨Æ¥ó³ø¾É¡H |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/24 ¤W¤È 11:39:11²Ä 1617 ½g¦^À³
|
¤Ñ©R¤j ÁÂÁ´£¨Ñ OBI-822 »P ¶PÀù¥Herceptin+¶P¯e§´(Perjeta) Áp¦X¥ÎÃĤ§¤ñ¸û |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/5/24 ¤W¤È 10:05:23²Ä 1616 ½g¦^À³
|
¤Ñ©R¤j¡A ·PÁ¡A³oÓ¤ÀªR¸ê®ÆÆZ³z¹ýªº¡A822ªGµM·|¬O¤@ӫܦ¨¥\ªº·sÃÄ ¤£¹Ln¥´¼Æ°w¤~·|ª¾¹D§ÜÅé¶q»P¦³¨S¦³®Ä¡A¦pªG¦³§ó§Öªº¿z¿ï¾÷¨î´N·|§ó¹ê¥Î ¯f±w¤£¥Î"¸Õ"¡A¥i¥Hª½±µ¨É¥Î´N¦n ²{¦b·Q¨Ó¤½¥qµo®i888ì¨Ó´N¬Oª¾¹D¦³¨Ç±wªÌ®Ú¥»¤£·|²£¥Í¹ïGHªº§ÜÅé¡AÄ@´º°µ¬°¤@Ó¥þ¤è¦ìµo®iªº¥@¬É¯Å¤½¥q ¬Û«H¥un°²¥H®É¤é«Ü¦³¾÷·|¯à¹ê²{ |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/5/24 ¤W¤È 08:49:48²Ä 1615 ½g¦^À³
|
¦U¦ì¤j¤j OBI-822°£¤F¡u¦³®Ä¡v¤§¥~¡AÁÙnª`·N¤@¤U¡u°Æ§@¥Î¡v¡H ¦pªG¡u°Æ§@¥Î¡v«Ü§C¡A©Î´X¥G¨S¦³¡A ¨ºª½±µ®³ÃÄÃÒªº¾÷·|¡A´N«D±`°ª¡I n¦b¡u°Æ§@¥Î¡v¤è±¡A¦h¤@ÂI°Q½×¡I ¤]n¦bªÑªF·|®É¡A°Ý¤@¤U±i¸³¡H ¶PÀù¥ªº¡u°Æ§@¥Î¡v¡A¦h¨ìÀ~¤H¡I |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/24 ¤W¤È 08:19:29²Ä 1614 ½g¦^À³
|
¥xÁÞ¤j »¡ªº·¥¬O µ¥ASCOµoªí ´N¬O¬Ó®a§¬¶¤F ½Ð±Ðpie¤j ®û¼í¤ÏÀ³ ¬O§_¯uªº °ª§C§ÜÅé¿@«×³£·|¤Þ°_¡H §Ú¥H¬°¥u¦³°ª¿@«× |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/24 ¤W¤È 07:56:24²Ä 1613 ½g¦^À³
|
¤G¤ë¨â«h¸ê°T ¥i¦AGoogle ¦^¨ý¤@¤UTFDA ·Qªk»P¥ß³õ OBI822¥Ó½Ð·sÃÄ ¹Ãĸp¡G¥¼¹w³]¥ß³õ ¯E¹©¤U¤@¨B¡G¥Ó½Ð·sÃij\¥iÃÒ |
|
|
·|û¡G¥m¾´10141821 µoªí®É¶¡:2016/5/24 ¤W¤È 06:38:15²Ä 1612 ½g¦^À³
|
999¤j¡A ¥h§a¡A¦w¤ß§i¶D¥L¦Ñ¤H®a¡A¨S¦³°ÝÃDªº¡A¨Åé¯à²£¥Í§ÜÅ骺¤H´N¦³Àø®Ä¡A ³Ñ¤Uªº¥u¬O¤@¨Ç§Þ³N©Ê©M·¾³qªº°ÝÃD¡AÃÄ¥»¨¨S¦³°ÝÃD¡C |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/5/24 ¤W¤È 01:53:36²Ä 1611 ½g¦^À³
|
Lu¤j¡G ÁÂÁ±z¡I ³o»ò¦³«H¤ß¡A¤Ó¶}¤ß¤F¡I ¯u¬O¦p¦¹³t«×¡A»a¥Í¦³ºÖ¤F¡I ¯E¹©ªº¦¨¥\¡A¤£¤î¨üÃøªº±wªÌ¡A³yºÖªº±wªÌ®aÄݧó¬OÃø¥H¦ôp¡C ¤j®a¨¯W¤F¡I¦@¦P¬°...¯E¹©¥[ªo...¥[¥[ªo... ÁÂÁ±z¡C |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/24 ¤W¤È 01:24:58²Ä 1610 ½g¦^À³
|
¤p§Ì·Q¨ì¤@°²»¡, ¥H¸ÑÄÀASCOºKn¤§¹êÅç¼Æ¾Ú, ¥H¤Î¸Ñª¼«á¤½¥q»¡ªk: ¦³¶W¹L80%ªº¤H°w¹ïOBI822²£¥Í§ÜÅé ²£¥Íªº§ÜÅ駡·|§ðÀ»Àù²ÓM, ¬O¿×²£¥ÍÀø®Ä °ß§ÜÅé¶q§CªÌ, ²£¥Í®û¼í®ÄÀ³«á, µLªk§Ö³t¶i¤@¨BÁY´î¸~½F, ¤j¶q»~§P, PFS¬Æ®t. ¥BÀø®Ä¤£ÅãµÛ, OS»P¹ï·Ó²Õ¬Ûªñ ¦Ó§ÜÅé¶q°ªªÌ, ²£¥Í®û¼í®ÄÀ³«á, ¯à°÷¶i¤@¨B§Ö³tÁY´î¸~½F, »~§P¶q¸û¤Ö, ¥B¹ê»ÚÀø®Ä¦n, PFS¤ÎOS³£»P¹ï·Ó²Õ©Ô¶}¶ZÂ÷ ¥H¤W°²»¡ÄÝ·¥«×¼ÖÆ[, ½Ð¤Å·í§ë¸ê¨Ì¾Ú |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/5/24 ¤W¤È 01:24:24²Ä 1609 ½g¦^À³
|
¤£¬O´X¦~¡A¬O´XÓ¤ë¡I ¦ý¬O¡A³Ì¤[±¡§Î¡A¦³¥i¯à¬O2¦~¡I¦ý¬O¾÷·|¤£¤j¡I |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/5/24 ¤W¤È 12:45:16²Ä 1608 ½g¦^À³
|
¥xÁÞ¤j«e½ú¡G OK¡I´N³o»ò¨M©w¤F¡I n¤£§Ú¯uªº¤T¤ß¤G·N¡K¤S¾á¤ß¨S¤Î®É¸[³ø,¤S©È¸[³ø¿ù»~ ·PÁ±zÄ_¶Qªº·N¨£¡I ¨º´N¤£«æ¤F¡K¦Aµ¥´X¦~§a¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/23 ¤U¤È 11:17:32²Ä 1607 ½g¦^À³
|
7 °ê»Ú±ÂÅvª÷°ª§C¥i«ÈÆ[¤ÏÀ³¨ÅÀùOBI822Á{§É¼Æ¾Úªºµû»ù 8 ¤@ÃĤ@¥ü¤¸ ·s¬F©²µo®i¥Í§Þ¬O¨«¦b¥¿½Tªº¤è¦V: Herceptin 2006-2015 ¥þ²y¾P°âªñ550»õ¬ü¤¸ ¦p¥[p2016¦~ ¹w¦ô±N¶W¹L600»õ¬ü¤¸ (³æÃÄ Herceptin MPFS ¬ù6-7Ó¤ë ¨ÅÀùOBI822 ¦b¦w¥þ©Ê ¥Í¬¡«~½è»P½×¤åºKn¹w¦ô ªºÀø®Ä¤£½×MPFS MOS ·|¤ñ Herceptin ¦n«Ü¦h ) 999¤j ¦³ÃÄÃÒ¤~¯àÃÒ©úÃĪ«¦w¥þ¦³®Ä ¤~¯à¶}½æ¦³À禬 ,¤£½×¥xÆW¥ý®³ÃÄÃҩάü°ê¥ý®³¨ìÃÄÃÒ ,®³¨ì«á¦A¤W¤s§iª¾¥O´L822¦¨¥\¤F¡I |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/5/23 ¤U¤È 10:44:17²Ä 1606 ½g¦^À³
|
¥xÁÞ¤j«e½ú¡G §Ú¤@ª½¦b´Á«Ý¦ó®É¯à¤W¤s²MÆF«e§iª¾®a¤÷822¦¨¥\¤F¡I«Ü§Ö¯à¤W¥«ÀÙ¤H¤F¡K ìªk»¡·|«á´N·Q¤W¤s¸[§i®a¤÷822¸Ñª¼¦¨¥\¤F¡A¨S·Q¨ì«áÄò¾D¨ü¨ì¦UºØªº¥´À»¡I ¬O§_¥i¥H½Ð±zµ¹§Ú«Øij¡KÀ³¸Ó¦bþÓ¶¥¬q¤W¤s§iª¾®a¤÷¤~¬O¥¿½Tªº¡H ÁöµM§Ú·QºÉ§Ö§iª¾®a¤÷¡K¦ý¨ä¹ê¥Ø«e§Ú¬Oº¡¯íµMªº¡K ¥i¯àªº¸Ü½Ðµ¹§Ú¤@¨Ç«Øij¦n¶Ü¡H ·PÁ±z¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/23 ¤U¤È 10:00:58²Ä 1605 ½g¦^À³
|
999¤j 6¤ë¥H«á¥i±K¤Áª`·N¥H¤Uµo®i:¨Ì¾Ú2¤ë22¤éªk»¡·|: °ê»Ú±ÂÅv Á{§É¶i«× TFDAÃÄÃҥӽР¥u·|¥[§Ö ¤£·|©µ«á 1 ¨ÅÀùOBI822¤G/¤TÁ{§É¸ÕÅç½×¤åµoªí¤½§i¼Æ¾Ú 2 §Z±_Àù¤G´ÁÁ{§Éµ²ªG¼Æ¾Ú¤½§i 3 °ê»Ú±ÂÅv¤½§i 4 °ê»ÚÁ{§É¸ÕÅç¦X§@¤½§i 5 ¬ü°êFDA¹ï¨ÅÀùOBI822¥¼¨Ó¤è¦Vªº½T©w ( Michael ¤TÓ¥i¯àµ²ªG ) 6 ¥xÆWTFDA¹ïOBI822ÃÄÃҥӽЮÖãµ²ªG (¥xÆWTFDAÃÄÃÒ ®Öã³q¹L µ¥¦Pì±o¶i¤JªF¨ó¥«³õ) |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/5/23 ¤U¤È 05:24:51²Ä 1604 ½g¦^À³
|
¥xÁÞ¤j«e½ú Æg¡I«B¹LÁ`·|¤Ñ´¸¡I Æg¡I¯u¬ÛÁ`·|¤j¥Õ¡I µL«ë¥²¦³ºÖ¡AºÖ³ø¨Ó¦Û¼w¡C ¦U¦ì¤j¤j¡A®¶§@¡A¦A®¶§@¡A¥[ªo¡A¥[ªo¡I ¯E¹©...¥[ªo¡A¥[ªo...¡I ¥@¬É¤§¥ú¡A¥@¬É¤§¥ú¡C ·PÁ±z¡I¥xÁÞ¤j«e½ú¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/23 ¤U¤È 04:59:37²Ä 1603 ½g¦^À³
|
²³¤j¤j A ¥H¤U±M®a¦³¬Ý¨ì¨ÅÀùOBI822 6¤ë½×¤å¼Æ¾Ú³Ì«n ¤¤ëªººKn¥u¬On§l¤Þ¨º¨Ç±M·~ÂåÀø¤Hû¦A²`¤JÁA¸Ñ¨ÅÀùOBI822 6¤ëªºÁ{§É¸Ô²Ó¼Æ¾Ú 1 ¼Ú¬ü¤é¸~½F±M¬ìÂå®v ( ¶}ÃÄ) 2 ¨ÅÀù¯f±w»P®aÄÝ ( ¨Ï¥Î·NÄ@) 3 ¬ü°êFDA ¼Ú·ùEMA¼fÃıM®a (¼fÃÄÃÒ) 4 ¥þ²y¤jªº¥Í§Þ¤½¥qÃı´ (±ÂÅv) 5 ASCO ·|û ( Âå¾Ç¸ê°T¬ã°Q»P¶Ç¼½ ) 6 ¼Ú¬ü°ê®a¯ÅÀù¯g¬ã¨s¤¤¤ß±M®a (Âå¾Ç¸ê°T¬ã°Q»P¶Ç¼½) 7 ¼Ú¬üÀù¯gÂå¾Ç¤¤¤ß±M®a(Âå¾Ç¸ê°T¬ã°Q»P¶Ç¼½) B ¹ï©ó¦³²£¥Í§K¬Ì¤ÏÀ³±wªÌªºPFS©MInterim OS§¡¦³ÅãµÛ§ïµ½³o¦³¶¡±µÃÒ©úOBI888ÃĮĪº·f°t¼ç¤O(·|ª½±µ²£¥Í§ÜÅé C ¤@¦¸Á{§É¸ÕÅ禬캡º¡,³o¨Ç¦¸±Ú¸s¼Æ¾Ú¤ÀªR¹ï©ó¥¼¨ÓÃĪ«¨Ï¥Î¹ï¶H»PÁ{§É¸ÕÅç³]p¤½¥q±N·|°µ¥X³Ìºë½Tªº¿z¿ï §ÚÌnÃöª`ªº¤£¬O¥¼°µ¥X³Ìºë½T¿z¿ïªº¬Q¤é¼Æ¾Ú ¦Ó¬O§óÃöª`°µ¥X³Ìºë½Tªº¿z¿ïªº©ú¤Ñ§ó«GÄRªº¼Æ¾Ú»Pµ²§½ ©ú¤Ñ¬O¥þ·sªº¤@¤Ñ ¤£¦P©ó¬Q¤Ñ¦b¶Â·t¤¤ºN¯Á ; ©ú¤Ñ¬O¶}³Ð·s§½ªº¤@¤Ñ ¤£¦P©ó¬Q¤Ñ¦b°²³]¤¤´ç¤é ©ú¤Ñ¬O¥Rº¡¦Û«Hªº¤@¤Ñ ¤£¦P©ó¬Q¤Ñ¥¢¸¨·K´a ©ú¤Ñ¬O¨ÅÀù¯f±w«¥Íªº¤@¤Ñ ¤£¦P©ó¬Q¤Ñ¤£¦wªºµ¥«Ý¥Í©Rªº²×µ² |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/23 ¤W¤È 07:07:26²Ä 1602 ½g¦^À³
|
¤Ñ©R¤j 822¬O§Úªº¤Ñ©R°Ú ¥t¥~ ½Ð±ÐCilff¤j ¤Ñ©R¤j Y¶ÀÁ`»¡IgG¥H¦~p¡A¨º¬°¦ó¤@´Á¹êÅç¨äºw«×¦b34¶g«á©úÅã¤U·Æ¡A¥i¥H¹w´Á·|Áͪñ0(¹Ï¤ù½Ð°Ñ¦Ò¤§«eCliff¤j©Òªþ)¡H ¨âªÌ®t§Oì¦]¦ó¦b¡H |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/5/23 ¤W¤È 12:13:51²Ä 1601 ½g¦^À³
|
¤p©_¤j: ÁÂÁ±zºë±mªº¤ÀªR. ¤]¦P®É´À§Ú¸Ñ´b¤F. ¤Ó·PÁ¤F ! |
|
|
·|û¡GAlien10142514 µoªí®É¶¡:2016/5/22 ¤U¤È 11:39:31²Ä 1600 ½g¦^À³
|
Walker¤j : ¬Oªº Group 3 : Group 2 : PFS¡AHR = 0.52 [95%CI 0.37-0.71]¡Ap< 0.0001¡FOS¡AHR = 0.52 [95%CI 0.29-0.92]¡Ap= 0.025 Cliff¤j, ¯E§J¤j : ¯à±o±z̪º¤p»{¦P, ¹ê¦b¤Ó°ª¿³¤F. ¤p§Ì¤@¤Ñ¨ì±ß³£¦b«ôŪ¦U¦ìªº¤j§@. ¤p©_¤j: ÁÂÁ±zªº¤À¨É, ¤Óºëªö¤F Pie¤j, Group3 vs. Group1 : PFS¡AHR = 0.71 [95%CI 0.52-0.97]¡Ap= 0.029¡FOS¡AHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04 Group3 vs. Group2 : PFS¡AHR = 0.52 [95%CI 0.37-0.71]¡Ap< 0.0001¡FOS¡AHR = 0.52 [95%CI 0.29-0.92]¡Ap= 0.025 ¤µ±ß¤p§Ì¤]¦b·Q³oÓ°ÝÃD, §Ú«D±`¦P·N±zªº¬Ýªk»Pµ²½×(§K¬ÌÀøªk¤ñ¸û¤£¾A¦X¥HPFS°µ¬°«ü¼Ð), ±q³o¨â²Õµ²ªG¤ñ¸û, ¥i¥H¬Ý¥X¤@ÂIºÝÙ 1. Group3 vs Group2 ¤¤ PFS ªº p< 0.0001, ªí¥Ü¨C¤@Óevent ´X¥G³£¬O Group3 Ĺ. µoª¢®û¼í¦P®Éµo¥Í¦b³o¨â²Õ¤W. 2. Group3 vs. Group1 ¤¤PFS ªºp= 0.029, ¹ï¤ñ©ó¤W²Õªºµ²ªG, Group3 ¦ü¥G¨S¦³¦b¨C¤@Ó event ¤W³£Ä¹, §Ú¤]²q¦³¤@ÂIµoª¢®û¼í®ÄÀ³³y¦¨PFSªºpȬ۹ï¤W¨S¨º»ò¦n. ¨â²ÕOS ªº p Ȩä¹ê®t²§¤£¤j, ©Ò¥H¨S¦³§ÜÅ骺¥i¯à¥u¬O¨S®Ä¦ý¤£·|Åý¯f±w´£¦¦º¤`. (good news) §Ú°ß¤@¦³¤@ÂIı±o©_©Çªº¬O, Group3 §ÜÅé±j«Ü¦h, ¤p§Ìª½Ä±¤Wµoª¢®û¼íªº¤H¼ÆÀ³¸Ó¤]·|¤ñgroup2 ¦h«Ü¦h, ²z½×¤Wè¶}©l»~§PªºÓ®×À³¸Ó·|¤ñ¸û¦h, ¬°¤°»ò Group3 vs. Group2 ¤¤ PFS ªº p< 0.0001 ? ³o¸Ñª¼ªº¾Ç°Ý¹ê¦b¤Ó¤j¤F, ¤p§Ì¤~²¨¾Ç²L§r >< |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/22 ¤U¤È 11:04:44²Ä 1599 ½g¦^À³
|
²³¤j¤j 1°ê¥~«n´CÅé¯É¯É³ø¾É¨Ó¦Û¥xÆWªºOBI822! ¼Ú¬ü¨ÅÀù¥½´Á¯f±w¦ü¥G¤w§ä¨ì¹Ú´K¥H¨Dªº¨}Ãħ®ÃÄ 2¯E¹©¨ÅÀù·sÃĽפåºKn ¹O9452¸U¦¸ÂI¾\ appweb.cna.com.tw/webm/menu/afe/201605220278.aspx 3¥þ²y¦³¦h¤ÖÂå¥Í¡AÀù¯g¬ãµo¤Hû¡A¾Ç³N³æ¦ì¬ã¨s¤Hû¡A¯f±w»P®aÄÝ¡A¥Í§Þ¤½¥q¬ãµo¤Hû¡A¸~½F¾Ç®a¡A°ê®aÀù¯g¬ã¨s³æ¦ìµ¥¯É¯É¤Wºô¾Ö¤J ASCOºô¯¸¾é¸Ñ¨ÅÀù¤è±ªº½×¤åºKn¡A¸Õ¹Ï«õ±¸¦³¼ç¤OªºÃĪ«¡A³oºØ¨D¯u¨Dµ½ªººë¯«¥O¤H·q¨Ø |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/22 ¤U¤È 10:25:03²Ä 1598 ½g¦^À³
|
»{¦P¤p©_¤jªº¬Ýªk¡A¤]´N¬OOSªº P value·|ÀHµÛÆ[¹î®É¶¡ªº¼W¥[³v¨B¦A°§C¡A¥Ø«eOSªº¤ë¼Æ»{¦P»¨¤jªº±À´ú¡A¦]¬°§K¬ÌÀøªkªº«á«l¸û±j ¤]´N¬O¨ÅÀùOBI822·|¥HOS¨ú³Ó¡C ¤½¥q¦b¤G¤ëªk»¡¤w´£¨ì¨ÅÀùOBI822¤w²Å¦X¬ü°êFDA®ÖãÃĪ«ªº¦U¶µn¨D: (¦w¥þ©Ê¡AÀø®Ä¡AMOA,¥Í¬¡«~½è¡A¯à¤j¶q»s³y«~½èéwªºÃĪ«) ³o¬O¥xÆWªº¦¨´N¡A¯Î°|ªøªº¦¨´N¡A¤]¬O¥xÆW¯E¹©ªº¦¨´N¡C¤£½×¬ü°êFDA³Ì«á·|ª½±µµ¹¤©Conditional approval ©În¨D°µ¤ñ¥xÆW¤H¼Æ¤Öªº¥þ²y¤T´Á¡A¯E¹©¤w¥ß©ó¤£±Ñ¤§¦a¡C |
|
|
·|û¡G¾å¦à10141996 µoªí®É¶¡:2016/5/22 ¤U¤È 10:20:03²Ä 1597 ½g¦^À³
|
Cliff ¤j¡A ·P®¦«üÂI¡A§Ú¶¶«K¬Ý¤F±z¦bpage 7 ªº¤@¨ÇPO ¤å¡AÄ_Âä@°ï¡A°J¤ß·PÁ¡I ¤Ó¦h¤F¡A¥u¯àºCºC¸É¤W¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/22 ¤U¤È 10:04:29²Ä 1596 ½g¦^À³
|
YK¦b¤G¤ëªk»¡·|¯S§O´£¨ì§K¬ÌÀøªk¬On¤ñ¸û·|¦³§K¬Ì¤ÏÀ³¯à²£¥Í§ÜÅ骺¯f±w»P¨S¦³§K¬Ì¤ÏÀ³¤£¯à²£¥Í§ÜÅé³o¨â²Õ¨Ó§@¤ñ¸û¡A¥¼¨Ó·|¥HOS·í¬°¥DnÀø®Ä«ü¼Ð¡C ³o¦¸ASCO½×¤åºKn¤¤µo²{¥un¯à²£¥Í¨¬°÷§ÜÅé»P¹ï·Ó²Õ¤ñ¸û©Î¹êÅç²Õ¤º¤ñ¸û¦³²£¥Í§ÜÅé»P¨S¦³²£¥Í§ÜÅ餣½×¦bPFS OS ³£¦³¹FÅãµÛÀø®Ä»P«D±`ÅãµÛÀø®Ä¡A³q¹LÃÄÃÒ«án¨Ï¥Î¨ÅÀùOBI822n¥ý¦³¤@Ó´ú¸Õ¹Lµ{¡A¯à²£¥Í¥|¿§ÜÅ骺¯f±w´N¥i¨Ï¥Î¡A²³æ¤è«K¡C¸g¹L¬D¿ï¯f±wªº¹Lµ{¤¤¤]¨Ï¥¼¨Ó¤T´Á¦¨¥\¾÷·|¤j¤j´£°ª¡A³o¬O³o¦¸Á{§É¸ÕÅ竤jªºµo²{¤§¤@¡C |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/22 ¤U¤È 09:58:56²Ä 1595 ½g¦^À³
|
¤p©_¤j ·PÁ¤À¨É, Àò¯q¨}¦h Alien¤j §Ú¦³¨Ç¤£¦Pªº¬Ýªk, ¤Á½R¤@¤U Group3 vs. Group1 : PFS¡AHR = 0.71 [95%CI 0.52-0.97]¡Ap= 0.029¡FOS¡AHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04 Group3 vs. Group2 : PFS¡AHR = 0.52 [95%CI 0.37-0.71]¡Ap< 0.0001¡FOS¡AHR = 0.52 [95%CI 0.29-0.92]¡Ap= 0.025 Y¥HGroup3°µ¬°°ò·Ç, ¥i¥Hµo²{Group1ÁÙ¬O¤ñGroup2ªí²{¦n¤@¨Ç ¥´Ó¤ñ¤è, Group3ĹGroup1 30¤À, Group3ĹGroup2 40¤À, ¥i¥H±À´úGroup1ĹGroup2 10¤À ·íµM²Îp¤W¤£¬O³o»ò²³æªººâ³N¦Ó¤w Y¥H¦¹·§©À¥Xµo, ¤]³\¥i¥H¤j·§±Àºâ¥X Group1 vs. Group2 : PFS¡AHR = 0.52/0.71 = 0.73¡FOS¡AHR = 0.52/0.57 = 0.91 ¦bPFSªí²{¤W, Group2©úÅã¤ñ¸û¸¨«á; ¦ý¬O¦bOSªí²{¤W, ®t²§´NÁY¤p¤F«Ü¦h ¤£ª¾¹D³o¸Ì±®û¼í®ÄÀ³ªº¼vÅT¦³¦h¤j ¦ü¥G¤]©IÀ³¤F¤½¥q»¡ªk, §K¬ÌÀøªk¤ñ¸û¤£¾A¦X¥HPFS°µ¬°«ü¼Ð |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/5/22 ¤U¤È 09:00:12²Ä 1594 ½g¦^À³
|
Alien¤j¡G ±zªº±À½×µ²ªG¡A°ò¥»¤W§Ú¤]ÃÙ¦P¡C ¾å¦à¤j¡G ±z°Ý¨ì¡G¡u¥´9 °w¡A¨C°wªºdosageY¥[«¡A§ÜÅé¥i¤£¥i¥H¦]¦¹¼W¥[¡A¥H¼W¥[Àø®Ä¡H ¤]´N¬O80¢H-85`%ªº¤H·|¦³§ÜÅé¡A¦ý¥u¦³50¢H¦³ÅãµÛÀø®Ä¡A¼W±jdosage ¥i¦æ¶Ü ?¡K¡K¡v §Ú·Q¡A³oÓ°ÝÃD²o¯A¨ì822ªº³Ì¨Î¾¯¶q¬O¦h¤Ö¡H¥Î¬Æ»ò¾¯¶q¸û¦³®Ä¡H ²{¦æªº¾¯¶q¨C¾¯¤º§tGlobo H 30£gg¡A¬O¨ú¦Û1999¦~MSKCCµoªíªºÄáÅ@¸¢Àù¤@´ÁÁ{§É¸ÕÅ窺µ²ªG¡Aµo²{§tGlobo H 30£ggªº»s¾¯¤ñ§tGlobo H 100£ggªº»s¾¯¥i¦b¤HÅ黤µo¥X§ó¦hªºGlobo H ¡Vspecific IgM¤ÎIgG¡C ¥i°Ñ¦Ò¥»ª©Page.7¡u·|û¡GCliffµoªí®É¶¡:2015/7/1 ¤U¤È 09:20:11²Ä 320 ½g¦^À³¡v ¡u822¤@´Á¸ÕÅ礤¡AIgM»PIgG titer®øªøÅܤƹϡG¡]For Prostate Ca¡^¡v IgM¡G ¡uwww.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=21925_pq0990752002.jpg ¡v IgG¡G ¡uwww.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=21925_pq0990752003.jpg ¡v ©Ò¥HÓ¤H»{¬°¼W¥[¾¯¶q¡AY¨C¾¯§tGlobo H¶q¥Ñ30£gg¼W¦Ü100£gg¡AÀ³¸Ó®ÄªG¤£¤j¡C |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/5/22 ¤U¤È 05:33:29²Ä 1593 ½g¦^À³
|
쥻¤½¥q©M¯Î°|ªø»¡¡A¦³§K¬Ì¤ÏÀ³ªº¡AIgG»PIgMªºÁp¶°¦³80%¬Æ¦Ü85%¡A³£¦³®Ä ¯E¹©2/22ªk»¡ ¤å¦rÀÉ ........ ³o¸ÌÁÙn±j½Õ¤@ÂI¡A¯Î°|ªø¬O§Ú̪º±M®a·|ij¦¨û¡A¥L¤]¬Ý¨ì§Ú̪º¼Æ¾Ú¡A¥L¤]§â³oӼƾڤ½¥¬¡A©Ò¥H§Ú¤]¦b³oÃä§â¥¦«·s»¡©ú¤@¤U¡A¤j¦h¼Æªº¯f¤H¥´§Ú̪º822(¶À:¶W¹L¯Î°|ªøªº¼Æ¦r¡A±i:¬°¤°»ò¬O¶W¹L¯Îªº¼Æ¦r¡A¦]¬°¥L¥Îªº¬O¥§¡È)¡A¦bÁ{§É¤Wµo²{¥un³æ¤@§ÜÅé¼W¥[¡A(IGM¼W¥[¡A¦³Á{§ÉÀø®Ä¡A³æ¤@IGG¼W¥[¡A¤]¦³Á{§ÉÀø®Ä¡A¨âÓ¥[¦b¤@°_¶W¹L¯Î°|ªøÁ¿ªº¼Æ¦r)´N¬Oµ´¤j¦h¼Æªº¤H³£·|²£¥Í§ÜÅé¡A¦³¤F§ÜÅé¡A´N¦³Á{§ÉÀø®Ä¡C ........ |
|
|
·|û¡G¾å¦à10141996 µoªí®É¶¡:2016/5/22 ¤U¤È 05:14:05²Ä 1592 ½g¦^À³
|
§Ú«üªº¬O°w¹ï¦³§ÜÅé¡A¦ý¬O¿@«×¤£°÷ªº±wªÌ¡A©Î¼W±jdosage¡A©Î¦h¥´´X°w¡A©ÎÁYµu®É¶¡¥´¡C |
|
|
·|û¡G¾å¦à10141996 µoªí®É¶¡:2016/5/22 ¤U¤È 05:04:26²Ä 1591 ½g¦^À³
|
¤p©_¤j¡BCliff¤j¡A ¹ï¤p©_¤jªº¡y¦³50%ªº¹êÅç²Õ±wªÌ¡A¹ï OPT-822/OPT-821 ²£¥Í Globo H ¯S²§IgG §ÜÅé (³o¬O«ü§ÜÅé®Ä»ù´¿¦bªvÀø´Á¶¡¤º¹F¨ì ≥ 1:160)¡z¡A쥻¤½¥q©M¯Î°|ªø»¡¡A¦³§K¬Ì¤ÏÀ³ªº¡AIgG»PIgMªºÁp¶°¦³80%¬Æ¦Ü85%¡A³£¦³®Ä¡C±qºKn¬Ý¡A¥Î²£¥Í Globo H ¯S²§IgG §ÜÅ骺50%¦¸±Ú¸s¤~¦³§â´¤¡A©Î³\¦³IgM¿@«×°ª¦ýIgG¿@«×¤£°ªªº¦¸±Ú¸sÀø®Ä¨S¨º»òÅãµÛ§a¡C §Ú¦³¤@Ó¥~¦æ¤Hªº°ÝÃD¡G ¥´9 °w¡A¨C°wªºdosageY¥[«¡A§ÜÅé¥i¤£¥i¥H¦]¦¹¼W¥[¡A¥H¼W¥[Àø®Ä¡H ¤]´N¬O80¢H-85`%ªº¤H·|¦³§ÜÅé¡A¦ý¥u¦³50¢H¦³ÅãµÛÀø®Ä¡A¼W±jdosage ¥i¦æ¶Ü ? ¦]¬°¨S¬Æ»ò°Æ§@¥Î¡C |
|
|
·|û¡G»¨10136549 µoªí®É¶¡:2016/5/22 ¤U¤È 04:13:00²Ä 1590 ½g¦^À³
|
½Ð°Ý¦U¦ì¤j¤j¡ã Allen¤jªºgroup3ªºOS¼Æ¾Ú¬O§_¤w¸g¦¨¼ô ¦pªG©|¥¼¦¨¼ô ¨ì¤µ¦~¤¤ë©³ À³¸Ó¥§¡ ¤w¸g¦³35Ó¤ë¤F¡I |
|
|
·|û¡Gwalker10141977 µoªí®É¶¡:2016/5/22 ¤U¤È 03:57:51²Ä 1589 ½g¦^À³
|
Alien ¤j Group 2 : Group 3 ¬O¤£¬O PFS¡AHR = 0.52 [95%CI 0.37-0.71]¡Ap< 0.0001¡FOS¡AHR = 0.52 [95%CI 0.29-0.92]¡Ap= 0.025 |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/22 ¤U¤È 01:35:30²Ä 1588 ½g¦^À³
|
Iriswu¤j ¥Ø«e±qºKn¤¤½T©w ¦³§K¬Ì²Õ »PµL§K¬Ì²Õªº¦ÒÅç¬O¦³±Æ°£²üº¸»XªvÀø®ÄªG ¦ý¬O¥´¤E°wopt ¸ò±±¨î²Õ¤ñ ºKn¨S»¡ ¦³µL±Æ°£ ¤£¹L¨Ì·Ó²Îp°µªk «e±¦³°µ «á±À³¸Ó¤]·|°µ ¤@¤Áµ¥asco¤½§i Allen¤j ±zªº±À½×µ²ªG °ò¥»¤W §ÚÃÙ¦P |
|
|
·|û¡GAlien10142514 µoªí®É¶¡:2016/5/22 ¤U¤È 01:19:16²Ä 1587 ½g¦^À³
|
¦U¦ì¤j¤j, ¤p§Ì²Ä¤@¦¸µo¨¥, ¤]«DÂåÃıM®a, ¦p¦³¤£¥¿½T³BÁٽФj®a¦h«ü±Ð¤F ±qºKn¤W¬Ý¨Ó¹êÅç²Õ¤]³£¦³¥´cyclophosphamide, ¨ä¤¤50% ªº¹êÅç²Õ¦³°ª¿@«×ªº§ÜÅé¤ÏÀ³ ©Ò¥H¤À¦¨¤TÓgroup ¨Ó¤ÀªR Group1 ±±¨î²Õ¤H¼Æ¦û1/3 Group2 ¹êÅç²Õ¨S¦³°ª¿@«×§ÜÅé¤H¼Æ¦û1/3 Group3 ¹êÅç²Õ¦³°ª¿@«×§ÜÅé¤H¼Æ¦û1/3 Group3 vs. Group1 : P = .029 for PFS ; P = .04 for OS ; ³o¼Æ¾Ú»¡©úÃĦpªG¯à¤Þµo°ª¿@«×§ÜÅé´N¦³®Ä. (Group2 + Group3) vs. Group1 : P = 0.77 for PFS ; ¥ª°¼¥[¤W Group3 , ¾ãӼƾÚÅܱo«Ü®t, ³oÁô§t¤F¤@Ó§t·N, ¨S¦³¤Þµo°ª¿@«×§ÜÅ骺Group2, ªí²{¥i¯à¸òGroup1¤@¼Ë, ¦ýÀ³¸Ó¤£·|¤ñ¸û®t¦]¬°¤j®a³£¦³¥´cyclophosphamide, ¸~½F¦b»¼©µ¤ÏÀ³®É¶¡¤º¨Ì·|³Qcyclophosphamide §í¨î¦í, ¦Ó¥B¨S¬Æ»ò§ÜÅé, ¤]À³¸Ó¤£¤Ó·|¦³®û¼í²{¶H. Group2 ¸ò Group1 ªºKM curve ±qÀY¨ì§À¥i¯à¶K¦b¤@°_. ²³æªº»¡´N¬O¦³¥´¸ò¨S¥´¤@¼Ë. ¬JµMGroup2 ªí²{¤W¬ù²öµ¥©ó Group1, ¨º§Ú̬O§_¥i¥H°²³]§¹¦¨¤E°wªº¸s²Õ¤¤, ¨Ó¦ÛGroup1 ªº¤H¼Æ¤j·§µ¥©ó¨Ó¦ÛGroup2 ªº¤H¼Æ, ³Ñ¤Uªº¬O¨Ó¦ÛGroup3 ªº¤H. (Group2_§¹¦¨¤E°w + Group3_§¹¦¨¤E°w) vs. Group1_§¹¦¨¤E°w : P= .057 for PFS ; ±µªñÅãµÛ, ¥i¥H»¡Group3_§¹¦¨¤E°wªº®ÄªGn¤£¿ù¤~¯à cover ¥ª°¼¨S®ÄªºGroup2_§¹¦¨¤E°w¶Ü? |
|
|
·|û¡GIriswu10136250 µoªí®É¶¡:2016/5/22 ¤W¤È 09:13:20²Ä 1586 ½g¦^À³
|
«ù¤[¯E§J¤j,subgroupªº²Îp¼Æ¦r¤£¬O¤w¸g¦³¸g°ò¦¯e¯fª¬ºA/²üº¸»XÀøªk¨Ï¥Î±¡ªp®Õ¥¿,³o¼Ë¤£´N¬O§â²üº¸»XÀøªkªº¼vÅT¦]¤lµ¹®³±¼¤F? |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/22 ¤W¤È 08:52:17²Ä 1585 ½g¦^À³
|
µ½¤H¤j °Ý¨ì¦n°ÝÃD Y68%²üº¸»XªvÀøªº¤H ¥þ³¡³£¬O¹ï·Ó²Õ¤Î¤Ö³¡¤À¹êÅç²Õ©O ¡H ³oµ¥©ó822¹ï¥´²üº¸»XªvÀøªº¹êÅç ¤£¬O822¥´´X¥G¹sªvÀøªº±±¨î²Õ¡H·íµM822®ÄªG³Q§C¦ô ´«¤@¨¤«×¨Ó»¡ Y68%³£¬O¹êÅç²Õªº¸Ü ´N¬O822+²üº¸»XªvÀø¤j±±¨î²Õ ²{¦bºKnªº822®ÄªG ´N°ª¦ô822¯u¥¿®Ä¥Î¤F ¥Ñ©ó68%¤ñ¨Ò n¦bASCO«á ¤~ª¾¹D ¤~¯à¤ñ¸ûª¾¹D822ªº²b®ÄªG ©Ò¥H§ë¸ê½Ð¤p¤ßÂÔ·V |
|
|
·|û¡G§ë¸êªÌ10141485 µoªí®É¶¡:2016/5/22 ¤W¤È 08:29:37²Ä 1584 ½g¦^À³
|
¦¦w¡A¦U¦ì¥ý¶i¡C§Ú·Q½Ð°Ý¦pªGfdan¨D°µ¤T´Á¡A¤j·§·|»Ýn¦h¤[¤~¯àµ²§ô¡C ¥t¥~¡A¦pªG¨ºBtd ³Ì§Ö¤]n¦h¤[©O¡H·íµM³Ì¦n¬O¥Î³o¦¸ªº¼Æ¾Úª½±µ¥Ó½ÐÃįg¡A¦ý³Ì®t¬Ý°_¨Ó¤]¥u¬O®É¶¡ªº°ÝÃD¡C ¦³¥i¯à¥ý¦³±ø¥ó³q¹Lµ¹Óconditional approve ¶Ü¡H |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2016/5/22 ¤W¤È 06:26:49²Ä 1583 ½g¦^À³
|
§Ú¥u¯à»¡¤W¨®®e©ö¤U¨®Ãø ®¥³ß¦U¦ì¯E¤Í §Æ±æ¯uªºº¦¦^700 §Ú¬Oıªºº¦«Ü¦h§Q¦h¤@ª½¥X¨Ó ´Nı±o©Ç©Çªº §Æ±æ¯E¤Í¦h¦h¨£½Ì |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2016/5/22 ¤W¤È 04:52:51²Ä 1582 ½g¦^À³
|
¤p©_¤j, «D±`·PÁ±z²Ó¤ß¤SºëÅPªº¤ÀªR. §Ú̪¾¹Dªº¸ê°T¤Ó¤Ö¤F, «ÜÃø§@¥¿½Tªº²Îp©M±À¦ô, ¨S¿ìªk³o¬O¤@¯ë¤p´²¤áªº±J©R. ¦ý¬O¤]¤£n¦Ç¤ß®ð¾k, ¹L¥h¤G¦~¦h, ¦bCliff¤j, ¦Ñ¥v¤j, ±z©M½Ñ¦ì¤j¤jªº±a»â«ü¾É¤U, ²³¯E¤Í½T¹êÀò¯q¨}¦h, ¤]°J¤ß¦a·PÁ±zÌ!!! ¦bºKnµo¥¬¤§«e, §Ṳ́@ª½¥H¬°¸ÕÅç²Õ©M¹ï·Ó²Õ¥u¦³¥´¤Ö¶qªºCyclophosphamide, ©Ò¥H±N¹ï·Ó²ÕªºM-PFS¦ôp¬°4~6Ó¤ë. ¦ý¬O¹ê»Ú¤W¬O62%ªº±wªÌ±µ¨ü²üº¸»XªvÀø, ¦Ó348¦ì¸ÕÅçªÌ¦³70%¬°²üº¸»X¨üÅ鶧©Ê¨ÅÀù±wªÌ, 13%¬°¤T³±©Ê¨ÅÀù±wªÌ. ²{¦bÁÙ¤£ª¾¹D±µ¨ü²üº¸»XªvÀø¬O¥ÎþºØÃÄ, ¾Ú§Ú¬dªº²üº¸»XªvÀøÃĦ³®õ²ö¦èªâ(Tamoxifen), ´_¨Å¯Ç(Letrozole), ¦w¬ü¹F(Anastrozole), ¿Õ°ÒÀù¯À(exemestane)µ¥. §Ú¨S¦³¥h¬d¨C¤@ºØÃĪºM-PFS©MM-OS, ¦ý¬O¾Ú½÷·çªº Ibrance+Letrozoleªº¤G´Á³ø§i, LetrozoleªºM-PFS¬°10.2Ó¤ë, M-OS¬°33.3Ó¤ë. §Ú·Q¨ä¥Lªº²üº¸»XªvÀøÃĪºM-PFS¥i¯à¤]¦b9~11Ӥ륪¥k, ©M±z¦ôpªº¾ãÅé348¤HªºM PFS¦b10Ó¤ë©Î11Ó¤ë´X¥G¤@¼Ë. ¦]¦¹¦³168¤H§¹¦¨9°w37©PªºÀøµ{, ³y¦¨¸ÕÅç²Õ©M¹ï·Ó²ÕªºPFS¦b10Ӥ뤧«e·|§á¦b¤@°_. ¦]¬°¸ÕÅç²Õ¦³¨Ç¤H¦³®û¼í¦Ó³Q´£¦»~§PPD, ¦]¦¹¸ÕÅç²Õ¸û¦´c¤Æ±wªÌªº¥§¡PFS¤ñ¹ï·Ó²ÕÁÙ§C, ¬O³y¦¨¾ãÅéPFS : HR = 0.96 [95% CI 0.74-1.25] , P= 0.77ªºì¦]. ¤£ª¾¹D¤½¥q°ª¼h¬O§_¬Ý¨ì³o°ÝÃD? ¦pªG©Ò¦³±wªÌ¦b´c¤Æ¤§«e³£¤£±µ¨ü²üº¸»XªvÀø, ¸Ñª¼ªºµ²ªG¥i¯à©M²{¦b§¹¥þ¤£¤@¼Ë??? ¤p§Ì§ó·Qª¾¹Dªº¬O¨º¨Ç§K¬Ì¤ÏÀ³©µ¿ð©M®û¼í²{¶Hªº±wªÌ¥Ø«eªº¶i®i¦p¦ó? ¸~½F¬OÄ~Äò¼W¤j? ©Îºû«ùéw? ©ÎÅܤp¤F? ¤£ª¾³o¨Ç±wªÌ¦³¨S¦³³QÄ~Äò°lÂÜÀˬd? Faith¤j, ¤Í°í±¡!!! |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/5/22 ¤W¤È 12:41:15²Ä 1581 ½g¦^À³
|
Faith¤j¡A ºKn·Q¦n¤F¡C 1.¥H«á¤£´±¦A°µ·sÃĸѪ¼²Îp±À¦ô¤F¡C¨âÓ¬P´Á«e¤~¸òCliff¸ÑÄÀ¡A¥i¯àPFSªºPȦb0.05¥ª¥kÂ\Àú¡AºKn¥X¨Ó³º¬O0.77¡A¦b¥h¦~6¤ëªÑªF·|ª¾¹D187©M229¨âӼƦr«á¡A¦pªG§@¹Ú¹Ú¨ìPÈ=0.77¡A¥i¯à¥h¦~ªÑ²¼´N©ê¤£¦í¤F¡A¹ê»Úªº±Æ¦C²Õ¦X¯u¬O·Q¤£¨ì°Ú¡I 2.¡y¦³50%ªº¹êÅç²Õ±wªÌ¡A¹ï OPT-822/OPT-821 ²£¥Í Globo H ¯S²§IgG §ÜÅé (³o¬O«ü§ÜÅé®Ä»ù´¿¦bªvÀø´Á¶¡¤º¹F¨ì ≥ 1:160)¡z¡A쥻¤½¥q©M¯Î°|ªø»¡¡A¦³§K¬Ì¤ÏÀ³ªº¡AIgG»PIgMªºÁp¶°¦³80%¬Æ¦Ü85%¡A³£¦³®Ä¡C±qºKn¬Ý¡A¥Î²£¥Í Globo H ¯S²§IgG §ÜÅ骺50%¦¸±Ú¸s¤~¦³§â´¤¡A©Î³\¦³IgM¿@«×°ª¦ýIgG¿@«×¤£°ªªº¦¸±Ú¸sÀø®Ä¨S¨º»òÅãµÛ§a¡C 3.¡u168 ¨Ò±wªÌ (48%) §¹¦¨ 9 ¦¸ª`®gÀøµ{¡v¡A¥H¥þ³¡348¤H¨Ó»¡¡A¦³168¤HªºPFS¶W¹L9Ó¤ë¡A¥Ñ³o¼Æ¦r¥i¥H±À½×¥X¾ãÅé348¤HªºM PFS¡A¥Î¥þ³¡348¤HªºPFS¼Æ¾Ú¨Ó¹º¤@±øKM curve¡A¦]¬°Á`¦@¦³¬ù37¤Hªºdrou outªº³]¸ê®Æ¡A©Ò¥HM PFS¤j¬ù¦b²Ä55%¥ª¥kªº±wªÌ¡A¤]´N¬O¤j¬ù±Æ²Ä191¦ìªº±wªÌ¡A¤]´N¬O±q«á±¼Æ¨Óªº²Ä157¦ì¡A168-157=11¡A¤]´N¬O±q9Ó¤ë¥H«áªº±wªÌ©¹«á±¼Æ11¦ì´N¬O¤j¬ùM PFSªº±wªÌ¡A±À¦ô¥i¯à¬O¸¨¦b10Ó¤ë©Î11Ó¤ë¡C±q¥H¤W±oª¾¡A¾ãÅé348¤HªºM PFS¦b10Ó¤ë©Î11Ó¤ë¡A¥h¦~¦b±oª¾187©M229³o¨âӼƦr«á¡A´N±À¥X¾ãÅé349¤HªºM PFSÀ³¸Ó¦b10~12Ó¤ë¡A¤£¥Î¾á¤ßµo¥ÍSTN-KLHªººGªp¡A¾ãÅé348¤H¦³10~12Ó¤ë³o»ò¦hÄ«ªG¥i¥H¤À°t¡A¦ý¤]¦]¬°¥H¬°¹ï·Ó²Õ¤À¨ìªºM PFS¤j¬ù4~6Ó¤ë¡A©Ò¥H¹êÅç²Õ¤@©w¦³»·¤j©ó10~12Ӥ몺īªG¥i¥H¤À°t¡A¦ýÅãµM¨Æ¹ê¤£¬O¦p¦¹¡A¹ï·Ó²Õªº±¡ªp¨S¦³¨º»ò®t¡AM PFS¤£·|¥u¦³4~6Ó¤ë¡A¥B¹ï·Ó²ÕPFS¶W¹L9Ӥ몺±wªÌ¤£·|¬O¥H«e¹w¦ôªº116¤Hªº1¦¨~2¦¨¡A¤H¼ÆÀ³¸Ón©úÅã¶W¹L¡A§_«h¤£·|¦³¾ãÅéPFSªºPÈ=0.77ªº±¡ªp¡C²³æÁ¿¡APÈ=0.77¬O¦]¬°¹ï·Ó²ÕÀø®Ä±¡ªp°ª©ó¹w´Á¡A¥H¤Î¹êÅç²Õ¦³©úÅã¼Æ¶qªº¡u«D²£¥Í 4¿Globo H ¯S²§IgG §ÜÅ骺±wªÌ¡vªºPFS¦b«e¥b¬q¿éµ¹¹ï·Ó²Õ¡A³o¨âÓ¦]¯À³y¦¨ªº¡C¤p§ÌÁÙ¬O²q¡A¹êÅç²ÕªºM PFS¤j©ó10Ó¤ë¡A¹ï·Ó²ÕªºM PFS¤p©ó9Ó¤ë¡A¤]´N¬O168¤H¤£·|¬O2¤ñ1ªº¤À°t¡A¹êÅç²Õ¤À°t¨ìªº·|¤j©ó2/3¡C 4.©Ò¦³ªºPÈ¥u¦³¤@Ó¬O»·¤p©ó0.05¡A¤j¦h¥u¬O²¤¤p©ó0.05ªºÅãµÛ¤ô·Ç¡A¨S¦³¥ô¦ó¼Æ¦r¥i°Ñ¦Òªº®ÉÔ¥ý¬ÝPÈ¡A¥X²{HRªº®ÉÔ´Nn¥HHR¨Ó§PÂ_¡AHR¤ñPȧóºë½T¡A·íµM³Ì«á³Ì§¹¾ãªº§e²{¦bKM curve¡CPȦb¹êÅç²Õªº50%¦³°ª¿@«×GH§ÜÅé»P¹ï·Ó²Õ¤ñ¸û¥H¤Î»PµL§K¬Ì¤ÏÀ³µÛ¤ñ¸û¡A¤À§O¦bPFS¤W¤ñ¸û¥H¤Î¦bOS¤W¤ñ¸û¡A¦]¬°¥u¦³¤j¬ù50%ªº¹êÅç²Õ¬ù116¤H»P¹ï·Ó²Õ116¤H¤ñ¸û¡A³oºâ¬O¤p¼Ë¥»¡A§ÚÌ¥±`¬Ý¨ìªº¤j«¬Á{§É¤T´Áªº¨C²Õ³£¦³300~400¤H¡A¦³®ÄªºÃĪ«ªºPȱ`±`¬O0.001ªº¯Å¼Æ¡A¤§«e¦³°Q½×¹L¡APȪºpºâ»P¼Ë¥»¼Æ§e¥¿¬ÛÃö¡A¥un¨â²ÕÀø®Ä¦³®t²§¬O½T©wªº¡A¼Ë¥»¼ÆÂX¤j¡A¥d¤èȤ]·|Åܤj¡APÈ·|Åܤp(¦ý¤£·|§ïÅÜKM curve)¡A´N·|§âPȱq0.01~0.05ªº¯Å¼Æ¡A°¨ì0.001¬Æ¦Ü0.0001ªº¯Å¼Æ¡A©Ò¥HºKnªºPȤp©ó0.05¡Aªí¥Ü²Îp¦³ÅãµÛ®t²§¡A°÷¤F¡C 5.¤p§Ìı±o°Ñ¦Ò»ùȳ̤jªº¼Æ¾Ú¬O¡AOS¡AHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04¡A³o¬O50%¦³°ª¿@«×GH§ÜÅ骺¹êÅç²Õ»P¹ï·Ó²ÕªºOS¤ñ¸û¡AOSªº¤ñ¸û¥i¥H¤j´T¥h°£§K¬Ì©µ¿ð¤Î®û¼í³y¦¨ªº¼vÅT¡C´Á¤¤¤ÀªRªºOS¤´¦³³\¦hªº³]¸ê®Æ(¨â²Õ³£ÁÙ¦³³\¦h¤H¬¡±o¦n¦nªº)¡APȦb´Á¤¤¤ÀªR¤w¸g§C©ó0.05¡AÀHµÛ®É¶¡ªºÆ[¹î¡A³]¸ê®Æ³vº¥¦¨¬°OS¸ê®Æ¡APÈÁÙ¥i¥H¶i¤@¨B°§C¡C¦ýHR=0.57¡A¥i¨£¹ï·Ó²ÕªºOS±¡ªp¤]¤£·|¤Ó®t(¤]¦LÃÒ²Ä3ÂIÁ¿ªº)¡A¥i¯à¬O¤p§Ì¤Ó¼ÖÆ[¤F¡A¤p§Ì¥H¬°»Pcyclo°µ¤ñ¸û¡AHR«Ü®e©ö´N¤p©ó0.5¡A«¢¡A쥻²q0.3~0.4±jªº¡CHRªº¼Æ¦rÁöµM¦]¬°³]¸ê®Æ¦hÁÙ·|ÅܤơA¦ý¨ä©Ê½è»PKM curve±µªñ¡A¥u·|ÀHµÛ³]¸ê®Æ³vº¥Âনevent¦Ó·L½Õ¡A¦ý¯à§â¦º¤`ªº·ÀI°§C43%¡A¤]ºâ¬O¤£¿ù¤F¡C 6.³o¤@ÂI§Úªº§â´¤«×¨S¨º»ò°ª¡A¦]¬°HR§Ú¤£ª¾¹Dn«ç»òpºâ¡A¥BCox model¯uªºÃøˤp§Ì¤F¡A¦ý¤p§ÌÁÙ¬O¸ÕµÛ§â§Úªº²z¸Ñ´yz¥X¨Ó¡CHR¡A Cliff¤jªº·Qªk¬O¡A¡uHR¬O·ÀI¯à¦]¥ÎÃĦӰ§C¦h¤Öªº«ü¼Ð¡AY¬OHR=0.71¡Aªí¥Ü«e²Õ¤ñ«á²Õªº·ÀI°¤F29¢H¡CCI¡]«H¿à°Ï¶¡¡^³£¤p©ó1¡A¨S¦³¸ó¶V1¡Aªí¥Ü¨C¦ì«e²Õ±wªÌ´X¥G³£¦³®ÄªG¡A¥u¬O®ÄªG¤j¤p®t§O¦Ó¤w¡A¤]´N»¡¨ºÓHR¡Õ1ªºµ²ªG¤£¬O³Qpooling¥X¨Óªº¡C¡v¡A«e¥b¬q¥y¤l¤p§Ìªº·Qªk»PCliff¤jªº·Qªk¤@¼Ë¡A«á¥b¬q¥y¤l¤£¦P¡C¥HHR=0.57 [95%CI 0.33-0.97]¬°¨Ò¡A¦bKM¹Ï§Î¤¤¡Ay¶b¬O¾÷²v¡Ax¶b¬O¦s¬¡®É¶¡¡A¦b¤£¦Pªº¦s¬¡®É¶¡¡A¹êÅç²Õ»P¹ï·Ó²Õ·|¦³¤£¦Pªº¦s¬¡¾÷²v¡A¨Ò¦p¦b6Ó¤ë¡B¦b1¦~¡B¦b2¦~µ¥µ¥¤£¦P®É¶¡¡A¹êÅç²Õ»P¹ï·Ó²Õªº¦s¬¡¾÷²v³£¤£¤@¼Ë¡A¦Ó¦º¤`¾÷²v´N¬O1-¦s¬¡¾÷²v¡A¡A¤]´N¬O»¡¡A¦b6Ó¤ë¡B¦b1¦~¡B¦b2¦~µ¥µ¥¤£¦P®É¶¡¡A¹êÅç²Õ»P¹ï·Ó²Õªº¦º¤`¾÷²v³£¤£¤@¼Ë¡A¹êÅç²Õªº¦º¤`·ÀI(¾÷²v)/¹ï·Ó²Õªº¦º¤`·ÀI(¾÷²v)=¸Ó¦s¬¡®É¶¡ªº·ÀI¤ñ¡A¤£¦Pªº®É¶¡¶b¤U¡A·ÀI¤ñ³q±`¤£¦P¡A¤£¬O¤@Ó±`¼Æ¡A¦ý¬°¤F¹ï¨â²Õªº¦º¤`ªº·ÀI°µ¥Xªí¹F¡A·|pºâ¥X¤@Ó¥Nªí©ÊªºHR¡A¦p¤W¨Òªº0.57´N¬O¨Ò¤l¤¤¥Nªí©ÊªºHR¡A¦ý¹ê»Ú¤W¤£¦Pªº¦s¬¡®É¶¡¡AHR¬OÅܰʪº¡A©Ò¥H·|¦³¤@Ó«H¿à°Ï¶¡¡ACIªºHR¦pªG³£¤p©ó1¡Aªí¥Ü¥ô¦ó¦s¬¡®É¶¡¡A¹êÅç²Õªº±wªÌ¦º¤`ªº·ÀI³£¤ñ¹ï·Ó²Õ§C¡A¦p¤W¨Òªº95%CI 0.33-0.97¡Aªí¥Ü¦b¤£¦Pªº¦s¬¡®É¶¡¡A¹êÅç²Õ°§C |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/5/21 ¤U¤È 11:19:18²Ä 1580 ½g¦^À³
|
¤§«e¤¶²Ð§Þ®vªB¤Í¶R¡A¥L¤]¨ú±o¬Y®a§ëÅUCEOªº¬Ýªk¡A¨ºCEOµû¦ô»¡¤£n¶R....¡F§Ú¹ï§Þ®v»¡¡G¡y¬OCEOÀ´822¡BÁÙ¬O°|ªøÀ´822¡H¡z¡A©ó¬O¡A§Þ®vªº¦¨¥»¬O365...§Æ±æ¤£¬O¶R¨ì¯E§Jªº... |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/5/21 ¤U¤È 11:02:49²Ä 1579 ½g¦^À³
|
¦p¦P¨º¨Ç¨éªÅªº¤@¼Ë¡An¥Ḻq¤£¬Û«HÅܬ°¡u¬Û«H¡v¬O«Ü§xÃøªº¡Fn§Ú̯E¤Í±q¬Û«HÅܦ¨¡u¤£¬Û«H¡v¤]¬O«Ü§xÃøªº...§Ú¥uÅ¥»¡¡A¦³¦ìÂå¥Í+¿ËªB¦n¤Í³£À£¨®a¤F...ºô¸ôªº¸Ü¡Aťť´N¦n... |
|
|
·|û¡G§Ú¬O´²¤á10141269 µoªí®É¶¡:2016/5/21 ¤U¤È 10:42:24²Ä 1578 ½g¦^À³
|
¯E«È¤j¡I¡I·íªì§AÁÙ¯S§O¤Wºô§i¶D¯E¤Í̧A½æ¦b¤T¦Ê¦h¡I¡I²{¦b¬Ý°_¨Ó§AÁÙ¯u¬O·|½æ°Ú¡I¡I¡I¨þ¨þ¨þ¡I¡I¡I |
|
|
·|û¡G§Ú¬O´²¤á10141269 µoªí®É¶¡:2016/5/21 ¤U¤È 10:35:43²Ä 1577 ½g¦^À³
|
¯E«È¤j¡I¡I§A¤§«e³£¤w¸g½æ±¼¤F¡A²{¦b§A¥u¬O¦b²´¬õ¡A¯E¹©¤@ª½º¦¡I¡I¯E¹©¬O¤£¬O³o»ò¦n±d¡A§A¦Û¤v¥h¨M©w¡I¡I¨S¥²n¤Wª©»Ä¨Ó»Ä¥hªº¡I¡IÁÂÁ¡I¡I |
|
|
·|û¡G¯E«È10140302 µoªí®É¶¡:2016/5/21 ¤U¤È 10:04:03²Ä 1576 ½g¦^À³
|
³o§@¥Î¾÷Âà¬O·sªº¡A´X¥G¨S°Æ§@¥Î¡A¦³¾÷·|®³¡u¿Õ¨©º¸¼ú¡vªº¡I ¦pªG³o»ò¦n §Ú²{¦b©Ð¤l¶U´Ú À£¨®a¶R ¤£´NÅK©wÁȪº ¨º¤j®a³£¤£¥Î¦b¤u§@¤F ³£À£¯E¹©´N¦n¤F ¯uªº¦³³o»ò¦n±d |
|
|
·|û¡GÁÙ¯u10138289 µoªí®É¶¡:2016/5/21 ¤U¤È 10:03:21²Ä 1575 ½g¦^À³
|
¦³¤@ӳ̰ò¥»ªº°ÝÃD, ¤p§Ì¤£²M·¡: "¯E¹©ªí¥Ü¡A¦³50¢Hªº¹êÅç²Õ±wªÌ¡A·|²£¥ÍGlobo H¯S²§IgG §ÜÅé¡A¹ï©ó¦³²£¥Í§K¬Ì¤ÏÀ³±wªÌªºPFS ©MInterim OS§¡¦³ÅãµÛ§ïµ½" ©Ò¿×¦³50¢Hªº¹êÅç²Õ±wªÌ¬O³Ìªì¹êÅç²Õ:232¤Hªº50%¶Ü ? |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/5/21 ¤U¤È 07:11:45²Ä 1574 ½g¦^À³
|
OBI-822©M¶PÀù¥¬O§¹¥þ¤£¦Pªº§@¥Î¾÷Âà¡A ³o§@¥Î¾÷Âà¬O·sªº¡A´X¥G¨S°Æ§@¥Î¡A¦³¾÷·|®³¡u¿Õ¨©º¸¼ú¡vªº¡I OBI-822ªº»ùÈ´N¦b¦¹¡I¤£¯à¤ñªº¡IÄê±ù¤ñÄ«ªG¡I ¶PÀù¥°Æ§@¥Î¨º»ò¤j¡C°Ñ¦Ò¥é³æ¡G www.roche.com.tw/content/dam/roche_taiwan/zh_TW/download/Herceptin.pdf www.roche.com.tw/home/products/products01/herceptin.html |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/21 ¤U¤È 04:03:15²Ä 1573 ½g¦^À³
|
ºKn¤¤ 168 ¨Ò±wªÌ (48%) §¹¦¨ 9 ¦¸ª`®gÀøµ{¡C ¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨ 9 ¦¸OPTª`®gÀøµ{ªÌ¡A¨äPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡C ¥H¦¹¨â¬q»¡ªk¡CÀ³¸Ó168¤H¥]§t¹êÅç²Õ»P±±¨î²Õªº¤H¡A¦ý¬O§¹¦¨9¦¸OPTª`®gªÌ¡AÀ³¸Óºâ¹êÅç²Õ¡A¦³´X¤H¡HY¥H¥þ³¡¸ÕÅç¤H¼Æ2:1¨Ó±À¦ô¡A¬ù¦³112¤H¡C §Ú²q·Q ¹ê»Ú¼Æ¦rÀ³¸Ó¤j©ó112¤H¡C²¦³ºÃĪ«¦³®Ä¡A¹êÅç²Õªº¤H¤ñ¸û·|Ä~Äò¥´°w¡C ³o112¤HÀ³¸Ó±Æ°£¤F¦]¬°§K¬Ì¹L±j¡]°²³]1:320¥H¤W) ¤@¤U¤l®û¼í¦ÓPDªº¤H¼Æ. ©Ò¥H¦oÌÀ³¸ÓÄÝ©ó¤ñ¸û¤¤«×§K¬Ì¤ÏÀ³ªº±Ú¸s(°²³]1:80-1:320¡^ ¦Ü©ó§K¬Ì¤ÏÀ³§C (°²³]1:80¥H¤U)©Î¬OµL§K¬Ì¤ÏÀ³ªº±Ú¸s¡A¬O¦ÛµM ¤ñ¸û¦PD ¤£·|¦C¦b112¦W³æ¤º ³o112¤H¸ò¹ï·Ó²Õ¤ñ¡Ampfs§Ö¹FÅãµÛ¤ô·Ç¡A«o¥¼¹FÅãµÛ¡A¦ó¬G¡Hȱo«ä¦Ò 1.³¡¤À¤H¼Æªº§K¬Ì¿@«×¤£°÷1:60 2.§K¬Ì§ÜÅ馳®Ä¤ÏÀ³«ùÄò®É¶¡ ¥i¯à¤£¬O«Ü¤[¡C ¥b°I´Á¤ñ¸ûµu¶Ü¡H |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/5/21 ¤U¤È 12:03:28²Ä 1572 ½g¦^À³
|
¤p©_¤j: ÁÂÁ±zªº@¤ß, ¤]±Ð¾É§Ú¦p¦ó¥h°Ý³oÃþ²Îp¤Wªº°ÝÃD. §Ú¸ÕµÛ¦A¨Ó¤@¦¸: 1) ¥h¦~10¤ëdata lock¥Nªí¸ê®Æ¦b¨º®É¶¡¦¨¼ô. ©Ò¦³¸Ñª¼ªº¼Æ¾Ú¤ÀªR¬Ò¥H¥h¦~10¤ë©Ò±oªº¼Æ¾Ú¬°°ò¦. 2) ±N9°w¥´§¹±wªÌ¸g®É¶¡¬Û¨ÌCox¤ÀªR¬O±N®É¶¡survival time³o¦]¯À¦Ò¼{¶i¥h, ³o¤w¸g¥X¨Óªº¼Æ¾Ú(HR=0.66 P=0.05)À³¸Ó¬O¥H¥h¦~10¤ë¬°°ò¦. ÁöµMdata¤w¸glock¦í¦ý¯E¹©¤´«ùÄò¦b°lÂܼƾÚ. ¦pªG9¤ë¥÷°Ñ¥[ESMO®É, ¨ì®É«·s¥H°lÂÜ¥X¨Óªº·s¼Æ¾Ú°µ®É¶¡¬Û¨ÌCox¤ÀªR, (¦]¬°¦³ªø§À®ÄÀ³, ²zÀ³ ¹êÅç²Õ«áÄòsurvial timeªº¼Æ¾Ú¬Û¸û¹ï·Ó²Õ«áÄòsurvival timeªº¼Æ¾Ú¦³Àu¶Õ) ¦bPFS¤£Åܪº±¡ªp¤U, PȤÎHRȬO§_·|§ó¦n? ¦]¬°³o¦¸ªºP=0.057 ®t²§¦³, ©Ò¥H³y¦¨§Úªºµo·QYÀH®É¶¡¬O§_¯à¨Ï³o¼Æ¾Ú ¦¬¦bP=0.05¤§¤º. §Úªº°ÝÃD´N¬O¥H¤W³oÓ°²³]¬O¥i¥H¦¨¥ßªº¶Ü ? ·PÁ !!! |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2016/5/21 ¤W¤È 01:26:51²Ä 1571 ½g¦^À³
|
¤£ª¾¨ÅÀù¤@´Á~¤T´Án¤£¥ý°µÁ{§É¹êÅç«á¤~¯à¥ÎÃÄ? |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/5/21 ¤W¤È 12:56:55²Ä 1570 ½g¦^À³
|
§Úªº¦Ñ¸£³U¨S¿ìªkt²ü¤Ó§xÃøªº¼Æ¾Ú¤ÀªR¡A§Ú¤Ñ¯u¤£±M·~ªº·Qªk¬O³o¼Ë¡K ¶PÀù¥ªºªvÀø¤ñ²v ¬O³QÀù¯g¯f¬rªº°ò¦]«¬ºA©T©w¤F ©Ò¥H¬O25¢H¡]¥[Ãؤ@°ï°Æ§@¥Î¡^ ¦ý¨M©w822ÃĮĪº¬O¯f¤Hªº§K¬Ì¨t²Î¡A¥un§K¬Ì¨t²ÎÁÙok ¤£n¬O¨ººØ¼Æ¨ì3´N±¾±¼ªº¤H¡A¸g¹L822ªvÀø¡A¦³§K¬Ì¤ÏÀ³´N¦³Àø®Ä ¯E¹©¯à³B²zªº ¥i¯à¬O¨ÅÀù1´Á100¢H ¨ÅÀù2´Á90¢H ¨ÅÀù¤T´Á80¢H¦n¤F ¨ÅÀù4´Á50¢H¡]©Î§ó¦h....¡^³o¼ËÁÙ¤£°÷¹À¡H¡H¥un¦´Áµo²{¡A´N¯à«Ü¤j¤ñ²v¦a«ì´_°·±d¡K¥un§K¬Ì¨t²ÎÁÙ¦³±Ï¡A´N¯à²£¥Í§ÜÅ馳Àø®Ä ¬Y¤H±o¤F¨ÅÀù¤@´Á¡A¦o·|¿ï¾Ü1.³Î±¼ 2.¤ÆÀø 3.¶PÀù¥ 4.obi-822¡H ¬Y¤H±o¤F¨ÅÀù¤G´Á¡A¦o·|¿ï¾Ü1.³Î±¼ 2.¤ÆÀø 3.¶PÀù¥ 4.obi-822¡H ¬Y¤H±o¤F¨ÅÀù¤T´Á¡A¦o·|¿ï¾Ü1.³Î±¼ 2.¤ÆÀø 3.¶PÀù¥ 4.obi-822¡H ¬Y¤H±o¤F¨ÅÀù¥|´Á¡A¦o·|¿ï¾Ü1.³Î±¼ 2.¤ÆÀø 3.¶PÀù¥ 4.obi-822¡H ´Nºâobi-822¹ï¦o¥i¯à¨SÀø®Ä¡A¥un¿ú¤£¬O°ÝÃD¡A¦o·|¤£·|¤]·Q¹Á¸Õ±µ¨üÂåÀø¦h¥´´X°w¡H¡H§Ú²q¨ä¥L¦hºØÀù¯g¾AÀ³¯gªºÀù¯g¯f¤H¡A³£·Q¨DÂå¥Í¤]¥´¨Ó¸Õ¸Õ¬Ý§a¡K ³oÃÄ¡A¨S¦³¼Ä¤â¡K |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/5/20 ¤U¤È 10:57:16²Ä 1569 ½g¦^À³
|
QQ¤j¡A Cox model¹ï¤p§Ì¦Ó¨¥¤ÓÃø¤F¡A¤p§Ì¤O¦³¥¼¶e¡AµLªkµû½×¡C §Ú¸ÕµÛ¤F¸Ñ±zªº°ÝÃD¡A±zªº·N«ä¬O¡A쥻¦b¥h¦~¤Q¤ëdata lock¡AY¹êÅç²Õ¨S¦³·sªºPD¥X²{¡A¦ý¹ï·Ó²Õ¤w¸g³£PD¤F¡A¦pªG®É¶¡©µ«á¤TÓ¤ë¡A¤]´N¬O¤µ¦~¤@¤ë¤~data lock¡A¬O§_pÈ»PHR¼Æ¾Ú·|§ó¦n¡H °ò¥»¤W¡A¥un¼Æ¾Ú¤w¸g¦¨¼ô¤F¡A¤]´N¬O¹F¨ìeventªº¼Æ¾Ú¨¬°÷¦h¡A®É¶¡¦A©¹«á©µªø¸Ñª¼¡A¼Æ¾ÚªºÅܤƳ£¤£·|¤Ó¤j¡A¥B¼Æ¾ÚªºÅܤƬO¤¤©Êªº¡A¥i¯à§ó¦n¤@¨Ç¡A¤]¥i¯à§ó®t¤@¨Ç¡C¦b±zªº¨Ò¤l¤¤¡A¹ï·Ó²ÕPD¡A¹êÅç²Õ³£¨SPD¡A©Ò¥H¼Æ¾Ú·|§ó¦n¤@¨Ç¡A¦ý¦bPFS¼Æ¾Ú¤w¸g¦¨¼ôªº±¡ªp¤U¡A¤j§½¤w©w¡APȤÎHR¦A§ó¦nªºµ{«×¦³¡C¦ýOS¦]¬°ÁÙ¦h³]¸ê®Æ¡A¤´¬O´Á¤¤¤ÀªR¡APÈ»PHR³£¦³§ó¦nªºªÅ¶¡¡A¨ä¤¤¥HPȪº§ïµ½µ{«×·|¸û¤j¡A³Ì¥Dn¬O¦]¬°pºâ¤è¦¡ªºÃö«Y¡C |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/5/20 ¤U¤È 02:37:44²Ä 1568 ½g¦^À³
|
¤p©_¤j: ¯u©êºp, ¦]¬°¹ï²Îp¤ÎÁ{§Éµ¥¤£¦æ, ©Ò¥H¤]°Ý±o¤£²M¤£·¡. §ÚªººÃ´b¬O, ¨Ì¾ÚCliff¤j´£¨Ñ¸ê®Æ¡¨Àù¯g¸ÕÅç¦s¬¡¸ê®Æ¤ÀªR¡¨²Ä8¶2, ¦pªGCox¼Ò«¬¥[¤J time-dependent (survival time), ¨º§Ų́úªº¸ê®Æ´¦ÅS®É¶¡ÂI¬O§_³y¦¨®t²§ ? Y822¥ÎÃIJժº¯f¤H¦b´¦ÅSªº®ÉÂI3Ó¤ë«á¨ÌÂÂOK, ¦Ó¹ï·Ó²Õ½TPD., ¦pªG3Ó¤ë«á¦A°µ¤@¦¸³otime-dependent cox¼Æ¾Ú, ¬O§_±o¥X¨Óªº¼Æ¾Ú·|§ó¦n ? ¥ç§YY¦b822¥ÎÃIJիùÄò«O«ùÀø®Äªº«e´£¤U(survival time+), ÀH®É¶¡±À²¾, ¬O§_·|§ïÅÜ¥¼¨Óªº¼Æ¾Ú, ¦p¦¹¼Æ¾Ú3Ó¤ë«á§ó·s, ¬O§_·|¦³¤£¦P ? §e²{§ó¥¿± ? ¥Õ¸Ü´N¬O¦pªG¥´§¹9°wªº¸ÕÅç²Õ¤HÀH®É¶¡©Ôªø«p§À¥X²{, ¦ý¹ï·Ó²Õ«o¨S¦³., Y¦b¥¼¨Ó®Ú¾Ú·í®Éªºsurvival time¦A°µ¤@¦¸®É¶¡¬Û¨Ìcox, ¬O§_¥X¨Óªº¼Æ¾Ú·|§e²{§ó¥¿± ? ·PÁ±z@¤ß¬Ý§Ú³o´X¥G§Ö»yµLÛ¦¸ªº°ÝÃD. ÁÂÁ«ü¾É. |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2016/5/20 ¤U¤È 02:11:08²Ä 1567 ½g¦^À³
|
¤p©_¤j ÁÂÁ±z ¤p§Ìªº¸ÑŪ,¤]´N¬O¥u¦³³o¤@²Õªº¼Æ¾Ú¬O¥H168¤Hpºâ ¡u¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨9¦¸OPTª`®gÀøµ{ªÌ¡A¨äPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡C¡v ¤p©_¤j~@¤ß.²Ó¤ß.Áo©ú.¥¿¸q....ÁÂÁ±z! |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/5/20 ¤U¤È 02:00:41²Ä 1566 ½g¦^À³
|
Faith¤j¡A ¡y³o¦¸ºKn¤¤ªºPFS©ÎOS¤§pÈpºâ, ¨Ì±z±À½×,¬O¥H348¤H©Î168¤Hpºâ?¡z ©Ò¦³ªº348¤H³£n¦C¤Jpºâ¡A¤£¯à¥u¦³PFSªí²{¦nªº¨Ó¤ñ ¡yDrop out ¤Î¥¼§¹¦¨9°w´Nµo¥Íevent, PDªº¯f±w,«á»Ý°lÂܪºOS,¦p¦ó½T©wÂk822®ÄªG?ÁÙ¬O´N³]¤F?¡z Drop out©ÎPDªº±wªÌÁöµM¤wÂ÷¶}¹êÅç¡A¤´µM¨C3Ó¤ë°lÂܤ@¦¸¬O§_OS Â÷¶}¹êÅç´N¥i¥H¥Î¥ô¦ó¤è¦¡°µ¨ä¥LªºªvÀø¡A³o¬O´L«±wªÌªºÅv¯q °µ¨ä¥¦ªvÀø©Î¤£°µ¥ô¦óªvÀø¡A¦b¹êÅç²Õ»P¹ï·Ó²Õªº±wªÌ¤¤¾÷²v¬O¤@¼Ëªº ¥i¯à¦]¨ä¥¦ªvÀø¦Ó¬¡ªº§ó¤[©ÎµL®Ä©Î§ó®t¡A¨â²Õ¾÷·|¤@¼Ë ¥u¦³822¦b±wªÌÅ餺ªº§@¥Î¬O¨â²Õªº±±¨îÅÜ¼Æ Y822µL®Ä¡A¨â²ÕªºOSªºKM¹Ï¤]·|¨S¦³®t²§ Y822¦³®Ä¡A¨â²ÕªºOSªºKM¹Ï·|¦³®t²§ ¤Ö¼Æ´XÓ¯S¨Ò¦]¨ä¥¦ªvÀø²£¥ÍOS ªº¤j´T§ïÅܤ£·|¼vÅT¾ãÅ骺²Îpµ²ªG QQ¤j¡A ¡y½Ð°Ý³o®É¶¡¬Û¨Ì¥X¨Óªº¬ÛÃö¼Æ¾Ú¦pPÈ, HR, CIµ¥, ¬O§_·|ÀH®É¶¡ ¥»¨ªº³]©w(survival time)¦Ó²£¥Í®t²§, ¥ç§YY¦P¼Ë¼Ë¥»°²³]¹êÅç²Õ©Ôªø3Ó¤ë ¹ï·Ó²Õ¤£Åܪºª¬ªp, ¼Æ¾Ú·|§ó§e²{¥¿± ?¡z ¤p§Ì¬Ý¤£À´±zªº·N«ä ¡y¥t¥~±z²q´úªº昰«ü168¤H²[»\¹êÅç²Õ¤Î¹ï·Ó²Õ¦Ó¦b³o²Õ¤º°µ¤ñ¸û, ¹ï§_ ?¡z §Ú¬O³o¼Ë²q¡A¤£µM¼Æ¦r¹ï¤£°_¨Ó¡C |
|
|
·|û¡G¤@¤Á³£¬O©R10142442 µoªí®É¶¡:2016/5/20 ¤U¤È 01:46:49²Ä 1565 ½g¦^À³
|
¤p©_¤j ¸g¹L±z¤@µfÁ|¨Ò¸ÑÄÀ ¤×¨ä¬O³o¤@¬q ³o¼Ë¨â²ÕªºKM¹Ï·|§e²{«e¥b¬q¤@¶}©l´N¤j´T©Ô¶}¡A«á¥b¬q¨â²Õ¦±½u¤Ï¦Óº¥º¥±µªñ¡A¨ì³Ì«á§ÀºÝªº¹Ï«¬·|±µ¦X¦b¤@°_ªº²{¶H¡A¤½¥q¤w¸g¬Ý¹L¤F¹êÅç²Õ¤¤50%²£¥ÍGlobo H ¯S²§IgG §ÜÅé°ª¿@«×ªº»P¹ï·Ó²ÕªºKM¹Ï¤F¡AY¦³¦¹²§¼Ë¡AÀ³¸Ó·|ĵı¡AASCO¤]¤£·|±µ¨ü½×¤åµoªí¡C Åý§Ú¬ðµMªºÁŵM¶}®Ô,»{¦P§Aªº·Qªk ªº½TÁÙ¬On·f°tKM¹Ï¤U¥h§PÂ_ ¯u¬Û¤~·|¶V¨Ó¶V©ú®Ô ¹ïOBI-822¶V¨Ó¶V¦³«H¤ß¤F |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/20 ¤U¤È 01:38:39²Ä 1564 ½g¦^À³
|
¤@¤Á¤j ©Ò¿×§K¬Ì¨t²Î¦nÃa¥u¬O¤@Ó·§©À©Ê»¡©ú¡AÃø¥H¥Î¤@«ü¼Ð¿Å¶q ©Ò¥HIriscWu¤j´£±o¨Ã¨S¿ù ¥»¨Ó¥u¬Oı±o¹ïºKn®³¦Û¤v ¹êÅç²ÕIgG²£¥Í¶q«e50% vs ¥þ³¡¹ï·Ó²Õ ¦n¤ñ®³¦Û¤v¯Zªº¦n¾Ç¥Í¸ò§O¯Zªº¦nÃa¾Ç¥Í¤ñ ¨ÓÅã¥Ü¦Û¤vªº¦n¦ü¥G¦³ÂI¸Ø¤j¤F ¤£¹L¦³«í¤j´£¿ô¤F ¥¼¨Ó¸g¹L¤@Ó¿z¿ï¾÷¨î§ä¥X¾A¦X¥D°Ê¦¡§K¬ÌÀøªkªº¯f±w(¨Ò¦p¥´¥|°w¡A§ÜÅé²£¥Í¶q°÷´N±µ¨ü)¡A¤]´N¬O§Úªº¯f±w¥þ¬O¦n¾Ç¥Í¡A¨º´N²Å¦X¤Wzªº¤ñ¸û±¡¹Ò ¥t¥~§ÜÅ餣¨¬©Î¨S¦³ªº¯f±w¡A¥¼¨Ó¤´¥i¨Ï¥Î888³æ®èªº¤è¦¡ÂåÀø ¯u²z·UÅG·U©ú¡A822Åý¤H§óȱo´Á«Ý |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/20 ¤U¤È 01:36:10²Ä 1563 ½g¦^À³
|
ºKn»¡: ¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨ 9 ¦¸OPTª`®gÀøµ{ªÌ¡A ¨äMPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡C 168¦ì§¹¦¨ 9 ¦¸OPTª`®gÀøµ{ªÌ¡A¨Ì·ÓºKnªº¤å·N¯ßµ¸¡A À³¸Ó¥]§t¹êÅç²Õ»P±±¨î²Õ¨â²Õ³¡¥÷¤ñ¸û§K¬Ì±j¡A¤ñ¸ûªø®É¶¡¥¼µo¯fªº¤H ¦pªG¤§«e¬OÀH¾÷¤À¬£(¹êÅç±±¨îÅo) °²³]¨â²Õ¼Ë¥»¦P½è ¥i¥H¥Î2:1±À´ú¨ä©Ò¦û¤ñ¨Ò Y¤£¬OÀH¾÷ ¤~¤ñ¸û¥i¯à¨â²Õ¤£¦P½è (§Ú·Q²Îp±M®a¤@©w·|¥ý¦ÒÅç¨â²Õ¦P½è©Ê°Õ ³o¬O¥À¼Æ¦ÒÅç«eªº°ò¥»°Ê§@Åo Y¤£¦P½è ¤~²Îp±±¨î À´¶Ü) ¦o̬OÄÝ©ó®É¶¡¤W¤ñ¸ûªø´Áªº®×¨Ò ©Ò¥H¥ÎCOX¼Ò¦¡¤ÀªR »ÝnÁקK®É¶¡¦]¯Àªº¤zÂZ ¥H´î¤Ö²Îp¤W¤£¦X°²³]ªº«¤jì«h°ÝÃD §Ú»{¬°³o¨Ç¤Hªº¯S¼x ¥i¯à¬O¥»¨§K¬Ì±j ¦³¨ä¥L»²§UªvÀø Åé½è ¦~ÄÖ ©Î¤HºØªº¯S®í³B ³o®É822¥´¤J¨Åé ¹J¨ì¤@Ó°ÝÃD ·í²Ä3 4°w¥´¤J¨Åé ¦h¼Æ¤H¤~¦³§K¬Ì¤ÏÀ³-©µ¿ð®ÄÀ³ ¨º´N¬O¥ý¤ÞµoªºIgMµu®Ä(¦ôp¥´°w«á1-2¤ë¿@«×³Ì°ª ¦Ó«á»¼´î) ¦Ó«á¤~¦³IgGªø®Ä(¦ôp5-6¤ë¿@«×³Ì°ª ¦Ó«á»¼´î) ¬°¦ó¤½¥qn¦ÒÅ祴§¹¤E°wªº¨â²Õ¼Ë¥»©O? ¤j®a¥ý·Q·Q §Ú»{¬°¬On¦ÒÅç822ÃĮĦ³¦hªø®Ä?´«¬ì¾Ç»¡ªk¬O822¤§IgGªø®Ä¦³¦hªø®Ä? ¥H¤U«ä¦Ò 1.³o¨â²Õ¼Ë¥»ªºKM¦±½u À³¸Ó¬O¤@¶}©l³£¬O¥ªº ª½¨ì¥´§¹²Ä¤E°w«áªº ¬Y¤@¶g¶}©l´_µoPD ©ó¬O¦±½u¶}©l»¼´î¤UÅs¡A¦pPie¤j¬Ýªk¡A±À´ú9°w«á¡A¬ù²Ä¤E¤ë«á¡AIgG¿@«×¤£¦A¦³822¨ë¿E¦Ó§Ö³t¤U° IgM¦¨S¤F¡A KM¦±½u¦¹®É§Ö³t¤U·Æ¡A±×²v¤ñ¥´°w®É´Á¤j¡A©ó¬O¸~½F´_µo§Ö¡APD§Ö³t¥X²{¡C 2.·Ó²z ¹êÅç²Õ¦]¬°IgM®ÄªG¥X²{ ¨äMPFS¡A·|³vº¥©Ô¶} ¹êÅçµ²ªG¤]Åã¥Ü¦p¦¹ §Y¦p (HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡A²q´ú¹êÅç²Õ¦±½u¤UÅs±×²v¤ñ¸û¤£±× ¹ï·Ó²Õ±×²v¤ñ¸û±× ¦b§Ú¨Ó¬Ý ²Îp¤W0.057 ¸ò0.05®t²§¤£¤j ¦ý¬O¬ì¾Ç´N¬O»¡¨S¦³ÅãµÛ ¦ý¬OÁ{§É¤W «Ü¥i¯à¹êÅç²ÕMPFS¥u¬O®t1Ó¤ë´N¹FÅãµÛ ¥i¬O¤w¸g¤ñ±±¨î²Õ¦h12Ó¤ë (¼Æ¾Ú¬OÁ|¨Òªº «D¬ã¨s³ø§i¼Æ¦r »Ýn¬ÝASCO¯u¹êªº¼Æ¦r) Ãø¹D¤£ºâÁ{§É¦³®Ä¶Ü? ¦hªá¤@¦Ê¸U´«¤@¦~¹Ø©R®É¶¡¦p¦ó? 3.¦]¬°¹êÅç²Õ822¤ÞµoIgG®É¶¡ºC¤S¿@«×¤Ö¡A©Ò¥H¥´§¹¤E°w¡AÃĮħK¬Ì¤O«ùÄò©Ê¤£°÷¡A©ó¬O¶}©lPD¡A ©Ò¥H¥H«eªº«p§À®ÄÀ³¸Ó¨S¦³¥X²{¦b³oÃþ§K¬Ì¤ñ¸û±j¡A¥´§¹¤E°w«á¡A®É¶¡©ìªø¡AIgG¿@«×¾U´îªº¨ü¸ÕªÌ¨¤W¡C ´«¨¥¤§¡A¦¹¦ÒÅç´£¨Ñ¥¼¨Ó¤E°w¤§«á¡A¬O§_Ä~Äò¬I¥´¡A¨Óºû«ù§K¬Ì®ÄªGªºÃÒ©ú?¦³Ä~Äò¥´¡A´N¦³ºû«ù®ÄªG? ³o¦h¤Ö»¡©ú822¤£¬O¥P¤¦¥i¥H¤@¦¸²×µ²¨ÅÀù¡A¦ý¬O§®ÃÄ¥i¥H©µ¦~¯q¹Ø 2.¬°¦ó¨S¦³¶¶«K´£¨ÑOSªº¦ÒÅçµ²ªG?¨ä¥L¦ÒÅç³£¦³µ¹ªü? §Ú²q´úì¦]¦³: (1)¥i¯à¬O¤Wzì¦]¡A©Ò¥H¦³¦ÒÅç¨S¦³¦C¥X¤£¦nªºOS¦ÒÅçµ²ªG¨Ó (2)¥i¯à¨S·Q¨ìn¦ÒÅç¡A©Îı±o¤£»Ýn¡A¤Ï¥¿¦ª¾¹DIgG¤£¦h¡A¯dµ¹¥H«á833¦ÒÅç (3)¦³¦ÒÅç¡A¦³µ²ªG¡A¦ý¬O«O¯d¦bASCOÃzÂI ¥H¤W¶È¨Ñ°Q½× ¤£¥i§@¬°§ë¸ê°Ñ¦Ò |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/5/20 ¤U¤È 01:02:48²Ä 1562 ½g¦^À³
|
T^T¤jªºÆ[ÂI¡A¤p§Ì¤]¥Î¼Æ¦r§Ç¦C¨Ó¥Ü·N §ÚÌ°²³]§K¬Ì¤O¦nÃa»PPFS¤ÎOS¦³¦Ê¤À¤§¦Êªº¬ÛÃö©Ê ¦Ó§K¬Ì¤O¦nÃaªº´ú¶q¤èªk´N¦b²£¥ÍGlobo H ¯S²§IgG §ÜÅé¿@«×ªº¦h¹è Y³o¦¸Á{§Éªº¹êÅç²Õ»P¹ï·Ó²Õ¬O¨S¦³®t²§ªº¦±½u¡A822¬OµL®Äªº PFS§Ç¦C¦p¤U¡G ¹êÅç²Õ¡G1¡A2¡A3¡A4¡A5¡A6¡A7¡A8¡A9¡A10¡A11¡A12¡A13¡A14¡A15¡A16¡A17¡A18¡A19¡A20 ¹ï·Ó²Õ¡G1¡A2¡A3¡A4¡A5¡A6¡A7¡A8¡A9¡A10¡A11¡A12¡A13¡A14¡A15¡A16¡A17¡A18¡A19¡A20 ¨â²ÕKM¦±½uµL®t²§¡APÈ=1 ¨â²Õ«á¥b¬q50%ªºPFS¤ñ¸ûªø¬O¦]¬°§K¬Ì¤O¤ñ¸û±j¡A¥B§e²{§¹¥þ¥¿¬ÛÃö ¦ý¸Ñª¼¥Î¤F50%²£¥ÍGlobo H ¯S²§IgG §ÜÅé¿@«×°ªªº¨Ó»P¹ï·Ó²Õ°µ¤ñ¸û ¦]¦¹¡A¹ïOPT-822/OPT-821²£¥ÍGlobo H ¯S²§IgG§ÜÅé (³o¬O«ü§ÜÅé®Ä»ù´¿¦bªvÀø´Á¶¡¤º¹F¨ì ≥ 1:160)¡C³o¨Ç²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ¡A·í»P¹ï·Ó²Õ¤ñ¸û¡A¦³¥H¤Uµ²ªG: PFS¡GHR = 0.71 [95%CI 0.52-0.97]¡Ap= 0.029¡F OS¡GHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04¡F¡v ¨ä¹ê¬O¥Î¥H¤Uªº¼Ë¥»¨Ó¤ñ¸û PFS§Ç¦C¦p¤U¡G ¹êÅç²Õ¡G11¡A12¡A13¡A14¡A15¡A16¡A17¡A18¡A19¡A20 ¹ï·Ó²Õ¡G1¡A2¡A3¡A4¡A5¡A6¡A7¡A8¡A9¡A10¡A11¡A12¡A13¡A14¡A15¡A16¡A17¡A18¡A19¡A20 ¦]¬°¹êÅç²Õªº¼Ë¥»¼Æ¬O¹ï·Ó²Õªº1¿¡A§Ú§â¨â²Õ¼Ë¥»¼Æ½Õ¦¨¤@¼Ë¤ñ¸û¦n¤F¸Ñ ¹êÅç²Õ¡G11¡A11¡A12¡A12¡A13¡A13¡A14¡A14¡A15¡A15¡A16¡A16¡A17¡A17¡A18¡A18¡A19¡A19¡A20¡A20 ¹ï·Ó²Õ¡G1¡A2¡A3¡A4¡A5¡A6¡A7¡A8¡A9¡A10¡A11¡A12¡A13¡A14¡A15¡A16¡A17¡A18¡A19¡A20 ³o¼Ë¨â²ÕªºKM¹Ï·|§e²{«e¥b¬q¤@¶}©l´N¤j´T©Ô¶}¡A«á¥b¬q¨â²Õ¦±½u¤Ï¦Óº¥º¥±µªñ¡A¨ì³Ì«á§ÀºÝªº¹Ï«¬·|±µ¦X¦b¤@°_ªº²{¶H¡A¤½¥q¤w¸g¬Ý¹L¤F¹êÅç²Õ¤¤50%²£¥ÍGlobo H ¯S²§IgG §ÜÅé°ª¿@«×ªº»P¹ï·Ó²ÕªºKM¹Ï¤F¡AY¦³¦¹²§¼Ë¡AÀ³¸Ó·|ĵı¡AASCO¤]¤£·|±µ¨ü½×¤åµoªí¡C ¨Æ¹ê¤W¡A¨â²Õ¨S¦³®t²§ªº¦±½u¡AY®³¹êÅç²Õ«á¥b¬q±jªº»P¹ï·Ó²Õ¤ñ¸û¡A©Î»P¦Û¤vªº«e¥b¬q¼Æ¾Ú¤ñ¸û¡A³£·|§e²{Ãþ¦ü¥H¤Wªº¤£¦X²zKM¹Ï¡APȤ]·|¹F¨ì«D±`«D±`ÅãµÛ¡Apºâ°_¨ÓPÈ¥²¶·¤p©ó0.001¡A¦ý¤½¥qºKn¤¤¹êÅç²Õ²Õ50%²£¥ÍGlobo H ¯S²§IgG §ÜÅé¿@«×°ª»P¹ï·Ó²Õ¤ñ¸û¡A¤S»PµL§K¬Ì¤ÏÀ³ªÌ¤ñ¸û¡A¦bPFS¤ÎOSªºPȦ³3ӼƾڪºPÈ¥u¬O¹F¨ìÅãµÛ¤ô·Ç¡AHR«h¬O¤£¿ù¦ý¨S¨ì¸Ø±iªº¦n¡A¦]¦¹±À½×¡A¹êÅç²Õ¤¤50%²£¥ÍGlobo H ¯S²§IgG §ÜÅé¿@«×°ªªº»P¹ï·Ó²Õªº¼Æ¾Ú¡A¨Ã«D¬O¦]¬°¨ú§K¬Ì¤O¦n´N¬¡±o¤[ªº«á¥b¬q¼Ë¥»»P¹ï·Ó²Õ¤ñ¸û¡C ¤p§Ìªº·Qªk»PIriswu¤j²¤¦P¡A§K¬Ì¤O¦nÃa¨Ã«D¦¹¦¸Á{§Éªº«ÂI¡A¨Æ¹ê¤W¡A¦¹¹êÅ窺¼Ë¥»ªº§K¬Ì¤O¡A»P¤@´Á©Î¤G´Á©Î¤T´Á©Î¥¿±`¤Hªº¼Ë¥»¥i¯à¦³©úÅ㪺®t²§¡A¦ý349¤H©¼¦¹¤§¶¡ªº®t²§¡A¦b¤wª¾ªº¥Í²z¼Æ¾Ú´ú¶q¤U¡A®t²§¨Ã¤£©úÅã¡Aþ¦ì±wªÌ·|²£¥Í°ª¿@«×§ÜÅéÁÙ¬On¥´¤F3~4°w¤~ª¾¹D¡C ¤p§Ìªº·Qªk¡A¤HÅ骺§K¬Ì¤O¥u¬OÀù¯g±wªÌ¸~½FÅܤƩά¡±oªøµuªº¤@Ó¦]¯À¡A¦³¨ä¥¦§ó«nªº³\¦h¦]¯À¼vÅT¸~½FªºÅܤƻP±wªÌªº¥Í©R¡A¦Ó822¦³®Äªº¥ý¨M±ø¥ó¬O§K¬Ì¤O¤ñ»Ý¯à²£¥Í¨¬°÷ªº§ÜÅé¡AµM«á¨Å骺¤º³¡²£¥Í¤F§ïÅÜ¡A¤]´N¬O©Ò¿×ªº¾÷Âà¡A³Ì«á¬Ý¨ìªº¬O§e²{¥XÀø®Ä¡C ¥t¥~ ¡u¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨9¦¸OPTª`®gÀøµ{ªÌ¡A¨äPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡C¡v Y³oÓ¤ñ¸û¬O168¦ì¶W¹L37¶g¤´¥¼PDªº±wªÌ¨Ó¤ñ¸û¡A¨Ì·Ó§K¬Ì¤O¦n´N¬O¬¡±o¦nªº°²³]¡A¦¹¤ñ¸û¬O§ä§K¬Ì¤O¦nªº«á¥b¬q¹êÅç²Õ»P¹ï·Ó²Õ¨Ó¤ñ¸û¡AY¨â²Õ¬O¨S¦³®t²§ªº¦±½u¡A822¨Ã¨S¦³µo¥Í§@¥Î¡A«h¥H¤WªºPÈÀ³¸Ó±µªñ1¡AHRªº¼Æ¦r¤]À³¸Ó±µªñ1¡C ¤£¹L³o¥u¬O¤p§Ìªº·Qªk¡AASCO¤½¥¬ªºKM¹Ï¦A¨Ó¦LÃÒ·Qªk¬O§_¥¿½T¡C |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/5/20 ¤U¤È 12:56:21²Ä 1561 ½g¦^À³
|
²³¤j¦w ¤p§Ì°O±o2/21ªk»¡®É±i¸³¦^µª¥þ²y¤T´Á³]p®É¦³»¡©ú¥¼¨Ó¥i¯à¤è¦V °ò©óÂùª¼¦³¹H¤H¹D¥ß³õ,©Ò¥H·|±Äopen-arm¤S¦³¹ï·Ó²Õªº¤@Ó°µªk ¤@²Õ¥´822(³z¹L¨Æ«e4°wªº¿z¿ï,¦³²£¥Í4³Q§ÜÅé¯Ç¤J¹êÅç,µL«hÂ÷¶},¹ï¤½¥q¯f¤H³£¦n) ¥t¤@¹ï·Ó²Õ¥´Ãþ¦ücyclophosphamide,©|¥¼¨M©w¥Î¬Æ»ò·|¦A¦æ°Q½×,«DÂùª¼,µL»Ýµ¥¥X°ÝÃD¤~¥i¨« ¦ü¥G¤£¥Î¾á¤ß¹ï·Ó²Õ§K¬Ì¨t²Î±j®zªº°ÝÃD,¥H¤W¨Ñ²³¤j°Ñ¦Ò |
|
|
·|û¡GIriswu10136250 µoªí®É¶¡:2016/5/20 ¤W¤È 11:58:18²Ä 1560 ½g¦^À³
|
Ó¤Hı±o§K¬Ì¨t²Î®t©Î¦n³o³£¬O¥t¥~¥[¤W¥hªº±ø¥ó,³£¬O¨S¦³¬ì¾Ç¼Æ¾Úªº´yz,¤]¸ò³o¦¸ªº¹êÅçµLÃöªº,³o¦¸¥Ø«eªº¹êÅç©Ò¶q´ú²£¥Íªº¼Æ¾Ú´N¬O§ÜÅ骺¿@«×,¦]¦¹©Ò¦³ªºµ²½×´N¥²¶·®Ú¾Ú¬ì¾Ç¤W¶q´úªºÅܦ]¨Ó±À½×,¤£¯à¥t¥~¤S¥[¤W¤@¨Ç±ø¥ó,³o¼Ë´NÅܱo«Ü©_©Ç. |
|
|
·|û¡G¤@¤Á³£¬O©R10142442 µoªí®É¶¡:2016/5/20 ¤W¤È 11:49:11²Ä 1559 ½g¦^À³
|
µL¦W¤j ¹ï©ó¹êÅç²Õ²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ¡A»P¹ï·Ó²Õ¤ñ¸û §Ú¤]¦³¨Ç¬Ýªk °²³]§Ṳ́À¦¨5²Õ¨Ó¬Ý 1.¹êÅç²Õ(§K¬Ì¨t²Î¦n+§K¬Ì¨t²Î®t) VS ¹ï·Ó²Õ(§K¬Ì¨t²Î¦n+§K¬Ì¨t²Î®t) 2.¹êÅç²Õ(§K¬Ì¨t²Î¦n) VS ¹ï·Ó²Õ(§K¬Ì¨t²Î¦n+§K¬Ì¨t²Î®t) 3.¹êÅç²Õ(§K¬Ì¨t²Î¦n) VS ¹êÅç²Õ(§K¬Ì¨t²Î®t) 4.¹êÅç²Õ(§K¬Ì¨t²Î¦n) VS ¹ï·Ó²Õ(§K¬Ì¨t²Î¦n) 5.¹ï·Ó²Õ(§K¬Ì¨t²Î¦n) VS ¹ï·Ó²Õ(§K¬Ì¨t²Î®t) ¨ä¤¤1,2,3²Õ¥i¥ÑºKn±oª¾µ²ªG ¦pªG§ÚÌ¥i¥Hª¾¹D²Ä4²Õµ²ªG©ÎªÌ¥i¥H¹ï·Ó3,5²Õ ¬O¤£¬O¥i¥H§ó«ÈÆ[ªºª¾¹D¹êÅç²Õ»P¹ï·Ó²Õªº®t²§ |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/20 ¤W¤È 11:25:41²Ä 1558 ½g¦^À³
|
¬Ý¹L¤@½g¤¤¬ã°|½×¤å¡A¤º®e¬O§Q¥Î½Õ¾ã¦õ¾¯¦¨¤À²£¥Í°w¹ïGH,SSEA4ªº§ÜÅé ¦]¦¹¡A´¿½Ð±Ðª©¤W¤j¤j¡A822²£¥Íªº§ÜÅé¥u¦³GH,©Î¦P®É¦³GH,SSEA3,SSEA4 ¦ýµL¤H¦^µª~ ¤£¹L¤§«e¤J¿ïASCOªº»¡©ú·|¤W¡A±i¸³»¡©ú²£¥Íªº§ÜÅ餣¥uGH,ÁÙ¦³SSEA3,SSEA4 ¤]´N¬O822¨Ã¤£¬O¥u²£¥ÍGH§ÜÅé¡A´N¯à®ø·À±aGH,SSEA3,SSEA4§Ü쪺Àù/·F²ÓM¡A¤£¬O1¹ï3¡A¦Ó¬O3¹ï3!! GH series§Üì¦bÀù²ÓM¡BÀù·F²ÓM¤W¤À¥¬ªºÁp¶°±µªñ100%¨S¿ù ¦ý¤£¦PÀù¯g¡BÀù·F²ÓM¤W¡BÀù²ÓM¤WªºGH,SSEA3,SSEA4ªº¤À¥¬¤ñ²v³£¤£¬Û¦P ¬Æ¦Ü·¥¤Ö¼Æªº¤H¡A§¹¥þ¨S¦³GH series ¦¹¦¸Á{§Éµ²ªGªºGH,SSEA3,SSEA4§ÜÅé²£¥Íºw«×¦p¦ó?¹ïÀ³ªºOS,PFS? §Ú·QÅܤƤӦh¤F¡A©Ò¥H½×¤åºKn¥H²£¥ÍGH¯S²§©ÊIgG§ÜÅéºw«×¹F1:160¥H¤W(¦P®É¤]¬O¹êÅç²Õ50%¤H¼Æ)¬°¤ñ¸û°ò·Ç ¦p¦¹¥i¬ð¥X¡G 1.Àø®Ä¨Î(¨}¦nªºHR,P value) 2.¾A¥Î¼s(50%) ¤Wzªºµ²½×®¶¾Ä¤H¤ß!!! ¦ýÅܤƹê¦b¤Ó¦h¤F¡A¦b¿³¾Ä¤§¾l ¤´¦³¥²n¼f·Vµ¥«Ý½×¤å²Ó¸`¸ê®Æ¦A¦æµû¦ô¦³µL¬Ý¤£¨ìªº·ÀI~~ |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/5/20 ¤W¤È 11:23:47²Ä 1557 ½g¦^À³
|
¤p©_¤j: ½Ð°Ý³o®É¶¡¬Û¨Ì¥X¨Óªº¬ÛÃö¼Æ¾Ú¦pPÈ, HR, CIµ¥, ¬O§_·|ÀH®É¶¡ ¥»¨ªº³]©w(survival time)¦Ó²£¥Í®t²§, ¥ç§YY¦P¼Ë¼Ë¥»°²³]¹êÅç²Õ©Ôªø3Ó¤ë ¹ï·Ó²Õ¤£Åܪºª¬ªp, ¼Æ¾Ú·|§ó§e²{¥¿± ? ½Ð±Ð±z§Ú³o¼Ëªº²z¸Ñ¬O§_¥¿½T ? ¥t ¥~±z²q´úªº昰«ü168¤H²[»\¹êÅç²Õ¤Î¹ï·Ó²Õ¦Ó¦b³o²Õ¤º°µ¤ñ¸û, ¹ï§_ ? ±z¤è«K®É¦A³Â·Ð«ü¾É¤@¤U, ·PÁÂ. T^T¤j: ÁÂÁ±z´£¨ÑªºÆ[ÂI, §Ú¹ï¦¬®×¤H¿ï±ø¥ó쥻¨S¦³¯S§O¥h¯d·N, ¥H«áÀ³ºÉ¶q¦b¯à¨ú±oªº¸ê®Æ½d³ò¤º©ñ¤J¤ñ¸û¤~·|§ó«ÈÆ[. ¤]¤@¨Ö·PÁÂCliff¤j, ¦Ñ´¤j, ¹x¥Û¤j, ¯E§J¤j, ¥xÁÞ¤j, µL¦W¤jµ¥¯E¤Í´£¨Ñªº¤ÀªRÆ[ÂI¤Î¸ê®Æ¤À¨É. ¨ü¯q¨}¦h, ÁÂÁÂ. ¯u¬O¯EÃv¡K¡K. |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2016/5/20 ¤W¤È 11:06:18²Ä 1556 ½g¦^À³
|
¤p©_¤j ÁÂÁ±z!³o´N³q¤F~ ¥t¥~,¦A½Ð±Ð±z¡G 1.³o¦¸ºKn¤¤ªºPFS©ÎOS¤§pÈpºâ, ¨Ì±z±À½×,¬O¥H348¤H©Î168¤Hpºâ? «ö·Ó¤p§Ìªº²z¸Ñ¬O168¤H! 2.Drop out ¤Î¥¼§¹¦¨9°w´Nµo¥Íevent, PDªº¯f±w,«á»Ý°lÂܪºOS,¦p¦ó½T©wÂk822®ÄªG?ÁÙ¬O´N³]¤F? ¥H¤W,·PÁÂ! ¦Ü©óºKn·Qªk,ºCºC¨Ó,¤@°_¬Û¤¬¤Á½R,ÁÂÁ±z! |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/20 ¤W¤È 10:58:52²Ä 1555 ½g¦^À³
|
µL¦W¤j»¡ªº¡A´N¬O§Ú¤@ª½¦b½èºÃªº¡A¦ý¬OÁ{§É¹êÅ窺³]p¦³¤@©wªºì«h¡A¤£¬OÀH«K¿ï50%§Y¥i¡C¦Ó¥B¦pªG¥Î§Aªº¿ïªk¡A¬Ý¤£¥X®t²§ªº¥i¯à©Ê·¥¤j¡C |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/5/20 ¤W¤È 10:51:58²Ä 1554 ½g¦^À³
|
pie¤j¡A¯E§J¤j ±zÌ°Q½×ªºÄ³ÃD¡A¤p§Ì¹Á¸Õ¥Î¼Æ¦r§Ç¦C¨Ó¥Ü·N PFS§Ç¦C ¹êÅç²Õ¡G1¡A2¡A3¡A4¡A5¡A6¡A7¡A8¡A9¡A10.5¡A11¡A12.5¡A13¡A14.5¡A15¡A16.5¡A17¡A18.5¡A19¡A24 ¹ï·Ó²Õ¡G1¡A2¡A3¡A4¡A5¡A6¡A7¡A8¡A9¡A10¡A11¡A12¡A13¡A14¡A15¡A16¡A17¡A18¡A19¡A20 ¡yÃö©ó½×¤å¤¤³Ì«á¤@¶µ¤ñ¸û, ¤p§Ì¦³ÓºÃ´b ¡u¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨9¦¸OPTª`®gÀøµ{ªÌ¡A¨äPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡C¡v ¯à§¹¦¨9¦¸OPTª`®gÀøµ{ªÌ, ªí¥Ü37©P¥¼PD, ³oÓ¸s²Õªº³Ì¤pPFS±q¤EÓ¤ë°_¸õ, MPFSÀ³¸Ó¬O§ó°ª ¥H³oÓ¸s²Õ©M¹ï·Ó²Õ¬Û¤ñ, PÈÁÙ¥u¦³0.057, ¬Oªí¥Ü¹ï·Ó²Õªí²{¸Ø±i±o¦n¶Ü¡H ÁÙ¬O»¡®É¶¡¬Û¨ÌCox¤ÀªR¦³¤°»ò¯S§Oªº¦a¤è?¡z pie¤jªº·N«äÀ³¸Ó¬O¡G PFS§Ç¦C ¹êÅç²Õ¡G 10.5¡A11¡A12.5¡A13¡A14.5¡A15¡A16.5¡A17¡A18.5¡A19¡A24 ¹ï·Ó²Õ¡G1¡A2¡A3¡A4¡A5¡A6¡A7¡A8¡A9¡A10¡A11¡A12¡A13¡A14¡A15¡A16¡A17¡A18¡A19¡A20 ³o¨â²Õ¨ÓµeKM¹Ï¡Aµe¥X¨ÓªºKM¹Ï¹êÅç²Õ§¹³Ó¡APȲzÀ³»·¤p©ó0.05 ¤p§Ì¹ï¡u¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨9¦¸OPTª`®gÀøµ{ªÌ¡A¨äPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡C¡v¤]«Ü¦n©_ ¦ý²q´ú¥i¯à¬O©Ò¦³¥´§¹9°wªº168¤H¤¤ªº¹êÅç²Õ»P¹ï·Ó²Õ¬Û¤ñ¡A¤~¥i¯à·|±o¨ì(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)ªº¼Æ¦r¡C ¥H¤W¦³¿ù½Ð«ü¥¿¡C |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/5/20 ¤W¤È 10:27:58²Ä 1553 ½g¦^À³
|
Faith¤j¡A ¥ô¦óÁ{§Édrop outªº©w¸q³£¬O¥¼¹Fevent¡A¨S¦³²z¥Ñ´N°h¥X ¦¹¦¸Á{§É¹êÅ窺event¬OPD©Î¦º¤` ¦]¦¹¨S¦³PD©Î¦º¤`´N°h¥Xªº´N¬Odrop out ¸ò¥´´X°w¨S¦³Ãö«Y ¦¹¦¸½×¤åºKn,¥´§¹9°wªº¦³168¤H! 104¦~5¤ë,PD229¤H,drop out 37¤H! ±zı±o¼Æ¦r©Ç©Çªº¡A¹ï¤£¨Ó¡H ¥H«e¦³°Q½×¹L¤F ¦pªG¥´9°w¤§«e´NPD¡A¸Ó±wªÌªºPFS¤w¸g½T©w¡A¹ïÁ{§É¤w°µ¥X°^Äm¡A¤£¯à¦A¥´ÃĤF ³o¨Ç±wªÌªºPFS¤w½T©w ¡A¤£ºâdrop out ©Ò¥H³Ì²×ªºdrop out¤H¼ÆÀ³¸Ó»P37¤H¬Û¥h¤£»· ¦Ü©óPD229¤H¡A¦³¨Ç¬O¥¼¥´§¹9°w´NPD¡A¦³¨Ç¬O¥´§¹9°w«á¤~PD ¬Q¤ÑºKnªº·Qªk¡AÁÙ¦b«ä¦Ò¤¤¡K |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/20 ¤W¤È 10:23:42²Ä 1552 ½g¦^À³
|
Faith¤j ¤p§Ì¤]¤£²M·¡drop outªº©w¸q, ¤£¦n·N«ä ¯E§J¤j 1.©ó¥´§¹¤E°wOPTªº¸s²Õ, ¥H¤Î¹ï·Ó²Õ, ·Q¹³¤@¤U¥L̪ºKM¹Ï «eªÌ¦b37¶g«e³£¬O§¹¥þ¥ªº, ¨S¦³¤U°, 37¶g«á¤~¶}©l¤U°, ¡K¡K¡K>¦¹¬q»¡ªk¡A¤£¦X¤@¯ëKM¦±½uª¬ªp¡A¤@¯ëKM¦±½u¬O ¥ª°ª¥k§C »¼´î¨ç¼Æ¹Ï§Î ³Ì¥kºÝ³q±`¦³Ãþ¦ü¤ô¥½uªº±¡§Î ¥´§¹¤E°wOPTªº¸s²Õ, ¦³¤@Ó¯S§Oªº±ø¥ó¶·º¡¨¬, ´N¬O¥´²Ä¤E°w¤§«e³£¨S¦³PD, ¤~·|¶i¦æ¨ì²Ä¤E°w ©Ò¥H¤~»¡³oÓ¸s²ÕªºKM¦±½u, ¤£¹³¤@¯ëªº±¡ªp, 37¶g(²Ä¤E°w)¤§«á¤~·|¶}©l»¼´î, ¦b³o¤§«e¬O¥ªº |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2016/5/20 ¤W¤È 09:44:33²Ä 1551 ½g¦^À³
|
Pie¤j¡BCliff¤j¡B¦Ñ´¤j¡B¥xÁÞ¤j..¦U¦ì¯E¤ÍÌ ¤p§Ì¹ï©ó¬Q¤é´£¤Îªº°ÝÃD©|¦³ºÃ°Ý½Ð±Ð¡G ¦¹¦¸½×¤åºKn,¥´§¹9°wªº¦³168¤H! 104¦~5¤ë,PD229¤H,drop out 37¤H! ½Ð±Ð~ YPD229¤¤,¦³³¡¤À¯f±w¨S¦³¶i¦æ§¹§¹¾ãÀøµ{¡]9°w¡^,¥]§t¦º¤`¤Î°h¥X.. ¨º»ò,³o¨Ç¤H¬O§_ºâdrop out? ¹ï©ó¦¹¦¸Á{§É¹êÅç,drop out¸Ó¦p¦ó©w¸q? ¥H¤W,·PÁÂ! |
|
|
·|û¡GµL¦W10141903 µoªí®É¶¡:2016/5/20 ¤W¤È 09:26:33²Ä 1550 ½g¦^À³
|
®¥³ß¯E¹©´ÂÀù¯g¤jÃĥؼФSÁÚ¶i¤F¤@¤j¨B °w¹ïASCO½×¤åºKn¡A´£¥X¤U¦CÆ[¹î¡G ¹êÅç²Õ²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ¡A»P¹ï·Ó²Õ¤ñ¸û¡Aµ²ªG PFS¡AHR = 0.71 [95%CI 0.52-0.97]¡Ap= 0.029 OS¡AHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04 ¥H¤WºKn¤ñ¸û¤è¦¡¡A©¿²¤¯f±w§K¬Ì¨t²Î°·¥þ«×¬O¼vÅTPFS,OSªº«¤j¦]¯À(¤×¨ä¬O¥D°Ê¦¡§K¬ÌÀøªkÀ³¬O¤½»{ªº)¡A¦]¦¹¦¹ºØ¤ñ¸û¤è¦¡¡A²¤¬°¼ÖÆ[ ¤ñ¸û«ÈÆ[«O¦uªº¤ñ¸û¤è¦¡¥i±N (¹êÅç²Õ²£¥Í§ÜÅé¶q«e50%) VS (¹ï·Ó²Õ§K¬Ì¨t²Î¦n+§K¬Ì¨t²Î®t) ½Õ¾ã¬°¡G (¹êÅç²Õ²£¥Í§ÜÅé¶q«e50%) VS (¹ï·Ó²ÕPFS,OS «e50%) |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/20 ¤W¤È 09:14:10²Ä 1549 ½g¦^À³
|
Cliff¤j ¤Î¦U¦ì¥ý¶i¡C ©Ò¥H§Ú»¡¬Ý¨ìOS benefit¤§«e¡AÁÙ¬OnÂÔ·V¡C·íµM¦pªG§Aª¾¹D¦³CR NEDªº¯f¤H¼Æ¡A´N¤£¤@¼Ë¤F! Atezolizumab ©M OBI-822¬O¤£¯à¤ñ¸ûªº¡C OBI822³o¦¸Áö»¡¬OBC stage 4¡A¦ý¬Dªº¯f¤H 5 yrs OS ¬O20%¥H¤W(¦]¬°§â«Ü®t±q¨Ó¨S¦³stable diseaseªº±Æ°£¤F)(¬Æ¦Ü²{¶¥¬q¥i¥H»¡¨ì30%)¡ADSS §ó¦n¡A³o¤]¬O³o¦¸¹ï·Ó²Õ¦s¬¡²v¤ñ¤@¯ëstage 4¦nªºì¦]¤§¤@¡A©Ò¥H«Ü¦h¯f¤H¤£·|¦º©óBC¡A²{¶¥¬q¤]¦³¤£¦PªvÀø¤è®×¡C Atezolizumab°µªºbladder cancer±Ú¸s5yrs DSS¬O 0. Atezolizumab¦b¥xÆW¦³¦¬®×¡A¥¦ªºÀø®Ä¬O§A¯uªº·ÓÅU¨ì¯f¤H¡A§Aµ´¹ïª¾¹D¯f¤H¥´ªº¬O ¯uÃÄÁÙ¬Oplacebo(¦]¬°¤ÓÅãµÛ¤F¡A¤£¥²µ¥data)¡A©Ò¥H¤£¸Ó©ñ¦b¤@°_¤ñ¸û¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/5/20 ¤W¤È 09:01:44²Ä 1548 ½g¦^À³
|
¯E§J¤j ¦³50%ªº¹êÅç²Õ±wªÌ¡A¹ï OPT-822/OPT-821 ²£¥Í Globo H ¯S²§IgG §ÜÅé (³o¬O«ü§ÜÅé®Ä»ù´¿¦bªvÀø´Á¶¡¤º¹F¨ì ≥ 1:160)¡C 1 ³o¨Ç²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ¡A·í»P¹ï·Ó²Õ¤ñ¸û¡A¦³¥H¤Uµ²ªG:(HR PFS OS ³£¦³ÅãµÛ®t²§) PFS¡AHR = 0.71 [95%CI 0.52-0.97]¡Ap= 0.029¡F OS¡AHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04¡F 2²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ¡A©MµL§K¬Ì¤ÏÀ³±wªÌ¤ñ¸û¡A¦³¥H¤Uµ²ªG:(³oÓ²Õ¤º¤ñ¸ûªºµ²ªGÀ³¬O¯E¹©¬ãµo¤Hû³Ì³¶ÅDªº) PFS¡AHR = 0.52 [95%CI 0.37-0.71]¡Ap< 0.0001¡F OS¡AHR = 0.52 [95%CI 0.29-0.92]¡Ap= 0.025 ¡]µ²ªG¸g°ò¦¯e¯fª¬ºA/²üº¸»XÀøªk¨Ï¥Î±¡ªp®Õ¥¿)¡C ³o¨âÓµ²ªGÅã¥Ü¡A²£¥Í§K¬Ì¤ÏÀ³±wªÌªºPFS ©MOS³£¦³ÅãµÛ§ïµ½¡C 3½×¤åºKn«á±´£¨ì: ¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨ 9 ¦¸OPTª`®gÀøµ{ªÌ¡A¨äPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡C ¾ãÅé¦Ó¨¥¡AOPT-822/OPT-821 @¨ü©Ê¨}¦n¡F³Ì±`¨£ªºÃĪ«¬ÛÃö¤£¨}¨Æ¥ó¬° 1¡B2 ¯Åªºª`®g³¡¦ì¥Ö½§¤ÏÀ³¡C ¯E§J¤j:¨äPFS¤]¦³§ïµ½ÁͶÕ, ³o·|¤£·|¬OÁÙ¦bÆ[¹î¤¤ , P = 0.057 ¤]¤£¬O³Ì«áµ²ªG , ¤]´N¬O»¡168 ¨Ò±wªÌ (48%) §¹¦¨ 9 ¦¸ª`®gÀøµ{¤¤ªº¹êÅç²ÕPD¤H¼Æ ©|µLªkµe¥XMPFS¦s¬¡¦±½u ??? |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/20 ¤W¤È 07:57:33²Ä 1547 ½g¦^À³
|
Pie¤j Cliff¤j À³±zÂI¦W ¦^À³¦p¤U Y¦³»~ ½Ð§ó¥¿ 1.©ó¥´§¹¤E°wOPTªº¸s²Õ, ¥H¤Î¹ï·Ó²Õ, ·Q¹³¤@¤U¥L̪ºKM¹Ï «eªÌ¦b37¶g«e³£¬O§¹¥þ¥ªº, ¨S¦³¤U°, 37¶g«á¤~¶}©l¤U°, ¡K¡K¡K>¦¹¬q»¡ªk¡A¤£¦X¤@¯ëKM¦±½uª¬ªp¡A¤@¯ëKM¦±½u¬O ¥ª°ª¥k§C »¼´î¨ç¼Æ¹Ï§Î ³Ì¥kºÝ³q±`¦³Ãþ¦ü¤ô¥½uªº±¡§Î 2.MPFS¤£ª¾¹D·|¦b¦h»·³B «áªÌ¥i¯à±q²Ä¤@¶g´N¶}©l´Néwªº¤U° ........>mpfs¨S¤½§G ½Ö³£»¡¤£·Ç ¦±½u¤U°µ{«×¤]¬O¦p¦¹ 3.¦L¶H¤¤§A¤§«e©M¤p©_¤j±À¥XPÈ«j±j¤j©ó0.05ªºKM¹Ï, «e´Á¨â²Õ¬O«Ü±µªñªº, «á´Á¤~¤À¶}.....>¬Oªº¡A¬Æ¦Ü§Ú̼ÒÀÀ¥X¨Ó¬O¥i¯à¦³±±¨î²Õªºmpfs¤ñ ¹êÅç²Õªº¤j¡A¤~¦³¿ìªk©è®ø¹êÅç²Õ«p§À¼Ë¥»ªº®ÄªG 4.²{¦b³o¨â²ÕKM¦±½u¥i¯à¤@¶}©l´N¤À¶}¤F, ÁÙ·|º¥º¥©Ô¤j®t¶Z, PÈ¥u¦³0.057, ¦³ÂIÃø¥H·Q¹³.....>¦p«ez¡Akm¦±½u¤@¶}©l°_ÂI³£¤@¼Ë,¦ý¬O¹êÅç²Õ¥´°w«á,¥X²{®û¼í²{¶H¡A³Q§PÂ_¬°LR PD ©ó¬O²Îp¤Wpfs´N½T»{¦¹¦s¬¡®É¶¡,µe°O¦bkm¦±½u¤W ¨Ãpºâ²Ö¿nªº¦s¬¡¤ñ²v,©Ò¥H´Nµe¥XÀHµÛ®É¶¡¼W¥[ ¦ý¬O¦s¬¡¤ñ²v»¼´îªº¦±½u ³Ì«á¹êÅçµ²§ô«e¨Sµo¯fªº ´N¬O«p§À ¦Ü©ó¦h«p ´N¬O¬Ý¤ô¥½u¤Á¨ìy¶bªº¤ñ²v §ÚÌ·íµMı±o¶V°ª¶V¦n ³o±µªñCRªº·§©À ²³æ¨Ó»¡ ¹êÅç²Õkm¦±½u«e´Á¤U°§Ö «á´Á¥½w ¦Ó¹ï·Ó²Õ¤ñ¸û«e´Á½w «á´Á§Ö ©Ò¥H mpfs¤@¤Á¨ì0.5¤ñ²v®É ¦ApºâpÈ ´NÅܱo¤£ÅãµÛ ¦ý¬O¦pªG¥h¬Ý¹êÅç²Õ«á´Áªº¼Ë¥» Á|¨Ò IgG¿@«×>160ªº¼Ë¥» ¨Ó¤ñ¸û±±¨î²Õ ´N¥i¥H¬Ý¨ì¨â±økm¦±½u¤@¶}©l´N©Ô¶}¶ZÂ÷ 5,cox¼Ò¦¡¬OÀËÅç¨â±økm¦±½uªº·ÀI¤ñ¨ç¼Æ¤§¼Æ¾Ç¼Ò¦¡ ¦ý¦³HRÀHµÛ®É¶¡«í±`ªº°²³] ¬°¤F³B²z¹ê»Ú¤WÀù¯g¯f¤H®É¶¡¶V¤[ ¯fµo¾÷·|¶V°ªªº±¡§Î ¦³¤TºØ±Æ°£¤èªk ¦pCliff©Ò´£¨Ñªººô¸ô¤å¥ó ¥»¹êÅç±Ä¨ú®É¶¡¬Û¨Ìªº¤è¦¡¨Ó±Æ°£ §Ṳ́§«e¼ÒÀÀ ¨Ã¨S¦³¹ï¦¹±Æ°£ |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/20 ¤W¤È 01:34:48²Ä 1546 ½g¦^À³
|
Cliff¤j ·PÁÂ, ¦A§ä®É¶¡¾Ç²ß ¯E§J¤j, Ãö©ó¥´§¹¤E°wOPTªº¸s²Õ, ¥H¤Î¹ï·Ó²Õ, ·Q¹³¤@¤U¥L̪ºKM¹Ï «eªÌ¦b37¶g«e³£¬O§¹¥þ¥ªº, ¨S¦³¤U°, 37¶g«á¤~¶}©l¤U°, MPFS¤£ª¾¹D·|¦b¦h»·³B «áªÌ¥i¯à±q²Ä¤@¶g´N¶}©l´Néwªº¤U° ¦L¶H¤¤§A¤§«e©M¤p©_¤j±À¥XPÈ«j±j¤j©ó0.05ªºKM¹Ï, «e´Á¨â²Õ¬O«Ü±µªñªº, «á´Á¤~¤À¶} ²{¦b³o¨â²ÕKM¦±½u¥i¯à¤@¶}©l´N¤À¶}¤F, ÁÙ·|º¥º¥©Ô¤j®t¶Z, PÈ¥u¦³0.057, ¦³ÂIÃø¥H·Q¹³ T^T¤j, Ãö©ó Atezolizumab, ¥H¥Ø«e¬d¨ìªº¸ê°T¨Ó¬Ý (¹êÅ礤PDL1°ªªí²{ªÌ¬ù¦û1/3) ¾ãÅéORR 15%, PDL1°ªªí²{ªÌORR 26%, PDL1µy§Cªí²{ªÌORR 18% ¾ãÅéMOS 7.9Ó¤ë, PDL1°ªªí²{ªÌMOS 11.4Ó¤ë, PDL1³Ì§Cªí²{ªÌMOS 6.7Ó¤ë ¾ãÅéMPFS 2.1Ó¤ë OBI822¯à¹ï50%ªº¤H°_ÅãµÛÀø®Ä, ¬Ý¨ÓÁÙ¤£¿ùªü, ´Nµ¥§ó¸Ô²Óªº¼Æ¾ÚÅo |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/5/20 ¤W¤È 12:49:27²Ä 1545 ½g¦^À³
|
¹x¥Û¤j¡G ±z´£¨ì¡uGH-specific IgG/IgM ¯à¦P®É»{ÃÑ GH¡BSSEA-3¡BSSEA-4 ³o¤TºØ§Üì (¦]¬°¤TªÌªø±o«Ü¬Û¹³)¡A©Ò¥H¯à»¤µo§K¬Ì²ÓM¦P®É¥hª®±þ±a¦³¥ü¤TºØªí±§Ü쪺Àù²ÓM¡C©Ò¥HµL¶·¦Ò¼{¥t¥~¨âºØ§Ü쪺 UgG/IgM¡C¡v ¤p§Ì¹ï³o¼Ëªº»¡ªk«ù«O¯d¬Ýªk¡A¦]¬°¨º±N¹H¤Ï§ÜÅé-§Üì±M¤@©Ê¡]½Ðª`·NGH-specificªº·N¸q¡^¡AÓ¤H»{¬°¬OGH³Q§Üì§e²{²ÓM¡]APC¡F¨Ò¦p¾ð¬ð²ÓM«K¬O¨ä¤¤¤@ºØ¡^§]¾½«á·|³Q¥´¸H¡A¥i¯à¦]¦¹¥X²{SSEA-3¡BSSEA-4¡A«Ý³o¤TºØ§Üì³Q§e²{¦bAPCªº²ÓM½¤®É¡A·|»¤µo¥X«áÄòªº¤@¹ï¤@ªº§ÜÅé¥X¨Ó¡GGH»¤µo¥X¹ï§ÜGHªº§ÜÅé¡BSSEA-3»¤µo¥X¹ï§ÜSSEA-3ªº§ÜÅé¡BSSEA-4»¤µo¥X¹ï§ÜSSEA-4ªº§ÜÅé¡A³o¼Ë¤ñ¸û¦X²z¡C ÁÙ¦³888¬O°w¹ïGH©Ò¬ãµoªº³æ®è§ÜÅé¡A§Ú¿Ë¤f°Ý¹L¥¦ªº¥Í¥À¡A¤½¥qªº¿à¥D¥ô¡A¤£·|¬O¤@¥´¤T¡AY¬O¤@¥´¤T¡A¨º¥¦ªº»ùÈ·|°§C¡A¦]¬°±M¤@©Ê¤£°÷¡C ˬO¹Ç¤j´£¨ìªº¡uSSEA3, SSEA4 ¬O§_¤]¦³¦p¦PGH¡A²ÎpPFS/OS¨Ã¶i¦æ¬Û¤¬¤ñ¸û? ÁÙ¬O»¡¤½¥q²Îp¤w¸g±NSSEA3,SSEA4³£²[»\¶i¥h¡AªxºÙGH¨t¦C¡v¡A§Ú쥻ı±o¬O¦³¥i¯à¡A¤]´N¬O»¡ºKnùتºGH¤@µüªx«üGH series¡A¦ý¬O¬dÃÒ^¤åºKnì¤å¨Ã¥¼´£¨ìGH seriesªº¦r²´¡A©Ò¥HºKnùØ©Òz¡AÓ¤HÁÙ¬O»{¬°¬O³æ«üGH§ÜÅé¦Ó¤w¡A¨Ã¥¼§â§ÜSSEA-3¡BSSEA-4§ÜÅ骺Àø®Äp¤J¡C pie¤j¡G ±z°Ý¨ì¡u®É¶¡¬Û¨ÌCox¤ÀªR¦³¤°»ò¯S§Oªº¦a¤è?¡v °ò¥»¤W¡ALog-rank testªº¯ÊÂI¬O¥u¯à´£¨ÑpÈ¡F¦ýCox¤ÀªRÁÙ¥i´£¨ÑÀø®Äµû¦ô¡]treatment effect¡^¡A¤]´N¬OHR¡]·ÀI«ü¼Æ¡^¡C¥i¥H°Ñ¦Ò³o¤@½g¡G¡uÀù¯g¸ÕÅ窺¦s¬¡¸ê®Æ¤ÀªR¡v¡]www.cde.org.tw/Content/Files/Knowledge/b0801107-dd21-41ef-8c7d-4c6c2edf1bd7.pdf ¡^¡CùرªºPage 8ªº²Ä¤GÂI¡u¦bCox¼Ò«¬¤¤¥[¤J¤@Ótime-dependentªºÅܼÆ...¡v¡A¬O¤£¬O´N¬O822ºKn¤¤ªº³Ì«á¤@¬q´£¨ìªº¡u®É¶¡¬Û¨ÌªºCox¤ÀªR¡v¡H ¦³½Ð«ù¤[ªº¯E§J¤j¡B²q·Q¤j¡B¹Ç¤j¡B¤p©_¤j¡B¤Ñ©R¤j¡Kµ¥¥Í²Î°ª¤â¸ÑŪ¡C ¸Û¤ß¤j¡G ±z»¡¡u§Ú¥h¥´¤F¬y·P¬Ì],¦b¬y·P°ª®p´Á®É,¤p§Ì¨Ã¨S¦³³Q¶Ç¬V,³o¨ì©³¬O¬Ì]²£¥Í¤F§@¥ÎÁÙ¬O§Úªº©è§Ü¤O±j?¡v ¤p§Ìı±o¤Wz¨âºØ±¡§Î³£¦³¥i¯à¡A¦A¥[¤W¤@Ó¡G±z¹B®ð¦n¡A¨S³Q¬y·P¯f¬r§ðÀ»¨ì¡C¤ñ¸û¦nªº¸ÑÄÀ¬O¦]¬°¬Ì]²£¥Í¤F§@¥Î¡A¨Ï±zªº©è§Ü¤OÅܱj¡A§Y¨Ï³Q§ðÀ»¤]µL®~¡C T^T¤j¡G ¡uÓ¤H¡v»{¬°822ªºCR·|¤ñAtezolizumabªº6%°ª¡A¦ý¥Ø«e¸ê®Æ¤£¥þ¡A¥þÄÝÓ¤H²q´ú¡A´Nµ¥¥¼¨Ó¼Æ¾Ú´¦¾å¡C ¥H¤U¯ÂÄݶòq¡A²@µL®Ú¾Ú¡A©Ò¥H¤£¥Î°Ý§Ú¬°¤°»ò¬O³o¼Ëºâ¡C 168¦ì¤¤¦³2/3¬O¸ÕÅç²Õ¡A§Y112¦ì¡CÕY¦³10¦ìNED¡A¨º10/112¡×8.9¢H¡Ö6¢H¡C ¦A»¡¤@¦¸¡A¯ÂÄݽM²q¡A¤£n·í¯u¡I |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/19 ¤U¤È 09:53:30²Ä 1544 ½g¦^À³
|
FDA Approves Atezolizumab for Bladder Cancer ù¤óªºP2¯f¤H¬Ometastatic bladder cancer progression post chemotherapy. ³oÓ±Ú¸s¯f¤H¥§¡¦s¬¡¤£¨ì6Ó¤ë¡A¦Ó¥B¨S¦³¥ô¦ó¦³®ÄªvÀø¤èªk¡Cµ²ªG¦³6%ªº¯f¤H CR¡A PDL1°ªªí²{¯f¤H12%CR¡C¯f¤H¦s¬¡´ÁÅãµÛ¤j´T©µªø¡C FDA·íµM·|approve. §Ú«Ü·Q¬Ý¬ÝOBI822ªº CR¦³¦h¤Ö |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/19 ¤U¤È 09:40:13²Ä 1543 ½g¦^À³
|
PIE¤j ³oÓ¸s²Õ©M¹ï·Ó²Õ¬Û¤ñ, PÈÁÙ¥u¦³0.057, ¬Oªí¥Ü¹ï·Ó²Õªí²{¸Ø±i±o¦n¶Ü? ©Ò¨¥®t¨o PÈ0.05 »P0.057®t²§«Ü¤p §Y²Îp®t²§¤p ¦ý¬OÁ{§É®ÄªG®t²§¤j ¤§«e¸Ñª¼®É¡A§Ú¸ò¤p©_¤j½×ÃÒ¹L¤F ¤]´£¨Ñ¼ÒÀÀ¼Æ¾Ú»PKM¹Ï ²³æµ²½× ¦]¬°¬OºKn ©Ò¥H¨S¦³´£¨Ñ¨â²ÕPFS OS ¦ý¬O ³o¸s²Õ¤ñ¹ï·Ó²Õ ¤@©wn¦n |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/5/19 ¤U¤È 09:29:39²Ä 1542 ½g¦^À³
|
T¤j©Ò´£ªº°ÝÃD«Ü¦n¡A½T¹êÀ³¸Ó«ùÄò°l¨s¡C ¥Ø«e¾ãÅé¹êÅç²ÕªºOS¼Æ¾Ú¡AHR¤¤È¬O0.79¡A¨Ã¤£®t¡A¦ý¬OCI°Ï¶¡¹L¤j¡A0.5~1.2¡C©Ò¥HPÈ°ª¹F0.27¡C ¤½¥q»¡trending significant¡A¦ý¬O³Ì²×PÈ·|¦¬ÀĨì¦h¤Ö¨Ã¤£²M·¡¡C¬O§_¤@©wn¨ì0.05¥i¯à¥¼¥²¡A¤£¹LÁ`¬O¶V§C¶V¨S¦³Äa©À¡C ¦hÁ¡I |
|
|
·|û¡Gªü©v10140551 µoªí®É¶¡:2016/5/19 ¤U¤È 09:25:52²Ä 1541 ½g¦^À³
|
²Ä¤@ÓPD-L1ÃÄÃÒ¹L¤F www.fiercebiotech.com/roche-bags-a-quick-approval-for-pd-l1-blockbuster-contender-atezo Roche¡¦s atezolizumab ª`·N¨ì¥L¬O¤G´Á®³ÃÄÃÒ¡AClinical trials¤W¦³64ÓÁ{§É... ¦Ü©ó¨º¨âÓPD-1ÃÄ¡A¤@Ó¬O±µªñ300ÓÁ{§É¡A¥t¤@Ó¬O±µªñ200Ó... OPT-822¡A«h¬O¨âÓ¡An¥[ªo¡C |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/19 ¤U¤È 09:04:07²Ä 1540 ½g¦^À³
|
²Î¤@±i¬ã¨sû´£¨ì ¹êÅç²Õ¹B®ð®t ¤À¨ì§K¬Ì¤O®tªº¤H ¤ñ¸û¦h ¨S¿ù¡A³o¬O«D±`¤£¬ì¾Çªº»¡ªk¡A¤Ï±Á¿¡A¨º§Ú¤]¥i¥H»¡OBI822§ëÃÄ«á·|¨Ï³¡¤À¯f¤H´c¤Æ¥[§Ö ©Ò¥H¦bOS benefit ªº½T¹ê¼Æ¾Ú¥X¨Ó¤§«e¡AÁÙ¬O¥u¯à»¡¼f·V¼ÖÆ[! |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/5/19 ¤U¤È 08:50:06²Ä 1539 ½g¦^À³
|
û¤u½s¸¹0822 ³ø¨ì ½Ð°Ý¤j®a¬O§_ª¾¹D¹êÅç²Õ»P¹ï·Ó²Õ¤À²Õªº³W«h? 1.Y¹êÅç¥i¥HÀH¾÷©â¼Ë¡A³W«h¬°¦ó? 2.Y¤£¯àÀH¾÷©â¼Ë¡A¦óºØ©â¼Ë¤èªk¬°¤§?³W«h¬°¦ó? 3.Y©â¼Ë«á¡A¥i¥HÀH¾÷¤À¬£ªºµ{§Ç¬°¦ó? 4.Y©â¼Ë«á¡A¤£¥i¥HÀH¾÷¤À¬£ªºµ{§Ç¬°¦ó? 5.Y¤£¥i¥HÀH¾÷¤À¬£¡A¤SnºÉ¶q±±¨î¨ä¥L¥i¯à²V»»ªºÅܶµ¡A¦p¦ó¨Ï¥Î¦@³m¤À¬£?¡Aµ{§Ç¬°¦ó? 6.Y¤£¯à¦@³m¤À¬£¡A¤S¦p¦ó¥H²Îp¤èªk±±¨î²V²cÅܶµ? ¥H¤WYª¾¹Dµª®× ´Nª¾¹êÅç²Õ»P±±¨î²Õ¦b¬ì¾Ç®aªº±±¨î¤U ¬OºÉ¥i¯àªº°ò·Ç½u¤@P ²Î¤@±i¬ã¨sû´£¨ì ¹êÅç²Õ¹B®ð®t ¤À¨ì§K¬Ì¤O®tªº¤H ¤ñ¸û¦h ¨ä¹ê³o»¡ªk ¸ò»¡¹ï·Ó²Õªº§K¬Ì¤O¤ñ¸û¦n ³£¬O¤@¼Ë¨S¦³¼Æ¦r®Ú¾Úªº²q·Q §ó¨S¦³¹êÅç±±¨î»P²Îp±±¨îªºÆ[©À |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/19 ¤U¤È 08:32:41²Ä 1538 ½g¦^À³
|
¸Û¤ß¤j: ¦³§K¬Ì¤ÏÀ³´N¦³ÅãµÛªºÀø®Ä?³o¬O³oÓÁ{§É¹êÅçnÃҹꪺ¡A¦ý§Ú¬Ý¨ìªº²{¦³¼Æ¾Ú¨S¿ìªkÃÒ¹ê°Ú! §Ú¬Ý¨ìªº¬O¦³§K¬Ì¤ÏÀ³¡A¯f±w¦s¬¡´Á¸ûªø¡A¦ý¬O³o¬O¦]ÁÙ¬OªGn¤p¤ß±À½×¡C ©Ò¥Hn¦³©ú½Tªº¹êÅç²Õ¤Î¹ï·Ó²Õ(¦¹¨â²Õ¬O¬Û¦P¥XµoÂI)¡A²{¦bsubgroup¤ÀªR¡A±À½×¦³®Äªº¨â²Õ«o¤£¬O¬Û¦P¥XµoÂI¡C §Ú¨Ã¤£¬O»¡OBI¨S®Ä¡A¦ýnÃÒ©ú¦³®Ä¡An¦A³]p¦nP3¡A§Ú¤£Ä±±o¬Oµu®É¶¡¥i¥H®³¨ìÃĵý¡C |
|
|
·|û¡G¸Û¤ß10142309 µoªí®É¶¡:2016/5/19 ¤U¤È 08:08:09²Ä 1537 ½g¦^À³
|
T^T¤j,§ÚÌ©Ò°Q½×ªº822¤£´N¬O¥D°Ê§K¬ÌÀøªk¬Ì]¶Ü?¥i¥H±Ò°Ê¤HÅ骺§K¬Ì¾÷¨î¥h¹ï§ÜÀù²ÓM,¦³§K¬Ì¤ÏÀ³ ´N¦³ÅãµÛªºÀø®Ä! ¸Ü»¡¤§«e§Ú¥h¥´¤F¬y·P¬Ì],¦b¬y·P°ª®p´Á®É,¤p§Ì¨Ã¨S¦³³Q¶Ç¬V,³o¨ì©³¬O¬Ì]²£¥Í¤F§@¥ÎÁÙ¬O§Úªº©è§Ü¤O±j? |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/5/19 ¤U¤È 07:37:59²Ä 1536 ½g¦^À³
|
¯Î°|ªø.¤½¥q¸gÀç¼h.¤jªÑªF(¤½¥q¬£¥ì·ù¥D) «D±`¦³¸Û«H»P¥¿ª½,³o¦b¥xÆW¥«³õ¤¤,¯u¬O¤Ö¨£ªº·¥«~ªü.. ¤Ó´Î¤F |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/19 ¤U¤È 06:50:17²Ä 1535 ½g¦^À³
|
ÁÂÁ¹x¥Û¤j&cliffªº»¡©ú¡A¥Õ¸Üªº»¡ nµû¦ô¥x¤j²¦·~©M¬F¤j²¦·~¾Ç¥Í©Ò±o¬O§_¦³®t²§¡A±N¥þ³¡¾Ç¥Íµû¤ñ«á©Ò±o¨S¦³®t²§¡C ¦ý¬O§â¥x¤j²¦·~«á´«¹L9Ó¤u§@(9¦¸ªvÀø)¦Ó¥B²{¦bÁÙ¦³¦¬¤J(¤´¦s¬¡)ªº¤H ©M©Ò¦³¬F¤j¾Ç¥Í©Ò±o¤ñ¸û«á µo²{¥x¤j²¦·~¾Ç¥Í½T¹ê¦¬¤J¤ñ¸û°ª¡C§ÚÁÙ¬O¬Ý¤£¥X¬O©À¥x¤jªºÃö«Y¡AÁÙ¬O¿z¿ï¦³¾Ô°«¤Oªº¾Ç¥Í[´«¹L9Ó¤u§@(9¦¸ªvÀø)¦Ó¥B²{¦bÁÙ¦³¦¬¤J(¤´¦s¬¡)ªº¤H]ªºÃö«Y |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/19 ¤U¤È 06:11:19²Ä 1534 ½g¦^À³
|
Ãö©ó½×¤å¤¤³Ì«á¤@¶µ¤ñ¸û, ¤p§Ì¦³ÓºÃ´b ¡u¸g®É¶¡¬Û¨ÌCox ¤ÀªR¨Ã»P¹ï·Ó²Õ¬Û¤ñ¤§«á¡A¹ï©ó§¹¦¨9¦¸OPTª`®gÀøµ{ªÌ¡A¨äPFS¤]¦³§ïµ½ÁͶÕ(HR = 0.66 [95% CI 0.42-1.01]¡AP = 0.057)¡C¡v ¯à§¹¦¨9¦¸OPTª`®gÀøµ{ªÌ, ªí¥Ü37©P¥¼PD, ³oÓ¸s²Õªº³Ì¤pPFS±q¤EÓ¤ë°_¸õ, MPFSÀ³¸Ó¬O§ó°ª ¥H³oÓ¸s²Õ©M¹ï·Ó²Õ¬Û¤ñ, PÈÁÙ¥u¦³0.057, ¬Oªí¥Ü¹ï·Ó²Õªí²{¸Ø±i±o¦n¶Ü? ÁÙ¬O»¡®É¶¡¬Û¨ÌCox¤ÀªR¦³¤°»ò¯S§Oªº¦a¤è? |
|
|
·|û¡Gpie10141536 µoªí®É¶¡:2016/5/19 ¤U¤È 06:04:05²Ä 1533 ½g¦^À³
|
2.¥t¥~¡A¤p§Ì¥Ø«e¦³ºÃ¼{ªºÂI¬O¡G¥u¦³¤@¦Ê¤»¤Q¤K¤H¥´§¹¤E°w¡A·íªì¤½§Gdrop outªº¤H¼Æ«o¥u¦³37¦ì¡H¤¤¶¡¸¨®tªº¼Æ¾Ú©|«Ý½T»{¡I °O±o¥h¦~¤¤ë®É¼Æ¾Ú¬OPD 229, drop out 37 PDªº¯f¤HYÁÙ¨S¥´§¹¤E°w, ¤]¤£·|Ä~Äò¥´¤F |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2016/5/19 ¤U¤È 05:19:18²Ä 1532 ½g¦^À³
|
¤j®a¨¯W¤F¡AÁÂÁ¤j®a¡I ¤p§Ì·Qªk¤À¨É¡G 1.³o¤@¦¸ªº¸Ñª¼¯uªº¬O¬Û·í¦¨¥\¡A¥i¥H¥Î¡u¾_¾Ù¡v¨Ó§Î®e¡A¦]¬°¬O¥D°Ê¦¡§K¬ÌÀøªk¡I¦Ó¥B¬O¥þ¥@¬É²Ä¤@Ó¥D°Ê¦¡§K¬ÌÀøªk¡I°O±o¯Î°|ªøªº¨º±i¹Ï¶Ü¡H¦b¹êÅç²Õ¤¤¡A±N¦³§K¬Ì¤ÏÀ³¡BµL§K¬Ì¤ÏÀ³©Ô¥X¨Ó¤ñ¸û¡ApȪG¯u¬Û·íÅåÆA¡I ¤½¥q¸Û«H¡B¯Î°|ªø¸Û«H¡ãȱo«H¿à¡I 2.¥t¥~¡A¤p§Ì¥Ø«e¦³ºÃ¼{ªºÂI¬O¡G¥u¦³¤@¦Ê¤»¤Q¤K¤H¥´§¹¤E°w¡A·íªì¤½§Gdrop outªº¤H¼Æ«o¥u¦³37¦ì¡H¤¤¶¡¸¨®tªº¼Æ¾Ú©|«Ý½T»{¡I 3.OS»Ý°lÂÜ5¦~¡A¥Ø«eªº¼Æ¾Ú¨Ã«D³Ì²×²Îp¼Æ¾Ú¡I 4.¬y·P¬Ì]ªº®ÄªG¤]¥u¦³¤C¦¨¦³ÃĮġA©µ¿ð¨â¶g«á¤~·|¶}©l§@¥Î¡A³o´N¬O¬Ì]ªº¯S©Ê¡I822¥i¬O¥Î¦bÀù¥½¯f¤H§r¡I 5.¤HÃþªvÀøÀù¯g¡A¹Ú´K¥H¨D´N¬O§Æ±æ¯à§ä¨ì§K¬ÌÀøªk¡A©Ò¥H¬ü°êÁ`²Î¼Ú¤Ú°¨¡A¥h¦~«Å¥¬Àù¯gµn¤ëp¹º¡A§Æ±æ¯à°÷¶}µo¥X§K¬Ì¬Ì]¡A¥HªvÀøÀù¯g¡A¦b¯E¹©ªº822¤W¡A¥Ø«e´N¬Oµn¤ëp¹ºªº¥ýÅX¡I©Ò¥H±N·|¾_°Ê°ê»Ú¡I 6.¥Ø«e«Ü¦h²Ó³¡¼Æ¾Ú©|¥¼¬Ý±o¥X¨Ó¡A¦ý¡A¤j¤è¦V¤w½T»{¤F¡A»P°|ªø¡B¤½¥q©Ò»¡¤@P¡I 7.¨¬°¯E¤Í¡A»P¦³ºa²j¡I ÁÂÁ¤j®aªº¥I¥X¡I¥[ªo¡I |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/5/19 ¤U¤È 03:40:45²Ä 1531 ½g¦^À³
|
ÁÂÁ¹x¥Û¤j»P«êô¤jªº»¡©ú ¨ä¹ê§Ú³Ì¥Dn§Æ±æ6/4¬Ý¨ì¬O¹Ï§Î¡A¤]´N¬O³o¤TºØK-M¦±½u (¸ÕÅç²Õ¹ï·Ó²Õ¡A50%°ª§ÜÅé»P¹ï·Ó²Õ¡A¹êÅç²Õ«e50%»P«á50%...µ¥) ÁÙ¦³¤ÀÃþ®ÄªG¡A§Y¶Pº¸»X/Her 2+, triple negativeµ¥ªº¤À§O"Àø®Ä"¦p¦ó 822ÁöµM¥i¥H°w¹ïµLÃÄ¥iÂ媺¤T³±©Ê(13%?)µÛ¤â¡A¦ýn±wªÌªá¿ú¶R³æÁÙ¬O±o¬ÝÃĮĦp¦ó ¦ýY¹ïHer2+¯à¤ñHerceptin+Perjeta²Õ¦XÃÄÁÙ±j¤j¡A³s³o¶ô¤]¦Y±o¨ì(23%) ·íµM³Ì¤j©vªºÁÙ¬O¦b»P¶Pº¸»XÀøªk¨Ï¥Î®Éªº²Õ¦X®ÄªG¡AÃĮİ÷¦n¤~¦Y±o¨ì ¾ãÅ饫³õ«Ü¤j¡A¯à¦³¦h¤jpotential »Pmarketing share...³o¬O¥¼¨Ó(¥~¸ê¡A§ë«H¡Aªk¤H¡A§A§Ú)µû¦ô«ÂI |
|
|
·|û¡G¤t´P10142339 µoªí®É¶¡:2016/5/19 ¤U¤È 03:26:33²Ä 1530 ½g¦^À³
|
¬Ý¨ì³oºØ¼Æ¾Ú¡A¬Æ¬O·P°Ê¡C¬JµM¬O¬ã¨s¡A«ÜÃø¯à°÷¹F¨ì100%®ÄªG¡A¦ý¥un¹ï¤j³¡¤À¨ÅÀù±wªÌ¦³®Ä¡A¤£Ä±±o«Ü°¶¤j¶Ü??¥[ªo!! |
|
|
·|û¡G«êô10142131 µoªí®É¶¡:2016/5/19 ¤U¤È 03:14:45²Ä 1529 ½g¦^À³
|
T¤j ¦HªÌ»{¬°¦¬®×¯f±w¨C¤Hªºª¬ªp¥»¨Ó´N¤£¦P¡A¦ý³£¬O3-4´Á¤w¸Õ¹L¨ä¥LÀøªk¦ÓµLªk§ïµ½ªº¯f±w¡A°ò¥»¤W³o¨Ç¤Hªº§K¬Ì¤O³£¬O«Ü®tªº¡A³o¨Ç¤H·í¤Uªº§K¬Ì¤O¥u¦³·¥ºÝÄê»P«D±`Äꪺ®t§O¦Ó¤w¡A©Ò¥HµLªk´N¦¹Â_©w²£¥Í§K¬Ì¤ÏÀ³ªÌ쥻ªº§K¬Ì¤O°ª©óµL§K¬Ì¤ÏÀ³ªÌ¡C ¦Ó¥B³æ´N¤w²£¥Í§K¬Ì¤ÏÀ³ªº50%ªºPFS»POS¤wÅãµÛÀu©ó¹ï·Ó²Õ¡A³o¼Ëªºµ²ªG´N¨¬¥H±Æ°£³o¼ËªººÃ¼{¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/5/19 ¤U¤È 03:14:16²Ä 1528 ½g¦^À³
|
±ø¤j¡A ¤p§Ìªº¸ÑŪ¬O¡GGH-specific IgG/IgM ¯à¦P®É»{ÃÑ GH¡BSSEA-3¡BSSEA-4 ³o¤TºØ§Üì (¦]¬°¤TªÌªø±o«Ü¬Û¹³)¡A©Ò¥H¯à»¤µo§K¬Ì²ÓM¦P®É¥hª®±þ±a¦³¥ü¤TºØªí±§Ü쪺Àù²ÓM¡C©Ò¥HµL¶·¦Ò¼{¥t¥~¨âºØ§Ü쪺 UgG/IgM¡C Y¤W±ªºÅÞ¿è¬O¹ïªº¡A¨º»ò833À³¸Ó¤]¬O¤@¼Ë¡A¤@¥´¤T¡C ¦Ü©ó888ªº¾÷¨î¬O¤@¥´¤TÁÙ¬O¤T¥´¤T¡A°Ý¤½¥qÅo¡I |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/5/19 ¤U¤È 02:51:16²Ä 1527 ½g¦^À³
|
T¤j¡A °Å¶KCliff¤jªº¦^À³¦p¤U¡G ¡u¹ïOPT-822/OPT-821²£¥ÍGlobo H ¯S²§IgG§ÜÅé (³o¬O«ü§ÜÅé®Ä»ù´¿¦bªvÀø´Á¶¡¤º¹F¨ì ≥ 1:160)¡C³o¨Ç²£¥Í§K¬Ì¤ÏÀ³ªº±wªÌ¡A·í»P¹ï·Ó²Õ¤ñ¸û¡A¦³¥H¤Uµ²ªG: PFS¡GHR = 0.71 [95%CI 0.52-0.97]¡Ap= 0.029¡F OS¡GHR=0.57 [95%CI 0.33-0.97]¡Ap = 0.04¡F¡v °£¤F¬Ý²Îp®Ä«×pȦ³¨S¦³¤p©ó0.05¥~¡AÁÙn¬ÝHRªº¼Æ¦r·U§C·U¦n¡F¥Bnª`·NCI¡]«H¿à°Ï¶¡¡^¦³¨S¦³¸ó¶V1¡C HR¬O·ÀI¯à¦]¥ÎÃĦӰ§C¦h¤Öªº«ü¼Ð¡AY¬OHR=0.71¡Aªí¥Ü«e²Õ¤ñ«á²Õªº·ÀI°¤F29¢H¡C CI¡]«H¿à°Ï¶¡¡^³£¤p©ó1¡A¨S¦³¸ó¶V1¡Aªí¥Ü¨C¦ì«e²Õ±wªÌ´X¥G³£¦³®ÄªG¡A¥u¬O®ÄªG¤j¤p®t§O¦Ó¤w¡A¤]´N»¡¨ºÓHR¡Õ1ªºµ²ªG¤£¬O³Qpooling¥X¨Óªº¡C Cliff¤j´£¨ìªºHR=0.71¬OPFS¡A¹ï§K¬ÌªvÀø¨Ó»¡¡A¥i¯à¤£¬O³Ì«nªº¼Æ¾Ú¡C¤£¹L¡A¦pªG§Æ±æ¥[³t§¹¦¨¥þ²y¤T´ÁÁ{§É¡A¯à¦³¤@Ó¦nªºPFS¼Æ¾Ú¯à°÷§ó§Ö®³¨ìÃÄÃÒ¡A¤£¥²¥hµ¥OS¼Æ¾Ú¡C ¤p§Ì§ó¬Ý«ªº¬OOSªºHR=0.57 (0.33~0.97)¡C¦Ü©óOSªºPÈ¥u¨ì0.04¡A«Ü¥i¯à¦]¬°¨â²Õªº¦s¬¡¤H¼ÆÁ٫ܦh¡An«ùÄò°lÂÜÀ³¸Ó¥i¥H¬Ý¨ìPÈ«ùÄò¤U°¡C ¤½¥q¦b2/22ªk»¡·í¤¤¥Î¤F¤@ӧήeµütrend-forward¡A¤½¥q»¡¹êÅç²Õªº OS becomes significant trending-forward, ¤]´N¬O»¡¶V©¹«á±¡A¨â²Õ¼Æ¾Ú·|¶V©Ô¶V¶}¡C³oӧήe¹ï©ó¾ãÅé¹êÅç²ÕªºOS¼Æ¾Ú¦P¼Ë¾A¥Î¡A½Ðª`·Ninterim OS¤ÀªRÁöµM¤£¨ãÅãµÛ©Ê¡A¦ý¬OOS/HRªº¦ôpȬO0.79 (0.51~1.22)¡APȬO0.29¡CÀHµÛ®É¶¡©Ôªø¡A¦pªG¹êÅç²ÕªºIgG«ùÄò¦³®Ä¡A´N·|§â¹êÅç²Õªº¦s¬¡¼Æ¾Ú©Ô¶}¡AÅýHRªºCI°Ï¶¡¦¬ÀÄ¡APȤU°¡C©Ò¥H²Î¤@¤µ¤Ñªº³ø§i»¡¤]¤£±Æ°£¾ãÅé¹êÅç²ÕªºOS·|¦b¤@¬q®É¶¡¤§«á¤U°¨ì0.05¡A¥i¥HÅý822ª½±µ¥Ó½ÐÃÄÃÒ¡C³o¬O§_¬OFDAµoÃÄÃÒªº¥²n±ø¥ó¡A¤p§Ì¤£ª¾¹D¡A¤]¤£»{¬°¡C¦]¬°³o¨Ç³£¬O²Îp¼Æ¾Ú¡A°ª§C¤£¬Oµ´¹ïÃöÁä¡CFDA³ÌÃö¤ßªº¬OMOA¡A¬Ý¨Ó¤wµLÄa©À¡C ¦³¨S¦³¥i¯à¥u¬O§K¬Ì¤O¦nªº¤H´N¬¡±o¤[¡A¨ä¹ê¸ò822ªºÃĮĵLÃö¡H¨ä¹ê³oµ¥©ó¬O»¡¡y822©Ò¿EµoªºGH-specific IgG/IgM¬O¾ÉPPFS»POS§ïµ½ªºÃöÁäMOA¾÷¨î¡z³oÓ°²»¡¦³°ÝÃD¡C³o¬OÓ®Ú¥»°ÝÃD¡A¤p§Ìª½Ä±»{¬°FDA¨Ã¥¼n¨Dt±ªºÁ|ÃÒ³d¥ô¡C©Î³\¤½¥q¥i¥Hµ¹¥X§ó§¹¾ãªºµªÂСC |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/5/19 ¤U¤È 01:56:02²Ä 1526 ½g¦^À³
|
ÁÂÁÂcliff¤jªº»¡©ú ªø½u¤jªº»¡©ú¤]«Ü¦X²z ¤µ¤Ñ½×¤åºKn¥X¨Ó¡AÃÒ©ú¯Î°|ªø»P±i¸³¶ÀÁ`»¡ªº³£¬O¯uªº¡A¤]´N¬O¦³§ÜÅé´N¦³Àø®Ä ¤w¸g¥i¥H±ÀÂ_822³£¨ã¦³§K¬Ì¤ÏÀ³ªº¯S©Ê(³¡¤À¤ÏÀ³¡A§K¬Ì©µ¿ð¡A®û¼íµ¥) §Ú·Q¦b6/4¬Ý¨ì½×¤åªº«ÂI¬O: 1.K-M¦±½u¡A¹êÅç²Õ¥¼¤ÀÃþªºPFS³Âªá, OS¬O§_³vº¥¤À¶}? ³oÓÁÙ¤£¬O³Ì«nªº¡A²Ä2ÂI¤~¬O¬ÝÂI 2.K-M¦±½u¡A¹êÅç²Õ¤ÀÃþ«á»P¹ï·Ó²ÕªºM PFS & M OS, ²¦³º°£¤FORR, P VALUE¥~¡AM PFS»PM OS¬O ¦Ò¶q822¯à°÷¨ã¦³¦h¤Ö¥«³õÄvª§¤O»P»ùȪºÃöÁä 3.¦pªG¦©±¼¦]¬°®û¼í¦Ó»~§P¬°PD¹ï¾ãÅé¸Ñª¼¥¼¹Lªº¼vÅT¦³¦h¤j? ³o¨Ç¤H«áÄò¬O§_ÁÙ¦³ÃĮġA§YOSªº"§ïµ½" (¦]¬°¤w§PPD) 4.¾ãÅéOS§ïµ½µ{«×¡AY822§ï¥ÎOS¨Ó¬Ý§ïµ½¬O§_¤ñPFS§ó¨Î«ÈÆ[¥B¦³§Q«áÄò¤T´Á¶i¦æ 5.SSEA3, SSEA4 ¬O§_¤]¦³¦p¦PGH¡A²ÎpPFS/OS¨Ã¶i¦æ¬Û¤¬¤ñ¸û? ÁÙ¬O»¡¤½¥q²Îp¤w¸g±NSSEA3,SSEA4³£²[»\¶i¥h ªxºÙGH¨t¦C .... ´Á«Ý6/4 |
|
|
·|û¡GT^T10142245 µoªí®É¶¡:2016/5/19 ¤U¤È 01:30:31²Ä 1525 ½g¦^À³
|
½Ð°Ý±q³o¼Ëªº¼Æ¾Ú¡A¦p¦óÃÒ©ú¯f¤H¦s¬¡¬OOBI822ªºÀø®Ä¡A§Úªº¸ÑŪ¬O ¦³IGGªº¤H¬¡±o¤[¡A¦ý¥i¯à¤]¥u¬O³o²Õ¤H¥»¨Ó§K¬Ì¤O´N¦n¡A©Ò¥H¬¡±o¤[¡A°²³]¹ï·Ó²Õ¤]¦³¬Û¦P¤ñ¨Òªº¤H¬¡±o¤[¡A¨º¨Ã¤£¬OÃĪ«ªºÀø®Ä(©Ò¥HP>0.05)¡A¦Ó¬O¯f¤H¥»¨¯S½è¡C |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/5/19 ¤U¤È 01:18:04²Ä 1524 ½g¦^À³
|
Understanding Breast Cancer Survival Rates www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-survival-by-stage 0 1 ´Á ¨ÅÀù5¦~¬Û¹ï¦s¬¡²v100% 2 ´Á¨ÅÀù5¦~¬Û¹ï¦s¬¡²v93% 3´Á¨ÅÀù5¦~¬Û¹ï¦s¬¡²v73% 4´Á¨ÅÀù5¦~¬Û¹ï¦s¬¡²v22% (¨ÅÀùOBI822¹êÅç²Õ¹ï¶H¬OÄÝ©ó Stage IV ) ¨ÅÀù5¦~¦s¬¡²v¦p¤W¡C ¹ï4´Á¨ÅÀù50%¦³®Ä¡A¨º®³¨ÓªvÀø2´Á¡B3´Á¨ÅÀù¡A¨Ã¹w¨¾½Æµo¡I¨º¡u¤@©w¡v¬O¤@ӫܦnªº¿ï¾Ü¡I OBI-822«D¥P¤¦¡A¦ý¡u¤@©w¡v¬O§®ÃÄ¡I |
|
|
·|û¡Gªø½u10139882 µoªí®É¶¡:2016/5/19 ¤U¤È 12:51:39²Ä 1523 ½g¦^À³
|
¦U¦ì¤j¤j¦n ½Ð°O±o±i¸³Á¿ªº ¹êÅç²Õ¦³¤Ó¦h¤H´£¦¥X§½¡]¤£µM¦U¦ì¤j¤j¦³»Ý¨ü³o¤TӤ몺·Î¼õ¶Ü¡H¡^ ®¥³ß¦U¦ì´N¬OÁÙ¦nÀø®Ä¬O«D±`¦n¡]¦³¤ÏÀ³¸ò¨S¤ÏÀ³¥i¹F¨ì«D±`ÅãµÛªºÀø®Ä¡A¦³¤ÏÀ³¸ò¨S¤ÏÀ³¥i¹F¨ì«D±`ÅãµÛªºÀø®Ä¡A¦³¤ÏÀ³¸ò¨S¤ÏÀ³¥i¹F¨ì«D±`ÅãµÛªºÀø®Ä¡A¤Ó«n¤F¡^¤]½T©wOBIªº¾÷Âà¬O¨S°ÝÃD¡A³o¤£«n¶Ü¡H³o¨Ç¥þ¬O§ÚÌnªº¡C¦Ü©ó¦³¦h¤Ö¤H¦³®Ä¡A¥Ñ¤µ¤Ñ¬Ý¨ì¦Ü¤Ö¬O¶P©µ¥ªº¨â¿¡A³o¤£¦n¶Ü¡H¦A¨Ó°ª¦w¥þ©Ê¡A³o´XÂI¨Ó¬Ý¤£±o¤F¤F¡I¡I¡I ¨ä¹ê¤j®a¤£n·Q¦¨¤Ó½ÆÂø¡A´N¬O¦³¤ÏÀ³¸ò¨S¤ÏÀ³¦Ó¤w¡A¦p¤½¦Ð¸ò±i¸³»¡ªº¡A¥ý¥´´X°w´N¨M©w¤@¤Á¤F¡A´N¬O³o»ò²³æ¡C¤£n§âOBI-822·í¦¨®Úµ´Àù¯gªº³Ì«á¤@ÁûÃÄ¡A¨ºn¨D¤Ó°ª¤F¡A¡C«á±´N¯dµ¹OBI-833 OBI-888§a¡I ³Ì«á¯E¹©ªº»ùÈ¡A¥xÆW¤H¨S¿ìªk¤F¸Ñ¡ãü¡I¡]°£¤F¯Eª©ªº¯E¤ÍÌ¡^¯dµ¹¥~¸ê¥h¨É¨üÅo¡I |
|
|
·|û¡G«êô10142131 µoªí®É¶¡:2016/5/19 ¤U¤È 12:35:19²Ä 1522 ½g¦^À³
|
¹êÅç²Õ¨S§K¬Ì¤ÏÀ³ªÌÀ³¸Ó¤ñ¹ï·Ó²Õ¥þÅé®t ³o¬O¥¿±`ªº¡A¦]¬°¨S²£¥Í§K¬Ì¤ÏÀ³¡A´Nªí¥Ü³o¨Ç¤Hª¬ªp¯S§O®t¡A³o¸s¤H»P¹ï·Ó²Õ¾ãÅé(ª¬ªp¦nÃa³£¦³)¤ñ¸û¡A·íµM·|¦³³o¼Ëªºµ²ªG¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/5/19 ¤U¤È 12:05:41²Ä 1521 ½g¦^À³
|
IrisWe¤j¡A ±zªºÅÞ¿è¬Ý¨ÓÀ³¸Ó¬O¡G§ÜÅé²£¥Í¦hªº¯f¤H¸Ó¬O¦]¬°¥L̪º§K¬Ì¨t²Î±j¡A§K¬Ì¨t²Î±jªº¯f¤H´Nºâ¤£¥´822(©Î¬O822ªºÃĮĤ£¨º»òÅãµÛ)¡A¥L̪ºPFS¸òOS¼Æ¦r¤]·|¤ñ§K¬Ì¨t²Î®zªº¯f¤H(ªí²{¦bIgG§ÜÅ餣¨¬¤W)n¨Ó±o¦n¡C ³oÓÅÞ¿èÀ³¸Ó¤j®a³£·|±µ¨ü¡C °ÝÃD¬O¡A³oÓÅ޿誺Á{§ÉÅãµÛ©Ê¦³¦h¤j¡A¨Ã¨S¦³¼Æ¾Ú¥i¥HÃÒ©ú¡C¨Ò¦p»¡¡A¥¦ªºÅãµÛ©Ê¬O§_¶W¹L²Îp¤Wªº©â¼Ë»~®t¡C µL½×¦p¦ó¡A³o¬OÓ¦n°ÝÃD¡AÀ³¸Ó¦bªÑªF·|®É©Î¬O6/5§¹¾ã¼Æ¾Ú¤½¥¬¤§«áªºªk»¡·|®Én¤½¥q»¡©ú¤@¤U¡C ¤£¹L¬JµMGH-specific IgGªº²£¥Í»PÀø®ÄÃö«Y©ú½T¡AMOAÀ³¸Ó¤w¸g¹F¨ì¡A¤U±´N¬ÝÁ{§ÉÅãµÛ©Ê¯à¤£¯àÅýFDAÂIÀY¤F¡C |
|
|
|